¶¶Òõ¶ÌÊÓƵ

Scientia Professor Vlado Perkovic

Scientia Professor Vlado Perkovic

Professor
Division of VC & President
VC Office

Vlado Perkovic is the Provost at UNSW Sydney, and previously the Dean of the Faculty of Medicine and Health and Scientia Professor at UNSW, a Professorial Fellow at The George Institute, Australia, and was a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is clinical trials and epidemiology, in particular, in preventing the progression of kidney disease and its complications. He leads several major international clinical trials and serves on the Steering Committees of several others. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.


Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training at The Royal Melbourne Hospital. He is a Fellow of the Royal Australasian College of Physicians, of the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology.

Ìý

Ìý

  • Book Chapters | 2018
    Rahimi K; Perkovic V, 2018, '47 Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration', in Hypertension: A Companion to Braunwald's Heart Disease, Elsevier, pp. 433 - 441,
    Book Chapters | 2018
    Rahimi K; Perkovic V, 2018, 'Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists' Collaboration', in Hypertension: A Companion to Braunwald's Heart Disease, pp. 433 - 441,
    Book Chapters | 2015
    Jun M; Perkovic V, 2015, 'Fibrates: risk-benefits and role in treating dyslipidemias', in Dyslipidemias Pathophysiology, Evaluation and Management, Humana Press
    Book Chapters | 2014
    Wang AY; Jardine M; Perkovic V, 2014, 'Kidney Disease in Diabetes', in Managing Cardiovascular Complications in Diabetes, pp. 58 - 86,
    Book Chapters | 2014
    Wang Y; Perkovic V; Jardine M, 2014, 'kidney disease in diabetes', in Managing Cardiovascular Complications in Diabetes, John Wiley & Sons
    Book Chapters | 2012
    Wang Y; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2012, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', in Wang Y (ed.), , John Wiley & Sons, Ltd,
    Book Chapters | 2011
    Gangadharan Komala M; Pianta TJ; Jardine MJ; Webster AC; Perkovic V, 2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients', in Gangadharan Komala M (ed.), , John Wiley & Sons, Ltd,
    Book Chapters | 2011
    Jun M; Perkovic V; Cass A, 2011, 'Intensive glycemic control and renal outcome', in Diabetes and the Kidney, Karger Medical and Scientific Publishers
    Book Chapters | 2010
    Badve SV; Beller E; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2010, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', in Badve SV (ed.), , John Wiley & Sons, Ltd,
    Book Chapters | 2010
    Razavian M; Di Micco L; Palmer SC; Craig JC; Perkovic V; Zoungas S; Webster AC; Jardine MJ; Strippoli GFM, 2010, 'Antiplatelet agents for chronic kidney disease', in Palmer SC (ed.), , John Wiley & Sons, Ltd,
    Book Chapters | 2009
    Gallagher M; Perkovic V; Jardine M; Cass A, 2009, 'Lipid lowering in chronic kidney disease', in Therapeutic Strategies in Lipid Disorders
    Book Chapters | 2009
    Perkovic V; Venkataraman V; Cooper B; Zoungas S; Webster AC, 2009, 'Antioxidants for chronic kidney disease', in Perkovic V (ed.), , John Wiley & Sons, Ltd,
    Book Chapters | 2004
    Perkovic V; Craig JC; Masterson R; Webster A, 2004, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', in Perkovic V (ed.), , John Wiley & Sons, Ltd,
  • Journal articles | 2024
    Kim D; Perkovic V; Kotwal S, 2024, 'Barriers to Care: New Medications and CKD', Kidney International Reports,
    Journal articles | 2024
    Kotwal S; Perkovic E; Perkovic V, 2024, 'Combination therapy with kidney protective therapies: Optimizing the benefits?', Current Opinion in Nephrology and Hypertension, 33, pp. 136 - 143,
    Journal articles | 2024
    Marx N; Kolkailah AA; Rosenstock J; Johansen OE; Cooper ME; Alexander JH; Toto RD; Wanner C; Espeland MA; Mattheus M; Schnaidt S; Perkovic V; Gollop ND; McGuire DK, 2024, 'Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin A Secondary Analysis of Randomized Clinical Trials', JAMA Cardiology,
    Journal articles | 2024
    Neuen BL; Heerspink HJL; Vart P; Claggett BL; Fletcher RA; Arnott C; de Oliveira Costa J; Falster MO; Pearson S-A; Mahaffey KW; Neal B; Agarwal R; Bakris G; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.', Circulation, 149, pp. 450 - 462,
    Journal articles | 2024
    Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data.', Lancet Reg Health West Pac, 43, pp. 100988,
    Journal articles | 2024
    Sharma A; Marques P; Neuen BL; Fletcher RA; Slee A; Rapattoni W; Ang FG; Arnott C; Levin A; Verma S; Perkovic V; Mahaffey KW, 2024, 'Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 26, pp. 758 - 762,
    Journal articles | 2024
    Sharma A; Razaghizad A; Joury A; Levin A; Bajaj HS; Mancini GBJ; Wong NC; Slee A; Ang FG; Rapattoni W; Neuen BL; Arnott C; Perkovic V; Mahaffey KW, 2024, 'Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.', J Am Heart Assoc, 13, pp. e031586,
    Journal articles | 2024
    Talbot B; Davies S; Burman J; Ritchie A; Snelling P; Lynch S; Park Y; Jones B; Garvey V; Jaure A; Jardine M; Perkovic V; Gallagher M; Brandwood A; Kaur N; Knight J, 2024, 'The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system', Peritoneal Dialysis International,
    Journal articles | 2024
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA, 2024, 'VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.', J Am Soc Nephrol,
    Journal articles | 2024
    Tobe SW; Mavrakanas TA; Bajaj HS; Levin A; Tangri N; Slee A; Neuen BL; Perkovic V; Mahaffey KW; Rapattoni W; Ang FG, 2024, 'Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE trials.', Diabetes Care,
    Journal articles | 2024
    Trachtman H; Radhakrishnan J; Rheault MN; Alpers CE; Barratt J; Heerspink HJL; Noronha IL; Perkovic V; Rovin B; Trimarchi H; Wong MG; Mercer A; Inrig J; Rote W; Murphy E; Bedard PW; Roth S; Bieler S; Komers R, 2024, 'FSGS Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study', Kidney International Reports,
    Journal articles | 2024
    Zhang H; Rizk DV; Perkovic V; Maes B; Kashihara N; Rovin B; Trimarchi H; Sprangers B; Meier M; Kollins D; Papachristofi O; Milojevic J; Junge G; Nidamarthy PK; Charney A; Barratt J, 2024, 'Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy', Kidney International, 105, pp. 189 - 199,
    Journal articles | 2023
    Barratt J; Rovin B; Wong MG; Alpers CE; Bieler S; He P; Inrig J; Komers R; Heerspink HJL; Mercer A; Noronha IL; Radhakrishnan J; Rheault MN; Rote W; Trachtman H; Trimarchi H; Perkovic V, 2023, 'IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study', Kidney International Reports, 8, pp. 1043 - 1056,
    Journal articles | 2023
    Barratt J; Rovin BH; Zhang H; Rizk DV; Kashihara N; Maes BD; Trimarchi H; Sprangers B; Meier M; Kollins D; Junge G; Milojevic J; Papachristofi O; Perkovic V, 2023, 'WCN23-0412 EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS OVER TIME IN IgA NEPHROPATHY', Kidney International Reports, 8, pp. S271 - S272,
    Journal articles | 2023
    Charytan DM; Mahaffey KW; Jardine MJ; Cannon CP; Neal B; Lambers Heerspink HJ; Agarwal R; Bakris GL; De Zeeuw D; Levin A; Pollock C; Zhang H; Zinman B; Rosenthal N; Perkovic V; Di Tanna GL; Yu J; Rogers K; Arnott C; Wheeler DC, 2023, 'Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering', BMJ Open Diabetes Research and Care, 11,
    Journal articles | 2023
    Cheung CK; Barratt J; Carroll K; Lafayette RA; Liew A; Suzuki Y; TesaÅ™ V; Trimarchi H; Wong MG; Zhang H; Perkovic V; Rizk DV, 2023, 'Targeting APRIL in the Treatment of IgA Nephropathy.', Clin J Am Soc Nephrol,
    Journal articles | 2023
    Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Agarwal R; Bakris G; Chang TI; Heerspink HJL; Jardine MJ; Mahaffey KW; Neal B; Pollock C; Jun M; Rodgers A; Perkovic V; Neuen BL, 2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12,
    Journal articles | 2023
    Fletcher RA; Jongs N; Chertow GM; McMurray JJV; Arnott C; Jardine MJ; Mahaffey KW; Perkovic V; Rockenschaub P; Rossing P; Correa-Rotter R; Toto RD; Vaduganathan M; Wheeler DC; Heerspink HJL; Neuen BL, 2023, 'Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials', Journal of the American Society of Nephrology, 34, pp. 1965 - 1975,
    Journal articles | 2023
    Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2023, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases,
    Journal articles | 2023
    Heerspink HJL; Jongs N; Neuen BL; Schloemer P; Vaduganathan M; Inker LA; Fletcher RA; Wheeler DC; Bakris G; Greene T; Chertow GM; Perkovic V, 2023, 'Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials', Kidney International, 104, pp. 181 - 188,
    Journal articles | 2023
    Heerspink HJL; Jongs N; Schloemer P; Little DJ; Brinker M; Tasto C; Karpefors M; Wheeler DC; Bakris G; Perkovic V; Nkulikiyinka R; Rossert J; Gasparyan SB, 2023, 'Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression', Journal of the American Society of Nephrology, 34, pp. 2025 - 2038,
    Journal articles | 2023
    Heerspink HJL; Radhakrishnan J; Alpers CE; Barratt J; Bieler S; Diva U; Inrig J; Komers R; Mercer A; Noronha IL; Rheault MN; Rote W; Rovin B; Trachtman H; Trimarchi H; Wong MG; Perkovic V; Alarmartine E; Chae DW; Del Vecchio L; Floege J; Hwang SJ; Jelakovic B; Maes B; Malecki R; Miglinas M; Nolasco FEB; Praga M; Rabindranath K; Rosenberg M; Tang SCW; Tesar V; Bose B; Gangadharan M; McDonald S; Peh C; Jahan S; Yeap C; Clayton P; Irish G; Thyagarajan N; Hollett P; Krishnasamy R; Carroll R; Jesudason S; Crail S; Coates T; Waugh J; Noble E; Mahadevan K; Campbell V; Salehi T; Lim W; Boudville N; Chakera A; Chan D; Krishnan A; Eqbal Y; Gillies A; Vilayur E; Maung Myint TM; Gray N; Cheetham M; Pollock C; Cooper B; Mather A; Roxburgh S; Shen Y; Stangenberg S; Siriwardana A; O'Lone E; Wan S; Neuen B; Tsun Kit Ha J; Kim D; Heath L; Jain A; Phua E; Li Y; Gallagher M; Jardine M; Ritchie A; Razavian M; Foote C; Wyndham R; Sen S; Endre Z; Erlich J; Fernando M; Yong K; Luxton G; Kotwal S; Roger S; Wijeratne V; Packham D; Fraser I; Vandewiele B; Laute M; Lemahieu W; Jamar S, 2023, 'Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial', The Lancet, 401, pp. 1584 - 1594,
    Journal articles | 2023
    Heerspink HJL; Vart P; Jongs N; Neuen BL; Bakris G; Claggett B; Vaduganathan M; McCausland F; Docherty KF; Jhund PS; Solomon SD; Perkovic V; McMurray JJV, 2023, 'Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials', Diabetes, Obesity and Metabolism, 25, pp. 3327 - 3336,
    Journal articles | 2023
    Inker LA; Collier W; Greene T; Miao S; Chaudhari J; Appel GB; Badve SV; Caravaca-Fontán F; Del Vecchio L; Floege J; Goicoechea M; Haaland B; Herrington WG; Imai E; Jafar TH; Lewis JB; Li PKT; Maes BD; Neuen BL; Perrone RD; Remuzzi G; Schena FP; Wanner C; Wetzels JFM; Woodward M; Heerspink HJL; Estacio RO; Hanratty R; Chalmers J; Canetta P; Barrett B; Neal B; Perkovic V; Mahaffey KW; Johnson D; Jardine M; von Eynatten M; Verde E; Verdalles U; Arroyo D; Chapman A; Torres V; Yu A; Brosnahan G; Hannedouche T; Chow KM; Szeto CC; Leung CB; Xie D; Hou FF; Dwyer J; Pohl MA; Raz I; Hunsicker LG; Vanacker A; Malfait T; Maschio G; Locatelli F; Blankestijn PJ; van Zuilen A; Kobayashi F; Makino H; Chan JCN; Andrulli S; Pozzi C; Casartelli D; Praga M; Trujillo H; Cavero T; Sevillano A; Ruggenenti P; Perna A; Carrara F; Keane WF; Manno C; Haynes R; Herrington WG; Baigent C; Landray M; Rauen T; Seikrit C; Wied S; Toto RD; de Jong PE; Saddelli M, 2023, 'A meta-analysis of GFR slope as a surrogate endpoint for kidney failure', Nature Medicine, 29, pp. 1867 - 1876,
    Journal articles | 2023
    Jain SS; Yu J; Arnott C; Neal B; Perkovic V; Neuen BL; Jardine M; Mahaffey KW, 2023, 'Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial', International Journal of Cardiology,
    Journal articles | 2023
    Jain SS; Yu J; Arnott C; Neal BC; Perkovic V; Neuen B; Jardine M; Mahaffey KW, 2023, 'TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 81, pp. 283 - 283,
    Journal articles | 2023
    Januzzi JL; Mohebi R; Liu Y; Sattar N; Heerspink HJL; Tefera E; Vaduganathan M; Butler J; Yavin Y; Li J; Pollock CA; Perkovic V; Neal B; Hansen MK, 2023, 'Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial', Circulation, 148, pp. 651 - 660,
    Journal articles | 2023
    Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports,
    Journal articles | 2023
    KIM D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Billot L; Zhang H; Perkovic V; Wong MG, 2023, 'WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL', Kidney International Reports, 8, pp. S51 - S52,
    Journal articles | 2023
    Kang A; Smyth B; Neuen BL; Heerspink HJL; Di Tanna GL; Zhang H; Arnott C; Hockham C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Mahaffey KW; Perkovic V; Jardine MJ, 2023, 'The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials', Diabetes, Obesity and Metabolism, 25, pp. 2151 - 2162,
    Journal articles | 2023
    Koshino A; Oshima M; Arnott C; Fletcher RA; Bakris GL; Jardine M; Mahaffey KW; Perkovic V; Pollock C; Heerspink HJL; Neuen BL, 2023, 'Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial', Diabetes, Obesity and Metabolism, 25, pp. 1413 - 1418,
    Journal articles | 2023
    Marx N; Deanfield JE; Gerward S; Hovingh GK; Plunde O; Pratley RE; Staerk-Ostergaard J; Perkovic V, 2023, 'Prevalence of systemic inflammation in individuals with atherosclerotic cardiovascular disease: baseline characteristics from the SELECT, SOUL and FLOW phase 3 trials of semaglutide', European Heart Journal, 44,
    Journal articles | 2023
    Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N, 2023, 'Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis', Nephrology Dialysis Transplantation, 38, pp. 1448 - 1458,
    Journal articles | 2023
    Neuen BL; Perkovic V; Bakris GL; Lambers Heerspink H; Vaduganathan M, 2023, 'Abstract 17437: Estimated Lifetime Benefits of Combination Therapy With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-Steroidal MRAs in Patients With Type 2 Diabetes and Albuminuria', Circulation, 148,
    Journal articles | 2023
    Perkovic V; Barratt J; Radhakrishnan J; Rizk D; Trimarchi H; Khawaja Z; Leiske J; Sorensen B; King A; Jones-Burton C; Campbell K, 2023, '#4333 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY', Nephrology Dialysis Transplantation, 38,
    Journal articles | 2023
    Rizk DV; Rovin BH; Zhang H; Kashihara N; Maes B; Trimarchi H; Perkovic V; Meier M; Kollins D; Papachristofi O; Charney A; Barratt J, 2023, 'Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study', Kidney International Reports, 8, pp. 968 - 979,
    Journal articles | 2023
    Rossing P; Baeres FMM; Bakris G; Bosch-Traberg H; Gislum M; Gough SCL; Idorn T; Lawson J; Mahaffey KW; Mann JFE; Mersebach H; Perkovic V; Tuttle K; Pratley R, 2023, 'The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease', Nephrology Dialysis Transplantation, 38, pp. 2041 - 2051,
    Journal articles | 2023
    Singh AK; Claggett BL; Perkovic V; Hiemstra T; Khavandi K; Lukas MA; Ranganathan P; Shannon JB; van Adelsberg J; Solomon S, 2023, '#3807 HEART FAILURE IN ASCEND-ND AND ASCEND-D', Nephrology Dialysis Transplantation, 38,
    Journal articles | 2023
    Singh AK; Mccausland FR; Claggett BL; Wanner C; Wiecek A; Atkins MB; Carroll K; Perkovic V; Mcmurray JJV; Wittes J; Snapinn S; Blackorby A; Meadowcroft A; Barker T; Dimino T; Mallett S; Cobitz AR; Solomon SD, 2023, 'Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents - post hoc analyses of the ASCEND-ND and ASCEND-D trials', Nephrology Dialysis Transplantation, 38, pp. 1890 - 1897,
    Journal articles | 2023
    Sridhar VS; Neuen BL; Fletcher RA; Slee A; Ang FG; Rapattoni W; Arnott C; Cherney DZ; Perkovic V; Wheeler DC; Levin A, 2023, 'Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials', Diabetes, Obesity and Metabolism, 25, pp. 2331 - 2339,
    Journal articles | 2023
    TALBOT B; Davies S; Burman J; Ritchie A; Snelling P; Lynch S; Park Y; Jones B; Garvey V; Jaure A; Jardine M; Perkovic V; Gallagher M; Brandwood A; Knight J, 2023, 'WCN23-0574 THE ELLEN MEDICAL DEVICES AFFORDABLE POINT-OF-CARE PERITONEAL DIALYSIS SYSTEM - A PILOT STUDY', Kidney International Reports, 8, pp. S350 - S350,
    Journal articles | 2023
    Yi TW; Smyth B; Di Tanna GL; Arnott C; Cardoza K; Kang A; Pollock C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Heerspink HJL; Neal B; Wheeler DC; Cannon CP; Zhang H; Zinman B; Perkovic V; Levin A; Mahaffey KW; Jardine M; Brenner BM; Greene T; Jardine MJ; Meininger G; Li N; Kolesnyk I; Aizenberg D; Pecoits-Filho R; Cherney D; Obrador G; Chertow G; Chang T; Hawley C; Ji L; Wada T; Jha V; Lim SK; Lim-Abrahan MA; Santos F; Chae DW; Hwang SJ; Vazelov E; Rychlík I; Hadjadj S; Krane V; Rosivall L; De Nicola L; Dreval A; Nowicki M; Schiller A; Distiller L; Górriz JL; Kolesnyk M; David ; Wheeler C; Guerrero RAA; Albisu JP; Alvarisqueta A; Bartolacci I; Berli MA; Bordonava A; Calella P; Cantero MC; Cartasegna LR; Cercos E; Coloma GC; Colombo H; Commendatore V; Cuadrado J; Cuneo CA; Cusumano AM; Douthat WG; Dran RD; Farias E; Fernandez MF; Finkelstein H; Fragale G; Fretes JO; Garcia NH; Gastaldi A; Gelersztein E; Glenny JA; Gonzalez JP; Colaso PDCG; Goycoa C; Greloni GC; Guinsburg A; Hermida S; Juncos LI; Klyver MI; Kraft F; Krynski F; Lanchiotti PV; Leon de la Fuente RA; Marchetta N; Mele P; Nicolai S; Novoa PA; Orio SI, 2023, 'Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial', American Journal of Kidney Diseases, 82, pp. 84 - 96.e1,
    Journal articles | 2023
    Yi TW; Wong MMY; Neuen BL; Arnott C; Poirier P; Seufert J; Slee A; Rapattoni W; Ang FG; Wheeler DC; Mahaffey KW; Perkovic V; Levin A, 2023, 'Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 25, pp. 2043 - 2047,
    Journal articles | 2023
    Yu J; Sweeting AN; Gianacas C; Houston L; Lee V; Fletcher RA; Perkovic V; Li Q; Neuen BL; Berwanger O; Heerspink HJL; de Zeeuw D; Arnott C, 2023, 'The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 25, pp. 3724 - 3735,
    Journal articles | 2023
    Zhang YM; Lv JC; Wong MG; Zhang H; Perkovic V, 2023, 'Glucocorticoids for IgA nephropathy—pro', Kidney International, 103, pp. 666 - 669,
    Journal articles | 2023
    van der Hoek S; Jongs N; Oshima M; Neuen BL; Stevens J; Perkovic V; Levin A; Mahaffey KW; Pollock C; Greene T; Wheeler DC; Jardine MJ; Heerspink HJL, 2023, 'Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial', Clinical journal of the American Society of Nephrology : CJASN, 18, pp. 748 - 758,
    Journal articles | 2022
    Baigent C; Emberson JR; Haynes R; Herrington WG; Judge P; Landray MJ; Mayne KJ; Ng SYA; Preiss D; Roddick AJ; Staplin N; Zhu D; Anker SD; Bhatt DL; Brueckmann M; Butler J; Cherney DZI; Green JB; Hauske SJ; Heerspink HJL; Inzucchi SE; Jardine MJ; Liu CC; Mahaffey KW; McCausland FR; McGuire DK; McMurray JJV; Neal B; Neuen BL; Packer M; Perkovic V; Sabatine MS; Solomon SD; Vaduganathan M; Wanner C; Wheeler DC; Wiviott SD; Zannad F, 2022, 'Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials', The Lancet, 400, pp. 1788 - 1801,
    Journal articles | 2022
    Barraclough JY; Yu J; Figtree GA; Perkovic V; Heerspink HJL; Neuen BL; Cannon CP; Mahaffey KW; Schutte AE; Neal B; Arnott C, 2022, 'Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 24, pp. 1072 - 1083,
    Journal articles | 2022
    Feng Y; Li Q; Finfer S; Myburgh J; Bellomo R; Perkovic V; Jardine M; Wang AY; Gallagher M, 2022, 'A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation', Frontiers in Cardiovascular Medicine, 9,
    Journal articles | 2022
    Ferrannini E; Baldi S; Scozzaro T; Tsimihodimos V; Tesfaye F; Shaw W; Rosenthal N; Figtree GA; Neal B; Mahaffey KW; Perkovic V; Hansen MK, 2022, 'Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)', Diabetes Care, 45, pp. 1893 - 1899,
    Journal articles | 2022
    Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Heerspink HJ; Neal B; Jun M; Rodgers A; Perkovic V; Neuen B, 2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79,
    Journal articles | 2022
    Hammett C; Badve SV; Kerr PG; Tran HA; Dundon BK; Lo S; Wong A; Joseph JE; Deague J; Perkovic V, 2022, 'Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice', Heart Lung and Circulation, 31, pp. 1604 - 1611,
    Journal articles | 2022
    Heerspink HJL; Oshima M; Zhang H; Li J; Agarwal R; Capuano G; Charytan DM; Craig J; de Zeeuw D; Di Tanna GL; Levin A; Neal B; Perkovic V; Wheeler DC; Yavin Y; Jardine MJ, 2022, 'Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial', American Journal of Kidney Diseases, 79, pp. 244 - 256.e1,
    Journal articles | 2022
    Heerspink HJL; Stack AG; Terkeltaub R; Greene TA; Inker LA; Bjursell M; Perl S; Rikte T; Erlandsson F; Perkovic V, 2022, 'Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia', Nephrology Dialysis Transplantation, 37, pp. 1461 - 1471,
    Journal articles | 2022
    Kolkailah AA; Marx N; Rosenstock J; Johansen OE; Cooper ME; Alexander JH; Toto R; Wanner C; Espeland MA; Mattheus M; Schnaidt S; Perkovic V; Gollop ND; McGuire DK, 2022, 'Abstract 12404: Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin', Circulation, 146,
    Journal articles | 2022
    Koshino A; Schechter M; Sen T; Vart P; Neuen BL; Neal B; Arnott C; Perkovic V; Ridker PM; Tuttle KR; Hansen MK; Heerspink HJL, 2022, 'Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS', Diabetes Care, 45, pp. 2644 - 2652,
    Journal articles | 2022
    Kotwal S; Perkovic V; Heerspink HJL, 2022, 'Platform Clinical Trials Within Nephrology—Interpreting the Evidence', American Journal of Kidney Diseases, 80, pp. 143 - 146,
    Journal articles | 2022
    Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, 24, pp. 1927 - 1938,
    Journal articles | 2022
    Li JW; Arnott C; Heerspink HJL; Mbiostat QL; Cannon CP; Wheeler DC; Charytan DM; Barraclough J; Figtree GA; Agarwal R; Bakris G; de Zeeuw D; Greene T; Levin A; Pollock C; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Neal B; Jardine MJ, 2022, 'Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial', Journal of the American Heart Association, 11,
    Journal articles | 2022
    Liao J; Kang A; Xia C; Young T; Di Tanna GL; Arnott C; Pollock C; Krishnan AV; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Heerspink HJL; Levin A; Neal B; Wheeler DC; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ; Smyth B, 2022, 'The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial', Diabetes and Metabolism, 48,
    Journal articles | 2022
    Liyanage T; Toyama T; Hockham C; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Hooi LS; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2022, 'Prevalence of chronic kidney disease in Asia: A systematic review and analysis', BMJ Global Health, 7,
    Journal articles | 2022
    Lv J; Wong MG; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Zhao M; Barbour S; Jardine MJ; Reich HN; Cattran D; Glassock R; Levin A; Wheeler DC; Woodward M; Billot L; Stepien S; Rogers K; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Zhang H; Perkovic V, 2022, 'Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial', JAMA - Journal of the American Medical Association, 327, pp. 1888 - 1898,
    Journal articles | 2022
    Mahaffey KW; Baeres FMM; Bakris G; Bosch-Traberg H; Gislum M; Lawson J; Mann JFE; Mersebach H; Perkovic V; Rossing P; Tuttle K; Pratley R, 2022, 'Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial', European Heart Journal, 43,
    Journal articles | 2022
    Mc Causland FR; Singh AK; Claggett BL; Carroll K; Wittes J; McMurray JJV; Perkovic V; Snapinn S; Lopes RD; Solomon SD, 2022, 'Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply', The New England journal of medicine, 387, pp. 2482 - 2485,
    Journal articles | 2022
    McCausland F; Singh A; Claggett B; Carroll K; Wittes J; McMurray JJV; Perkovic V; Snappin S; Lopes R; Solomon S, 2022, 'Differing approaches to analyse on-treatment cardiovascular events comparing daprodustat with darbepoetin: results from the ASCEND-ND trial', European Heart Journal, 43,
    Journal articles | 2022
    Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K; Agodoa L; Algra A; Asselbergs FW; Beckett N; Berge E; Black H; Brouwers FPJ; Brown M; Bulpitt CJ; Byington B; Cutler J; Devereaux RB; Dwyer J; Estacio R; Fagard R; Fox K; Fukui T; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis J; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer C; Patel A; Pfeffer M; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Pitt B; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J, 2022, 'Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis', The Lancet Diabetes and Endocrinology, 10, pp. 645 - 654,
    Journal articles | 2022
    Neuen BL; Oshima M; Agarwal R; Arnott C; Cherney DZ; Edwards R; Langkilde AM; Mahaffey KW; McGuire DK; Neal B; Perkovic V; Pong A; Sabatine MS; Raz I; Toyama T; Wanner C; Wheeler DC; Wiviott SD; Zinman B; Heerspink HJL, 2022, 'Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized, Controlled Trials', Circulation, 145, pp. 1460 - 1470,
    Journal articles | 2022
    Nunes JC; Yu J; Arnott C; Jardine MJ; Perkovic V; Mahaffey KW, 2022, 'Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program', Diabetes, Obesity and Metabolism, 24, pp. 2459 - 2464,
    Journal articles | 2022
    Perkovic V; Blackorby A; Cizman B; Carroll K; Cobitz AR; Davies R; Dimino TL; Jha V; Johansen KL; Lopes RD; Kler L; Macdougall IC; Mcmurray JJV; Meadowcroft AM; Obrador GT; Solomon S; Taft L; Wanner C; Waikar SS; Wheeler DC; Wiecek A; Singh AK, 2022, 'The ASCEND-ND trial: study design and participant characteristics', Nephrology Dialysis Transplantation, 37, pp. 2157 - 2170,
    Journal articles | 2022
    Ridker PM; Tuttle KR; Perkovic V; Libby P; Macfadyen JG, 2022, 'Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy', European Heart Journal, 43, pp. 4832 - 4844,
    Journal articles | 2022
    Sarraju A; Bakris G; Cannon CP; Cherney D; Damaraju CV; Figtree GA; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Neal B; Jardine MJ; Blais J; Kosiborod M; Levin A; Lingvay I; Weir MR; Perkovic V; Mahaffey KW, 2022, 'Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria', Journal of the American College of Cardiology, 80, pp. 1721 - 1731,
    Journal articles | 2022
    See EJ; Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Davison S; Ghnaimat M; Harden P; Htay H; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx V; Neuen B; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; Syed S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Kazancioglu RT; Wang AYM; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey F; Perkovic V; Jindal KK; Okpechi IG; Tonelli M; Feehally J; Harris DC; Johnson DW, 2022, 'Availability, coverage, and scope of health information systems for kidney care across world countries and regions', Nephrology Dialysis Transplantation, 37, pp. 159 - 167,
    Journal articles | 2022
    Shah N; Perkovic V; Kotwal S, 2022, 'Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria', Expert Review of Clinical Pharmacology, 15, pp. 827 - 842,
    Journal articles | 2022
    Shaman AM; Bain SC; Bakris GL; Buse JB; Idorn T; Mahaffey KW; Mann JFE; Nauck MA; Rasmussen S; Rossing P; Wolthers B; Zinman B; Perkovic V, 2022, 'Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER', Circulation, 145, pp. 575 - 585,
    Journal articles | 2022
    Singh AK; Acharya A; Carroll K; Lopes RD; McCausland FR; Mulloy L; Perkovic V; Solomon S; Waikar SS; Wanner C; Wong MG; Cobitz AR; Mallett SA; Shaddinger BC; McMurray JJV, 2022, 'Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials', European Heart Journal, 43,
    Journal articles | 2022
    Singh AK; Blackorby A; Cizman B; Carroll K; Cobitz AR; Davies R; Jha V; Johansen KL; Lopes RD; Kler L; Macdougall IC; McMurray JJV; Meadowcroft AM; Obrador GT; Perkovic V; Solomon S; Wanner C; Waikar SS; Wheeler DC; Wiecek A, 2022, 'Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial', Nephrology Dialysis Transplantation, 37, pp. 960 - 972,
    Journal articles | 2022
    Singh AK; Cizman B; Carroll K; McMurray JJV; Perkovic V; Jha V; Johansen KL; Lopes RD; Macdougall IC; Obrador GT; Waikar SS; Wanner C; Wheeler DC; Wiecek A; Stankus N; Strutz F; Blackorby A; Cobitz AR; Meadowcroft AM; Paul G; Ranganathan P; Sedani S; Solomon S, 2022, 'Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial', JAMA Internal Medicine, 182, pp. 592 - 602,
    Journal articles | 2022
    Smeijer JD; Koomen J; Kohan DE; McMurray JJV; Bakris GL; Correa-Rotter R; Hou FF; Januzzi JL; Kitzman DW; Kolansky DM; Makino H; Perkovic V; Tobe S; Parving HH; de Zeeuw D; Heerspink HJL, 2022, 'Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure', JACC: Heart Failure, 10, pp. 498 - 507,
    Journal articles | 2022
    Smeijer JD; Koomen JV; Kohan DE; McMurray JJV; Bakris GL; Correa-Rotter R; Hou FF; Kitzman DW; Makino H; Mayer G; Nowicki M; Perkovic V; Rossing P; Tobe S; Parving HH; de Zeeuw D; Heerspink HJL, 2022, 'Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease', Clinical Pharmacology and Therapeutics, 112, pp. 1098 - 1107,
    Journal articles | 2022
    Tye SC; Jongs N; Coca SG; Sundström J; Arnott C; Neal B; Perkovic V; Mahaffey KW; Vart P; Heerspink HJL, 2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure', Cardiovascular Diabetology, 21,
    Journal articles | 2022
    Waijer SW; Provenzano M; Mulder S; Rossing P; Persson F; Perkovic V; Heerspink HJL, 2022, 'Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology', Diabetes, Obesity and Metabolism, 24, pp. 983 - 990,
    Journal articles | 2022
    Waijer SW; Sen T; Arnott C; Neal B; Kosterink JGW; Mahaffey KW; Parikh CR; de Zeeuw D; Perkovic V; Neuen BL; Coca SG; Hansen MK; Gansevoort RT; Heerspink HJL, 2022, 'Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease', Clinical Journal of the American Society of Nephrology, 17, pp. 251 - 259,
    Journal articles | 2022
    Wong MG; Lv J; Perkovic V, 2022, 'Oral Methylprednisolone and Decline in Kidney Function or Kidney Failure in Patients with IgA Nephropathy - Reply', JAMA, 328, pp. 1108 - 1109,
    Journal articles | 2022
    Young TK; Toussaint ND; Di Tanna GL; Arnott C; Hockham C; Kang A; Schutte AE; Perkovic V; Mahaffey KW; Agarwal R; Bakris GL; Charytan DM; Heerspink HJL; Levin A; Pollock C; Wheeler DC; Zhang H; Jardine MJ, 2022, 'Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial', Journal of Diabetes Research, 2022,
    Journal articles | 2021
    Adler A; Agodoa L; Algra A; Asselbergs FW; Beckett NS; Berge E; Black H; Brouwers FPJ; Brown M; Bulpitt CJ; Byington RP; Chalmers J; Cushman WC; Cutler J; Davis BR; Devereaux RB; Dwyer J; Estacio R; Fagard R; Fox K; Fukui T; Gupta AK; Holman RR; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis JB; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer CR; Patel A; Pepine CJ; Pfeffer MA; Pitt B; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Woodward M; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J; Turnbull F; Viberti G; Wang J, 2021, 'Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis', The Lancet, 397, pp. 1625 - 1636,
    Journal articles | 2021
    Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K; Adler A; Agodoa L; Algra A; Asselbergs FW; Beckett N; Berge E; Black H; Brouwers FPJ; Brown M; Bulpitt CJ; Byington B; Cushman WC; Cutler J; Devereaux RB; Dwyer J; Estacio R; Fagard R; Fox K; Fukui T; Gupta AK; Holman RR; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis J; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer C; Patel A; Pepine CJ; Pfeffer M; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Pitt B; Rodgers A; Rothwell P; Salimi-Khorshidi G; Turnbull F; Viberti G; Wang J, 2021, 'Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis', The Lancet Oncology, 22, pp. 558 - 570,
    Journal articles | 2021
    Evans RDR; Smyth B; Levin A; Jha V; Wheeler DC; Jardine M; Perkovic V; Damster S; Malik C; de Zeeuw D; Hiemstra T, 2021, 'The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals', Kidney International, 99, pp. 551 - 554,
    Journal articles | 2021
    Feng KY; Li JW; Ianus J; de Zeeuw D; Fulcher GR; Pfeifer M; Matthews DR; Jardine MJ; Perkovic V; Neal B; Mahaffey KW, 2021, 'Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis', Diabetes, Obesity and Metabolism, 23, pp. 2707 - 2715,
    Journal articles | 2021
    Heerspink HJL; Xie D; Bakris G; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray JJV; Perkovic V; Rossing P; Parving HH; de Zeeuw D, 2021, 'Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: A prespecified analysis from the SONAR trial', Journal of the American Society of Nephrology, 32,
    Journal articles | 2021
    Htay H; Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Gharbi MB; Davison SN; Ghnaimat M; Harden P; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx VA; Neuen B; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; See EJ; Saad S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Kazancioglu RT; Yee-Moon Wang A; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey FJ; Perkovic V; Jindal KK; Okpechi IG; Tonelli M; Harris DC; Johnson DW, 2021, 'Hemodialysis Use and Practice Patterns: An International Survey Study', American Journal of Kidney Diseases, 77, pp. 326 - 335.e1,
    Journal articles | 2021
    Jardine M; Zhou Z; Lambers Heerspink HJ; Hockham C; Li Q; Agarwal R; Bakris GL; Cannon CP; Charytan DM; Greene T; Levin A; Li JW; Neuen BL; Neal B; Oh R; Oshima M; Pollock C; Wheeler DC; de Zeeuw D; Zhang H; Zinman B; Mahaffey KW; Perkovic V, 2021, 'Kidney, cardiovascular, and safety outcomes of canagliflozin according to baseline albuminuria a credence secondary analysis', Clinical Journal of the American Society of Nephrology, 16, pp. 384 - 395,
    Journal articles | 2021
    Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425,
    Journal articles | 2021
    Kalantar-Zadeh K; Jafar TH; Nitsch D; Neuen BL; Perkovic V, 2021, 'Chronic kidney disease', The Lancet, 398, pp. 786 - 802,
    Journal articles | 2021
    Kang A; Arnold R; Gallagher M; Snelling P; Green J; Fernando M; Kiernan MC; Hand S; Grimley K; Burman J; Heath A; Rogers K; Bhattacharya A; Smyth B; Bradbury T; Hawley C; Perkovic V; Krishnan AV; Jardine MJ, 2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1365 - 1375,
    Journal articles | 2021
    Koomen JV; Stevens J; Bakris G; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray JJV; Parving HH; Perkovic V; Tobe SW; de Zeeuw D; Heerspink HJL, 2021, 'Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial', Diabetes, Obesity and Metabolism, 23, pp. 561 - 568,
    Journal articles | 2021
    Koomen JV; Stevens J; Bakris G; Correa-Rotter R; Hou FF; Kitzman DW; Kohan DE; Makino H; McMurray JJV; Parving HH; Perkovic V; Tobe SW; de Zeeuw D; Heerspink HJL, 2021, 'Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease', Clinical Pharmacology and Therapeutics, 109, pp. 1631 - 1638,
    Journal articles | 2021
    Kotwal S; Perkovic V, 2021, 'Forever starts now: Effects of glucose-lowering therapies on acute kidney injury', Clinical Journal of the American Society of Nephrology, 16, pp. 6 - 8,
    Journal articles | 2021
    Li C; Zhou Z; Neuen BL; Yu J; Huang Y; Young T; Li J; Li L; Perkovic V; Jardine MJ; Keay L; Markoulli M; Rosenthal N; Capuano G; Yavin Y; Neal B; Arnott C, 2021, 'Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 23, pp. 252 - 257,
    Journal articles | 2021
    Liao J; Kang A; Xia C; Arnott C; Di Tanna GL; Krishnan AV; Pollock CA; Agarwal R; Bakris G; Heerspink HL; Levin A; De Zeeuw D; Neal B; Zhang H; Wheeler DC; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ; Smyth B, 2021, 'The Impact of Canagliflozin on the Risk of Neuropathy Events: Results from the CREDENCE Trial', DIABETES, 70,
    Journal articles | 2021
    Mann JFE; Buse JB; Idorn T; Leiter LA; Pratley RE; Rasmussen S; Vilsbøll T; Wolthers B; Perkovic V, 2021, 'Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis', Diabetes, Obesity and Metabolism, 23, pp. 2058 - 2066,
    Journal articles | 2021
    Nataatmadja M; Krishnasamy R; Zuo L; Hong D; Smyth B; Jun M; de Zoysa JR; Howard K; Wang J; Lu C; Liu Z; Chan CT; Cass A; Perkovic V; Jardine M; Gray NA, 2021, 'Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis', Kidney International Reports, 6, pp. 1058 - 1065,
    Journal articles | 2021
    Neuen BL; Arnott C; Perkovic V; Figtree G; de Zeeuw D; Fulcher G; Jun M; Jardine MJ; Zoungas S; Pollock C; Mahaffey KW; Neal B; Heerspink HJL, 2021, 'Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes', Diabetes, Obesity and Metabolism, 23, pp. 382 - 390,
    Journal articles | 2021
    Neuen BL; Jardine MJ; Perkovic V, 2021, 'Sodium-glucose cotransporter 2 inhibition: Which patient with chronic kidney disease should be treated in the future?', Nephrology Dialysis Transplantation, 35, pp. I48 - I55,
    Journal articles | 2021
    Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC, 2021, 'Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program', American Journal of Kidney Diseases, 77, pp. 23 - 34.e1,
    Journal articles | 2021
    Neuen BL; Oshima M; Perkovic V; Agarwal R; Arnott C; Bakris G; Cannon CP; Charytan DM; Edwards R; Górriz JL; Jardine MJ; Levin A; Neal B; De Nicola L; Pollock C; Rosenthal N; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial', European Heart Journal, 42, pp. 4891 - 4901,
    Journal articles | 2021
    Neuen BL; Oshima M; Perkovic V; Arnott C; Bakris G; Cannon CP; Charytan DM; Jardine M; Levin A; Neal B; Pollock C; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial', European Heart Journal, 42,
    Journal articles | 2021
    O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773,
    Journal articles | 2021
    Oshima M; Hara A; Toyama T; Jun M; Pollock C; Jardine M; Harrap S; Poulter N; Cooper ME; Woodward M; Chalmers J; Perkovic V; Wong MG; Wada T, 2021, 'Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor', Kidney International Reports, 6, pp. 284 - 295,
    Journal articles | 2021
    Oshima M; Jardine MJ; Agarwal R; Bakris G; Cannon CP; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Lim SK; Mahaffey KW; Neal B; Pollock C; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Perkovic V; Heerspink HJL, 2021, 'Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice', Kidney International, 99, pp. 999 - 1009,
    Journal articles | 2021
    Perkovic V; Blackorby A; Cizman B; Carroll K; Cobitz A; Davies R; DiMino T; Jha V; Johansen K; Lopes R; Kler L; Macdougall I; McMurray J; Meadowcroft A; Obrador G; Solomon S; Taft L; Wanner C; Waikar SS; Wheeler D; Wiecek AJ; Singh A, 2021, 'MO559ASCEND-ND: STUDY DESIGN AND BASELINE CHARACTERISTICS', Nephrology Dialysis Transplantation, 36,
    Journal articles | 2021
    Perkovic V; Koitka-Weber A; Cooper ME; Schernthaner G; Pfarr E; Woerle HJ; von Eynatten M; Wanner C, 2021, 'Choice of endpoint in kidney outcome trials: Considerations from the EMPA-REG OUTCOMEVR trial', Nephrology Dialysis Transplantation, 35, pp. 2103 - 2111,
    Journal articles | 2021
    Perkovic V; Rovin B; Zhang H; Kashihara N; Maes B; Rizk D; Wang W; Meier M; Kollins D; Papachristofi O; Charney A; Barratt J, 2021, 'MO148A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LNP023 IN PRIMARY IGA NEPHROPATHY PATIENTS', Nephrology Dialysis Transplantation, 36,
    Journal articles | 2021
    Rahimi K; Bidel Z; Nazarzadeh M; Copland E; Canoy D; Wamil M; Majert J; McManus R; Adler A; Agodoa L; Algra A; Asselbergs FW; Beckett NS; Berge E; Black H; Boersma E; Brouwers FPJ; Brown M; Brugts JJ; Bulpitt CJ; Byington RP; Cushman WC; Cutler J; Devereaux RB; Dwyer JP; Estacio R; Fagard R; Fox K; Fukui T; Gupta AK; Holman RR; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis JB; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer CR; Patel A; Pfeffer MA; Pitt B; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Woodward M; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J; Turnbull F; Viberti G; Wang J; Chalmers J; Davis BR, 2021, 'Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis', The Lancet, 398, pp. 1053 - 1064,
    Journal articles | 2021
    Sarraju A; Li JW; Cannon CP; Chang TI; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey KW, 2021, 'Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial', American Heart Journal, 233, pp. 141 - 148,
    Journal articles | 2021
    Sen T; Li J; Neuen BL; Arnott C; Neal B; Perkovic V; Mahaffey KW; Shaw W; Canovatchel W; Hansen MK; Heerspink HJL, 2021, 'Association between circulating gdf-15 and cardio-renal outcomes and effect of canagliflozin: Results from the canvas trial', Journal of the American Heart Association, 10,
    Journal articles | 2021
    Sen T; Li J; Neuen BL; Neal B; Arnott C; Parikh CR; Coca SG; Perkovic V; Mahaffey KW; Yavin Y; Rosenthal N; Hansen MK; Heerspink HJL, 2021, 'Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial', Diabetologia, 64, pp. 2147 - 2158,
    Journal articles | 2021
    Singh AK; Carroll K; McMurray JJV; Solomon S; Jha V; Johansen KL; Lopes RD; Macdougall IC; Obrador GT; Waikar SS; Wanner C; Wheeler DC; Więcek A; Blackorby A; Cizman B; Cobitz AR; Davies R; DiMino TL; Kler L; Meadowcroft AM; Taft L; Perkovic V, 2021, 'Daprodustat for the treatment of anemia in patients not undergoing dialysis', New England Journal of Medicine, 385, pp. 2313 - 2324,
    Journal articles | 2021
    Singh AK; Carroll K; Perkovic V; Solomon S; Jha V; Johansen KL; Lopes RD; Macdougall IC; Obrador GT; Waikar SS; Wanner C; Wheeler DC; Więcek A; Blackorby A; Cizman B; Cobitz AR; Davies R; Dole J; Kler L; Meadowcroft AM; Zhu X; McMurray JJV, 2021, 'Daprodustat for the treatment of anemia in patients undergoing dialysis', New England Journal of Medicine, 385, pp. 2325 - 2335,
    Journal articles | 2021
    Waijer SW; Gansevoort RT; Bakris GL; Correa-Rotter R; Hou FF; Kohan DE; Kitzman DW; Makino H; McMurray JJV; Perkovic V; Tobe S; Parving HH; de Zeeuw D; Heerspink HJL, 2021, 'The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function A Post Hoc Analysis of the SONAR Randomized Trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1824 - 1832,
    Journal articles | 2021
    Wang KM; Li JW; Bhalla V; Jardine MJ; Neal B; de Zeeuw D; Fulcher G; Perkovic V; Mahaffey KW; Chang TI, 2021, 'Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program', Endocrinology, Diabetes and Metabolism, 4,
    Journal articles | 2021
    Wanner C; Cooper ME; Johansen OE; Toto R; Rosenstock J; McGuire DK; Kahn SE; Pfarr E; Schnaidt S; Von Eynatten M; George JT; Gollop ND; Marx N; Alexander JH; Zinman B; Perkovic V, 2021, 'Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: The CARMELINA randomized controlled trial', Clinical Kidney Journal, 14, pp. 226 - 236,
    Journal articles | 2021
    Wanner C; Cooper ME; Johansen OE; Toto R; Rosenstock J; McGuire DK; Kahn SE; Pfarr E; Schnaidt S; von Eynatten M; George JT; Gollop ND; Marx N; Alexander JH; Zinman B; Perkovic V, 2021, 'Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephroticrange proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial (Clinical Kidney Journal (sfaa225) DOI: 10.1093/ckj/sfaa225)', Clinical Kidney Journal, 14, pp. 2136,
    Journal articles | 2021
    Weir MR; Slee A; Sun T; Balis D; Oh R; de Zeeuw D; Perkovic V, 2021, 'Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program', Clinical Kidney Journal, 14, pp. 1396 - 1402,
    Journal articles | 2021
    Wheeler DC; Weir M; Gogate J; Perkovic V; Mahaffey KW, 2021, 'EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR EVENTS BY BASELINE ALBUMINURIA: INTEGRATED ANALYSIS FROM THE CANVAS PROGRAM AND CREDENCE TRIAL', NEPHROLOGY DIALYSIS TRANSPLANTATION, 36,
    Journal articles | 2021
    Wong MG; Lv J; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Zhao M; Barbour S; Reich HN; Cattran D; Glassock R; Levin A; Jardine MJ; Wheeler DC; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Zhang H; Perkovic V, 2021, 'The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics', American Journal of Nephrology, 52, pp. 827 - 836,
    Journal articles | 2021
    Ye N; Jardine MJ; Oshima M; Hockham C; Heerspink HJL; Agarwal R; Bakris G; Schutte AE; Arnott C; Chang TI; Górriz JL; Cannon CP; Charytan DM; De Zeeuw D; Levin A; Mahaffey KW; Neal B; Pollock C; Wheeler DC; Luca Di Tanna G; Cheng H; Perkovic V; Neuen BL, 2021, 'Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial', Circulation, 143, pp. 1735 - 1749,
    Journal articles | 2021
    Yeung E; Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang G; Bellorin-Font E; Benghanem Gharbi M; Davison S; Ghnaimat M; Harden P; Jha V; Kalantar-Zadeh K; Kerr P; Klarenbach S; Kovesdy C; Luyckx V; Neuen B; O'Donoghue D; Ossareh S; Perl J; Ur Rashid H; Rondeau E; See E; Saad S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Turan Kazancioglu R; Wang AYM; Wiebe N; Yang CW; Zemchenkov A; Zhao M; Jager KJ; Caskey F; Perkovic V; Jindal K; Okpechi IG; Tonelli M; Feehally J; Harris DCH; Johnson D, 2021, 'Current status of health systems financing and oversight for end-stage kidney disease care: A cross-sectional global survey', BMJ Open, 11,
    Journal articles | 2021
    Yi TW; Smyth B; Kang A; Cardoza K; Di Tanna GL; Arnott C; Pollock CA; Agarwal R; Bakris G; Cannon CP; De Zeeuw D; Heerspink HL; Levin A; Neal B; Wheeler DC; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ, 2021, 'Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial', DIABETES, 70,
    Journal articles | 2021
    Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M, 2021, 'Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program', Diabetologia, 64, pp. 2402 - 2414,
    Journal articles | 2021
    Yu J; Arnott C; Neuen BL; Heersprink HL; Mahaffey KW; Cannon CP; Khan SS; Baldridge AS; Shah SJ; Huang Y; Li C; Figtree GA; Perkovic V; Jardine MJ; Neal B; Huffman MD, 2021, 'Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program (vol 8, pg 1482, 2021)', ESC HEART FAILURE, 8, pp. 3447 - 3447,
    Journal articles | 2021
    Yu J; Arnott C; Neuen BL; Heersprink HL; Mahaffey KW; Cannon CP; Khan SS; Baldridge AS; Shah SJ; Huang Y; Li C; Figtree GA; Perkovic V; Jardine MJ; Neal B; Huffman MD, 2021, 'Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program', ESC Heart Failure, 8, pp. 1482 - 1493,
    Journal articles | 2021
    Yu J; Li J; Leaver PJ; Arnott C; Huffman MD; Udell JA; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Matthews DR; Shaw W; Rosenthal N; Neal B; Figtree GA, 2021, 'Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial', Cardiovascular Research, 118, pp. 1103 - 1114,
    Journal articles | 2021
    Yu J; Zhou Z; Mahaffey KW; Matthews DR; Neuen BL; Heerspink HJL; Jardine MJ; Li JW; Perkovic V; Neal B; Arnott C, 2021, 'An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials', International Journal of Cardiology, 324, pp. 165 - 172,
    Journal articles | 2021
    Zhou Z; Jardine MJ; Li Q; Neuen BL; Cannon CP; De Zeeuw D; Edwards R; Levin A; Mahaffey KW; Perkovic V; Neal B; Lindley RI; Guerrero RAA; Aizenberg D; Albisu JP; Alvarisqueta A; Bartolacci I; Berli MA; Bordonava A; Calella P; Cantero MC; Cartasegna LR; Cercos E; Coloma GC; Colombo H; Commendatore V; Cuadrado J; Cuneo CA; Cusumano AM; Douthat WG; Dran RD; Farias E; Fernandez MF; Finkelstein H; Fragale G; Fretes JO; Garcia NH; Gastaldi A; Gelersztein E; Glenny JA; Gonzalez JP; Del Carmen Gonzalez Colaso P; Goycoa C; Greloni GC; Guinsburg A; Hermida S; Juncos LI; Klyver MI; Kraft F; Krynski F; Lanchiotti PV; De La Fuente RAL; Marchetta N; Mele P; Nicolai S; Novoa PA; Orio SI; Otreras F; Oviedo A; Raffaele P; Resk JH; Rista L; Papini NR; Sala J; Santos JC; Schiavi LB; Sessa H; Casabella TS; Ulla MR; Valdez M; Vallejos A; Villarino A; Visco VE; Wassermann A; Zaidman CJ; Cheung NW; Droste C; Fraser I; Johnson D; Mah PM; Nicholls K; Packham D; Proietto J; Roberts A; Roger S; Tsang V; Raduan RA; Da Costa FAA; Amodeo C; Turatti LAA; Bregman R; Sanches FCC; Canani LH; Chacra AR; Borges JLC; Vêncio SAC; Da Silva Franco RJ; D'Avila D; De Souza Portes E; De Souza P, 2021, 'Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis', Stroke, 52, pp. 1545 - 1556,
    Journal articles | 2020
    Arnott C; Huang Y; Neuen BL; Di Tanna GL; Cannon CP; Oh R; Edwards R; Kavalam M; Rosenthal N; Perkovic V; Jardine MJ; Mahaffey K; Neal B, 2020, 'The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.', Diabetes Obes Metab,
    Journal articles | 2020
    Arnott C; Li J-W; Cannon CP; Neuen B; Heerspink HL; Neal B; Charytan DM; Agarwal R; Bakris GL; De Zeeuw D; Greene T; Levin A; Pollock C; Chang T; Rosenthal N; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey K, 2020, 'THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL', Journal of the American College of Cardiology, 75, pp. 674 - 674,
    Journal articles | 2020
    Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B, 2020, 'Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, 9,
    Journal articles | 2020
    Arnott C; Neuen BL; Heerspink HJL; Figtree GA; Kosiborod M; Lam CS; Cannon CP; Rosenthal N; Shaw W; Mahaffey KW; Jardine MJ; Perkovic V; Neal B, 2020, 'The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program', International Journal of Cardiology, 318, pp. 126 - 129,
    Journal articles | 2020
    Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513,
    Journal articles | 2020
    Bakris G; Oshima M; Mahaffey KW; Agarwal R; Cannon CP; Capuano G; Charytan DM; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Levin A; Neal B; Oh R; Pollock C; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Jardine MJ; Perkovic V, 2020, 'Effects of canagliflozin in patients with baseline eGFR <30 ml/min per 1.73 m2: Subgroup analysis of the randomized CREDENCE trial', Clinical Journal of the American Society of Nephrology, 15, pp. 1705 - 1714,
    Journal articles | 2020
    Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris G; Charytan DM; De Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine MJ; Levin A; Li JW; Neal B; Pollock C; Wheeler DC; Zhang H; Zinman B; Mahaffey KW, 2020, 'Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial', Circulation, 141, pp. 407 - 410,
    Journal articles | 2020
    Inagaki N; Yang W; Watada H; Ji L; Schnaidt S; Pfarr E; Okamura T; Johansen OE; George JT; von Eynatten M; Rosenstock J; Perkovic V; Wanner C; Cooper ME; Alexander JH; Komuro I; Nangaku M, 2020, 'Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial', Diabetology International, 11, pp. 129 - 141,
    Journal articles | 2020
    Jardine M; Zhou Z; Heerspink HJL; Li Q; Agarwal R; Bakris G; Charytan DM; Oh R; Pollock C; Wheeler DC; Zeeuw DD; Zhang H; Zinman B; Mahaffey KW; Perkovic V, 2020, 'SAT-156 RENAL, CARDIOVASCULAR, AND SAFETY OUTCOMES OF CANAGLIFLOZIN ACCORDING TO BASELINE ALBUMINURIA: A CREDENCE SECONDARY ANALYSIS', Kidney International Reports, 5, pp. S67 - S67,
    Journal articles | 2020
    Jardine MJ; Zhou Z; Mahaffey KW; Oshima M; Agarwal R; Bakris G; Bajaj HS; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Di Tanna GL; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Qiu R; Sun T; Wheeler DC; Zhang H; Zinman B; Rosenthal N; Perkovic V, 2020, 'Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial', Journal of the American Society of Nephrology, 31, pp. 1128 - 1139,
    Journal articles | 2020
    Kang A; Neuen B; Lambers Heerspink H; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M, 2020, 'P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35,
    Journal articles | 2020
    Kang A; Smyth B; Neuen B; Lambers Heerspink H; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M, 2020, 'P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35,
    Journal articles | 2020
    Levin A; Agarwal R; Herrington WG; Heerspink HL; Mann JFE; Shahinfar S; Tuttle KR; Donner JA; Jha V; Nangaku M; de Zeeuw D; Jardine MJ; Mahaffey KW; Thompson AM; Beaucage M; Chong K; Roberts GV; Sunwold D; Vorster H; Warren M; Damster S; Malik C; Perkovic V; Anand S; Argent N; Babak E; Banerjee D; Barratt J; Bello AK; Bernardo AA; Blais J; Canovatchel W; Caskey FJ; Coresh J; de Boer IH; Eckardt KU; Evans RD; Feldman HI; Fogo AB; Gudmundsdottir H; Hamano T; Harris DCH; Hauske SJ; Haynes R; Herzog CA; Hiemstra T; Idorn T; Inker L; Ishida JH; Johnson DW; Jones-Burton C; Joseph A; Koitka-Weber A; Kretzler M; Lawatscheck R; Liew A; Moist L; Naicker S; Nakashima R; Patel U; Filho RP; Rose JB; Rosenberg NL; Sinsakul M; Smoyer WE; Sola L; Sood AR; Stengel B; Taal MW; Tanaka M; Tonelli M; Tong A; Toto R; Trask M; Ulasi II; Wanner C; Wheeler DC; Wolthers BO; Wright HM; Yamada Y; Zakharova E, 2020, 'International consensus definitions of clinical trial outcomes for kidney failure: 2020', Kidney International, 98, pp. 849 - 859,
    Journal articles | 2020
    Levin A; Perkovic V; Wheeler DC; Hantel S; George JT; von Eynatten M; Koitka-Weber A; Wanner C, 2020, 'Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: Post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial', Clinical Journal of the American Society of Nephrology, 15, pp. 1433 - 1444,
    Journal articles | 2020
    Li J; Jardine MJ; Neal B; Heerspink HL; Cannon C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Pollock CA; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Perkovic V; Mahaffey KW; Arnott C, 2020, 'Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease', DIABETES, 69,
    Journal articles | 2020
    Li JW; Neal B; Perkovic V; de Zeeuw D; Neuen BL; Arnott C; Simpson R; Oh R; Mahaffey KW; Heerspink HJL, 2020, 'Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes', Kidney International, 98, pp. 769 - 777,
    Journal articles | 2020
    Li JW; Woodward M; Perkovic V; Figtree GA; Heerspink HJL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR; Neal B, 2020, 'Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes', JACC: Heart Failure, 8, pp. 57 - 66,
    Journal articles | 2020
    Liyanage T; Toyama T; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Seong HL; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2020, 'SUN-107 THE PREVALENCE OF CHRONIC KIDNEY DISEASE IN ASIA – A SYSTEMATIC REVIEW AND ANALYSIS', Kidney International Reports, 5, pp. S245 - S245,
    Journal articles | 2020
    Matthews DR; Wysham C; Davies M; Slee A; Alba M; Lee M; Perkovic V; Mahaffey KW; Neal B, 2020, 'Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 2199 - 2203,
    Journal articles | 2020
    Muanda FT; Weir MA; Bathini L; Clemens KK; Perkovic V; Sood MM; McArthur E; Sontrop JM; Kim RB; Garg AX, 2020, 'Higher-dose sitagliptin and the risk of congestive heart failure in older adults with CKD', Clinical Journal of the American Society of Nephrology, 15, pp. 1728 - 1739,
    Journal articles | 2020
    Neuen BL; Perkovic V, 2020, 'Pilot trials in nephrology: Establishing a base for large-scale randomized trials', Journal of the American Society of Nephrology, 31, pp. 4 - 6,
    Journal articles | 2020
    OSHIMA M; Wong MG; Hara A; Toyama T; Jun M; Jardine M; Pollock C; Woodward M; Chalmers J; Perkovic V; Wada T, 2020, 'SUN-161 CIRCULATING AUTOANTIBODIES TOÌýERYTHROPOIETIN RECEPTOR AND KIDNEY DISEASE PROGRESSION IN TYPE 2 DIABETES MELLITUS: RESULTS FROM THE ADVANCE STUDIES', Kidney International Reports, 5, pp. S267 - S267,
    Journal articles | 2020
    Ohkuma T; Van Gaal L; Shaw W; Mahaffey KW; de Zeeuw D; Matthews DR; Perkovic V; Neal B, 2020, 'Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 530 - 539,
    Journal articles | 2020
    Oshima M; Neal B; Toyama T; Ohkuma T; Li Q; de Zeeuw D; Heerspink HJL; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V, 2020, 'Different eGFR decline thresholds and renal effects of canagliflozin: Data from the CANVAS program', Journal of the American Society of Nephrology, 31, pp. 2446 - 2456,
    Journal articles | 2020
    Oshima M; Neuen BL; Jardine MJ; Bakris G; Edwards R; Levin A; Mahaffey KW; Neal B; Pollock C; Rosenthal N; Wada T; Wheeler DC; Perkovic V; Heerspink HJL, 2020, 'Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial', The Lancet Diabetes and Endocrinology, 8, pp. 903 - 914,
    Journal articles | 2020
    Oshima M; Neuen BL; Li JW; Perkovic V; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Mahaffey KW; de Nicola L; Pollock C; Rosenthal N; Wheeler DC; Jardine MJ; Heerspink HJL, 2020, 'Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A post hoc analysis from the Credence trial', Journal of the American Society of Nephrology, 31, pp. 2925 - 2936,
    Journal articles | 2020
    Perkovic V; Toto R; Cooper ME; Mann JFE; Rosenstock J; McGuire DK; Kahn SE; Marx N; Alexander JH; Zinman B; Pfarr E; Schnaidt S; Meinicke T; Eynatten MV; George JT; Johansen OE; Wanner C, 2020, 'Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: Secondary analysis of the carmelina randomized trial', Diabetes Care, 43, pp. 1803 - 1812,
    Journal articles | 2020
    Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M, 2020, 'Comparative efficacy and safety of bp-lowering pharmacotherapy in patients undergoing maintenance dialysis: A network meta-analysis of randomized, controlled trials', Clinical Journal of the American Society of Nephrology, 15, pp. 1129 - 1138,
    Journal articles | 2020
    Smyth B; Chan CT; Grieve SM; Puranik R; Zuo L; Hong D; Gray NA; De Zoysa JR; Scaria A; Gallagher M; Perkovic V; Jardine M, 2020, 'Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis', Journal of Cardiac Failure, 26, pp. 482 - 491,
    Journal articles | 2020
    Smyth B; Chan CT; Grieve SM; Puranik R; Zuo L; Hong D; Gray NA; de Zoysa JR; Scaria A; Gallagher M; Perkovic V; Jardine M, 2020, 'Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning', Journal of Cardiac Failure, 26, pp. 1028 - 1029,
    Journal articles | 2020
    Smyth B; Zuo L; Gray NA; Chan CT; de Zoysa JR; Hong D; Rogers K; Wang J; Cass A; Gallagher M; Perkovic V; Jardine M, 2020, 'No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial', Nephrology, 25, pp. 792 - 800,
    Journal articles | 2020
    Torda A; Perkovic V; Velan G, 2020, 'The impact of COVID-19 pandemic on medical education', Medical Journal of Australia,
    Journal articles | 2020
    Torda AJ; Velan G; Perkovic V, 2020, 'The impact of the COVID-19 pandemic on medical education', Medical Journal of Australia, 213, pp. 334 - 334.e1,
    Journal articles | 2020
    Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM; Wyndham R; Vilayur E; Cooper B; Wong MG; Tan KS; van Eps C; Cho Y; Barbara J; Paizis K; McMahon LP; Nelson C; Gafor AHA; Meng OL; Mushahar L; Maher E, 2020, 'A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)', Journal of the American Society of Nephrology, 31, pp. 2653 - 2666,
    Journal articles | 2020
    Tuttle K; Cherney D; Hadjadj S; Idorn T; Mosenzon O; Perkovic V; Rasmussen S; Wolthers B; Bain SC, 2020, 'MO051EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS', Nephrology Dialysis Transplantation, 35,
    Journal articles | 2020
    Tuttle K; Cherney D; Hadjadj S; Idorn T; Mosenzon O; Perkovic V; Rasmussen S; Wolthers B; Bain SC, 2020, 'TO002REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6', Nephrology Dialysis Transplantation, 35,
    Journal articles | 2020
    Young T; Li J-W; Kang A; Heerspink H; Hockham C; Arnott C; Neuen B; Zoungas S; Mahaffey KW; Perkovic V; De Zeeuw D; Fulcher G; Neal B; Jardine M, 2020, 'P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM', Nephrology Dialysis Transplantation, 35,
    Journal articles | 2020
    Zhu B; Jun M; Jardine MJ; Wang YJ; Perkovic V, 2020, 'Haemodialysis duration, frequency and intensity for end-stage kidney disease', Cochrane Database of Systematic Reviews, 2020,
    Journal articles | 2019
    Atkins ER; Perkovic V, 2019, 'Blood pressure: At what level is treatment worthwhile?', Australian Prescriber, 42, pp. 127 - 130,
    Journal articles | 2019
    Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Davison SN; Ghnaimat M; Harden P; Htay H; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx VA; Neuen BL; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; See E; Saad S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Turan Kazancioglu R; Wang AYM; Wiebe N; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey F; Perkovic V; Jindal KK; Okpechi IG; Tonelli M; Feehally J; Harris DC; Johnson DW, 2019, 'Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey', The BMJ, 367,
    Journal articles | 2019
    Chang AR; Grams ME; Ballew SH; Bilo H; Correa A; Evans M; Gutierrez OM; Hosseinpanah F; Iseki K; Kenealy T; Klein B; Kronenberg F; Lee BJ; Li Y; Miura K; Navaneethan SD; Roderick PJ; Valdivielso JM; Visseren FLJ; Zhang L; Gansevoort RT; Hallan SI; Levey AS; Matsushita K; Shalev V; Woodward M, 2019, 'Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium', BMJ (Online), 364,
    Journal articles | 2019
    Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV; Cheung M; Wheeler DC; Winkelmayer WC; Mann JFE; Bakris GL; Damasceno A; Dwyer JP; Fried LF; Haynes R; Hirawa N; Holdaas H; Ibrahim HN; Ingelfinger JR; Iseki K; Khwaja A; Kimmel PL; Kovesdy CP; Ku E; Lerma EV; Luft FC; Lv J; McFadden CB; Muntner P; Myers MG; Navaneethan SD; Parati G; Peixoto AJ; Prasad R; Rahman M; Rocco MV; Rodrigues CIS; Roger SD; Stergiou GS; Tomlinson LA; Tonelli M; Toto RD; Tsukamoto Y; Walker R; Wang AYM; Wang J; Warady BA; Whelton PK; Williamson JD, 2019, 'Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', Kidney International, 95, pp. 1027 - 1036,
    Journal articles | 2019
    Cooper ME; Perkovic V; Groop PH; Hocher B; Hehnke U; Meinicke T; Koitka-Weber A; Van Der Walt S; Von Eynatten M, 2019, 'Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptinwith renin-angiotensin system inhibitors in type 2 diabetic patientswith albuminuria', Journal of Hypertension, 37, pp. 1294 - 1300,
    Journal articles | 2019
    Coresh J; Heerspink HJL; Sang Y; Matsushita K; Arnlov J; Astor BC; Black C; Brunskill NJ; Carrero JJ; Feldman HI; Fox CS; Inker LA; Ishani A; Ito S; Jassal S; Konta T; Polkinghorne K; Romundstad S; Solbu MD; Stempniewicz N; Stengel B; Tonelli M; Umesawa M; Waikar SS; Wen CP; Wetzels JFM; Woodward M; Grams ME; Kovesdy CP; Levey AS; Gansevoort RT; Appel LJ; Greene T; Chen TK; Chalmers J; Arima H; Perkovic V; Levin A; Djurdjev O; Tang M; Nally J; Navaneethan SD; Schold JD; Weldegiorgis M; Herrington WG; Smith M; Hsu CY; Hwang SJ; Chang AR; Kirchner HL; Green JA; Ho K; Marks A; Prescott G; Clark LE; Fluck N; Shalev V; Chodick G; Blankestijn PJ; Van Zuilen A; Van den Brand JA; Sarnak MJ; Bottinger E; Nadkarni GN; Ellis SG; Nadukuru R; Metzger M; Flamant M; Houillier P; Haymann JP; Froissart M; Kenealy T; Elley RC; Collins JF; Drury PL; Cuddeback JK; Ciemins EL; Stempniewicz R; Nelson RG; Knowler WC; Bakker SJ; Major RW; Medcalf JF; Shepherd D; Barrett-Connor E; Bergstrom J; Ix JH; Molnar MZ; Sumida K; de Zeeuw D; Brenner B; Qureshi AR; Elinder CG; Runesson B; Evans M; Segelmark M; Stendahl M; Schön S; Naimark DM; Tangri N, 2019, 'Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies', The Lancet Diabetes and Endocrinology, 7, pp. 115 - 127,
    Journal articles | 2019
    Figtree G; Radholm K; Barrett TD; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B, 2019, 'EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE OUTCOMES WITH AND WITHOUT PRESERVED EJECTION FRACTION IN TYPE 2 DIABETES: RESULTS FROM THE CANVAS PROGRAM', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73, pp. 685 - 685,
    Journal articles | 2019
    Figtree GA; RÃ¥dholm K; Barrett TD; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B, 2019, 'Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program', Circulation, 139, pp. 2591 - 2593,
    Journal articles | 2019
    Garg AX; Chan MTV; Cuerden MS; Devereaux PJ; Abbasi SH; Hildebrand A; Lamontagne F; Lamy A; Noiseux N; Parikh CR; Perkovic V; Quantz M; Rochon A; Royse A; Sessler DI; Shah PJ; Sontrop JM; Tagarakis GI; Teoh KH; Vincent J; Walsh M; Yared JP; Yusuf S; Whitlock RP, 2019, 'Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: A randomized controlled trial', CMAJ, 191, pp. E247 - E256,
    Journal articles | 2019
    Gray NA; Zuo L; Hong D; Smyth B; Jun M; De Zoysa J; Vo K; Howard K; Wang J; Lu C; Liu Z; Cass A; Perkovic V; Jardine M, 2019, 'Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial', Nephrology, 24, pp. 1056 - 1063,
    Journal articles | 2019
    Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189,
    Journal articles | 2019
    Heerspink HJL; Greene T; Tighiouart H; Gansevoort RT; Coresh J; Simon AL; Chan TM; Hou FF; Lewis JB; Locatelli F; Praga M; Schena FP; Levey AS; Inker LA; Sevillano A; Kamper AL; van Zuilen AD; Brenner BM; Maes B; Ihle BU; Barret B; Leung CB; Szeto CC; Fitzner C; Wanner C; Pozzi C; Montagnino CP; Xie D; de Zeeuw D; Lewis E; Verde E; Gutierrez E; Imai E; Caravaca F; Fervenza FC; Kobayashi F; Moroni G; Becker GJ; Beck GJ; Appel GB; Frisch G; van Essen GG; Maschio G; Remuzzi G; Montogrino G; Parving HH; Heerspink HJL; Makino H; Jehan I; Wetzels JFM; Donadio J; Dwyer J; van den Brand J; Kusek J; Lachin JM; Luño J; Lewis JB; Floege J; Abebe KZ; Chow KM; Hunsicker LG; del Vecchio L; Carlo M; Goicoechea M; von Eynatten M; Poulter N; Chaturvedi N; Passerini P; de Jong PE; Blankestijn PJ; Li P; Ruggenenti P; Zucchelli P; Kincaid-Smith PS; Hilgers RD; Estacio RO; Rohde RD; Katafuchi R; Toto RD; Schrier RW; Rodby RA; Perrone RD; Ito S; Klahr S; Andrulli S; Strandgaard S; Hannedouche TP; Rauen T; Verdalles U; Perkovic V; Keane W, 2019, 'Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials', The Lancet Diabetes and Endocrinology, 7, pp. 128 - 139,
    Journal articles | 2019
    Heerspink HJL; Parving HH; Andress DL; Bakris G; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray JJV; Melnick JZ; Miller MG; Pergola PE; Perkovic V; Tobe S; Yi T; Wigderson M; de Zeeuw D; Elbert A; Vallejos A; Alvarisqueta A; Maffei L; Juncos L; de Arteaga J; Greloni G; Farias E; Zucchini A; Vogel D; Cusumano A; Santos J; Fraenkel M; Gallagher M; Davis T; Acharya S; Cooke D; Suranyi M; Roger S; Toussaint N; Pollock C; Chan D; Stranks S; MacIsaac R; Endre Z; Schmidt A; Prager R; Mayer G; Warling X; Jadoul M; Hougardy J; Vercammen C; Van Vlem B; Gillard P; Costa e Forti A; Borges JL; Santos Canani L; Eliaschewitz F; Leite S; Fraige Filho F; Paschoalin R; Moura Neto JA; Deboni L; de Lourdes Noronha I; Cercato C; Prompt CA; Zanella M; Rassi N; D'Avila D; Milagres R; Felicio J; Pecoits Filho R; Riella MC; Salles J; Keitel E; Draibe S; Amodeo C; Youmbissi J; Roy L; Cournoyer S; Jolly S; Pichette V; Nesrallah G; Bajaj HS; Khandwala H; Aronson R; Goluch R; Tam P; Rabbat C; Bailey G; Chow S; Castillo A; Danin Vargas A; Gonzalez F; Munoz R; Gutierrez V; Godoy G; Zhao H; Liu Z; Zhao M; Guo X; Su B, 2019, 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial', The Lancet, 393, pp. 1937 - 1947,
    Journal articles | 2019
    Inker LA; Grams ME; Levey AS; Coresh J; Cirillo M; Collins JF; Gansevoort RT; Gutierrez OM; Hamano T; Heine GH; Ishikawa S; Jee SH; Kronenberg F; Landray MJ; Miura K; Nadkarni GN; Peralta CA; Rothenbacher D; Schaeffner E; Sedaghat S; Shlipak MG; Zhang L; van Zuilen AD; Hallan SI; Kovesdy CP; Woodward M; Levin A; Astor B; Appel L; Greene T; Chen T; Chalmers J; Arima H; Perkovic V; Yatsuya H; Tamakoshi K; Li Y; Hirakawa Y; Matsushita K; Sang Y; Polkinghorne K; Chadban S; Atkins R; Djurdjev O; Liu L; Zhao M; Wang F; Wang J; Ebert N; Martus P; Tang M; Emrich I; Seiler S; Zawada A; Nally J; Navaneethan S; Schold J; Sarnak M; Katz R; Hiramoto J; Iso H; Yamagishi K; Umesawa M; Muraki I; Fukagawa M; Maruyama S; Hasegawa T; Fujii N; Wheeler D; Emberson J; Townend J; Brenner H; Schöttker B; Saum KU; Fox C; Hwang SJ; Köttgen A; Schneider MP; Eckardt KU; Green J; Kirchner HL; Chang AR; Ho K; Ito S; Miyazaki M; Nakayama M; Yamada G; Irie F; Sairenchi T; Yano Y; Kotani K; Nakamura T; Kimm H; Mok Y; Chodick G; Shalev V; Wetzels JFM; Blankestijn PJ; van den Brand J; Kollerits B, 2019, 'Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium', American Journal of Kidney Diseases, 73, pp. 206 - 217,
    Journal articles | 2019
    Inker LA; Heerspink HJL; Tighiouart H; Levey AS; Coresh J; Gansevoort RT; Simon AL; Ying J; Beck GJ; Wanner C; Floege J; Li PKT; Perkovic V; Vonesh EF; Greene T, 2019, 'GFR slope as a surrogate end point for kidney disease progression in clinical trials: A meta-analysis of treatment effects of randomized controlled trials', Journal of the American Society of Nephrology, 30, pp. 1735 - 1745,
    Journal articles | 2019
    Jardine MJ; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Zhang J; Hao J; Perkovic V; Heerspink HL; Wu Y; Yan LL; Neal B, 2019, 'Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial', Journal of Renal Nutrition, 29, pp. 276 - 284,
    Journal articles | 2019
    Jardine MJ; Mahaffey KW; Perkovic V, 2019, 'Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply', The New England journal of medicine, 381, pp. 1089 - 1090,
    Journal articles | 2019
    Jun M; Jardine MJ; Perkovic V; Pilard Q; Billot L; Rodgers A; Rogers K; Gallagher M, 2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLoS ONE, 14,
    Journal articles | 2019
    Kahn S; Perkovic V; Johansen OE; Rosenstock J; McGuire D; Toto R; Nikolaus M; Alexander J; Zinman B; Pfarr E; Schnaidt S; Meinicke T; George J; von Eynatten M; Cooper M; Wanner C, 2019, 'SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA', Journal of the Endocrine Society, 3,
    Journal articles | 2019
    Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', DIABETES, 68,
    Journal articles | 2019
    Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228,
    Journal articles | 2019
    Liao JL; van den Broek-Best O; Smyth B; Hong D; Vo K; Zuo L; Gray NA; Chan CT; de Zoysa J; Perkovic V; Jiang L; Jardine M, 2019, 'Effect of extended hours dialysis on sleep quality in a randomized trial', Nephrology, 24, pp. 430 - 437,
    Journal articles | 2019
    Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM, 2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, 9,
    Journal articles | 2019
    MATTHEWS DR; WYSHAM CH; DAVIES MJ; SLEE A; ALBA M; LEE M; CAPUANO G; PERKOVIC V; MAHAFFEY KW; NEAL B, 2019, 'Effects of Canagliflozin (CANA) on Initiation of Insulin in CANVAS Program', Diabetes, 68,
    Journal articles | 2019
    Mahaffey KW; Jardine MJ; Bompoint S; Cannon CP; Neal B; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Capuano G; De Zeeuw D; Greene T; Levin A; Pollock C; Sun T; Wheeler DC; Yavin Y; Zhang H; Zinman B; Rosenthal N; Brenner BM; Perkovic V, 2019, 'Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial', Circulation, 140, pp. 739 - 750,
    Journal articles | 2019
    Marx N; McGuire DK; Johansen O; Rosenstock J; Kahn SE; Cooper ME; Toto R; Wanner C; Pfarr E; Schnaidt SY; George JT; Von Eynatten M; Perkovic V; Zinman B; Alexander JA, 2019, 'P6272First plus recurrent CV and hospitalization events in the CArdiovascular and Renal Microvascular outcomE study with LINAgliptin (CARMELINA) in patients with type 2 diabetes and cardiorenal disease', European Heart Journal, 40,
    Journal articles | 2019
    Marx N; Mcguire DK; Johansen OE; Rosenstock J; Kahn SE; Cooper ME; Toto RD; Wanner C; Pfarr E; Schnaidt S; George J; Von Eynatten M; Perkovic V; Zinman B; Alexander JH, 2019, 'Analyses of First plus Recurrent Cardiovascular and Hospitalization Events in the Cardiovascular and Renal Microvascular Outcome Study with Linagliptin (CARMELINA) in Patients with Type 2 Diabetes and Cardiorenal Disease', DIABETES, 68,
    Journal articles | 2019
    Matthews DR; Li Q; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Hiatt WR; Nehler M; Fabbrini E; Kavalam M; Lee M; Neal B, 2019, 'Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program', Diabetologia,
    Journal articles | 2019
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; Von Eynatten M; Marx N, 2019, 'Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA', Circulation, 139, pp. 351 - 361,
    Journal articles | 2019
    Neuen B; Heerspink H; Neal B; Matthews D; de Zeeuw D; Mahaffey K; Davidson J; Jardine M; Zoungas S; Perkovic V, 2019, 'Abstract #259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin', Endocrine Practice, 25, pp. 99 - 100,
    Journal articles | 2019
    Neuen BL; Cherney DZ; Jardine MJ; Perkovic V, 2019, 'Sodium-glucose cotransporter inhibitors in type 2 diabetes: Thinking beyond glucose lowering', CMAJ, 191, pp. E1128 - E1135,
    Journal articles | 2019
    Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Li Q; Jardine M; Oh R; Heerspink HL; Perkovic V, 2019, 'Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program', Journal of the American Society of Nephrology, 30, pp. 2229 - 2242,
    Journal articles | 2019
    Neuen BL; Young T; Heerspink HJL; Neal B; Perkovic V; Billot L; Mahaffey KW; Charytan DM; Wheeler DC; Arnott C; Bompoint S; Levin A; Jardine MJ, 2019, 'SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, 7, pp. 845 - 854,
    Journal articles | 2019
    OSHIMA M; Jun M; Toyama T; Perkovic V; Chalmers J; Woodward M, 2019, 'SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES', Kidney International Reports, 4, pp. S128 - S128,
    Journal articles | 2019
    Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M, 2019, 'Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes', Clinical Journal of the American Society of Nephrology, 14, pp. 862 - 872,
    Journal articles | 2019
    Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M, 2019, 'Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial', Hypertension, 73, pp. 84 - 91,
    Journal articles | 2019
    Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V, 2019, 'The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study', Diabetologia, 62, pp. 1988 - 1997,
    Journal articles | 2019
    Oshima M; Ohkuma T; Neal B; Li Q; De Zeeuw D; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V, 2019, 'FP484DIFFERENT eGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM', Nephrology Dialysis Transplantation, 34,
    Journal articles | 2019
    Perkovic V; Bain S; Bakris G; Buse J; Gondolf T; Idorn T; Lausvig N; Mahaffey K; Marso S; Nauck M; Pratley R; Rossing P; Zinman B; Mann J, 2019, 'FP482EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER', Nephrology Dialysis Transplantation, 34,
    Journal articles | 2019
    Perkovic V; Bain S; Bakris G; Buse J; Idorn T; Mahaffey K; Marso S; Nauck M; Pratley R; Rasmussen S; Rossing P; Tornoe K; Zinman B; Mann J, 2019, 'FP483EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) – A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER', Nephrology Dialysis Transplantation, 34,
    Journal articles | 2019
    Perkovic V; Bain S; Bakris G; Buse J; Idorn T; Mahaffey K; Marso S; Nauck M; Pratley R; Rasmussen S; Rossing P; Tornoe K; Zinman B; Mann J, 2019, 'SaO010EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES – A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS', Nephrology Dialysis Transplantation, 34,
    Journal articles | 2019
    Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW, 2019, 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicine, 380, pp. 2295 - 2306,
    Journal articles | 2019
    Perkovic V, 2019, 'Blood pressure: at what level is treatment worthwhile? (vol 42, pg 127, 2019)', AUSTRALIAN PRESCRIBER, 42, pp. 175 - 175,
    Journal articles | 2019
    Perkovic V, 2019, 'SGLT2 inhibitor lowers risk of kidney failure in type 2diabetes', Pharmaceutical Journal, 303,
    Journal articles | 2019
    Rahimi K; Canoy D; Nazarzadeh M; Salimi-Khorshidi G; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ, 2019, 'Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)', BMJ Open, 9,
    Journal articles | 2019
    Rosenstock J; Kahn SE; Johansen OE; Cooper ME; Marx N; Alexander JH; Toto RD; Wanner C; Pfarr E; Schnaidt S; George J; Von Eynatten M; Mcguire DK; Perkovic V; Zinman B, 2019, 'Interrelationship between Hypoglycemia and CV and Mortality Outcomes in Type 2 Diabetes in the CARMELINA Trial', DIABETES, 68,
    Journal articles | 2019
    Rosenstock J; Perkovic V; Johansen OE; Cooper ME; Kahn SE; Marx N; Alexander JH; Pencina M; Toto RD; Wanner C; Zinman B; Woerle HJ; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; Von Eynatten M; McGuire DK, 2019, 'Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial', JAMA - Journal of the American Medical Association, 321, pp. 69 - 79,
    Journal articles | 2019
    Smyth B; Haber A; Trongtrakul K; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease: A Meta-analysis', JAMA Internal Medicine, 179, pp. 1316 - 1324,
    Journal articles | 2019
    Smyth B; Haber A; Trongtrakul K; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'SAT-041 A META-ANALYSIS OF THE REPRESENTATIVENESS OF RANDOMIZED CONTROLLED TRIAL COHORTS IN END-STAGE KIDNEY DISEASE', Kidney International Reports, 4, pp. S21 - S21,
    Journal articles | 2019
    Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ, 2019, 'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Open, 9,
    Journal articles | 2019
    Smyth B; Trongtrakul K; Haber A; Talbot B; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'Inequities in the global representation of sites participating in large, multicentre dialysis trials: A systematic review', BMJ Global Health, 4,
    Journal articles | 2019
    Smyth B; van den Broek-Best O; Hong D; Howard K; Rogers K; Zuo L; Gray NA; de Zoysa JR; Chan CT; Lin H; Zhang L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M, 2019, 'Varying association of extended hours dialysis with quality of life', Clinical Journal of the American Society of Nephrology, 14, pp. 1751 - 1762,
    Journal articles | 2019
    Thompson A; Carroll K; Inker LA; Floege J; Perkovic V; Boyer-Suavet S; Major RW; Schimpf JI; Barratt J; Cattran DC; Gillespie BS; Kausz A; Mercer AW; Reich HN; Rovin BH; West M; Nachman PH, 2019, 'Proteinuria reduction as a surrogate end point in trials of IgA nephropathy', Clinical Journal of the American Society of Nephrology, 14, pp. 469 - 481,
    Journal articles | 2019
    Toto R; Perkovic V; Johansen OE; Cooper M; Rosenstock J; Kahn S; Marx N; Alexander JH; George J; Zinman B, 2019, 'Abstract #289 Effect of Linagliptin on Cardiovascular and Kidney Outcomes in Patients with Type 2 Diabetes and Kidney Disease: Carmelina®', Endocrine Practice, 25, pp. 117 - 118,
    Journal articles | 2019
    Toyama T; NEUEN B; Jun M; Ohkuma T; Neal B; Jardine M; Heerspink H; Ninomiya T; Wada T; Perkovic V, 2019, 'SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEYÌýDISEASE', Kidney International Reports, 4, pp. S133 - S133,
    Journal articles | 2019
    Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 21, pp. 1237 - 1250,
    Journal articles | 2019
    Verma S; Mazer CD; Perkovic V, 2019, 'Is it time to REWIND the cardiorenal clock in diabetes?', The Lancet, 394, pp. 95 - 97,
    Journal articles | 2019
    Zhan Z; Smyth B; Toussaint ND; Gray NA; Zuo L; De Zoysa JR; Chan CT; Jin C; Scaria A; Hawley CM; Perkovic V; Jardine MJ; Zhang L, 2019, 'Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study', BMC Nephrology, 20,
    Journal articles | 2019
    Zhang L; Zuo L; Yu F; Wang H; Bai K; Chen R; Chu H; Gan L; Gao B; Zhao M-H; Wang Y; Zhang H; He X; Liu L; Long J; Shi Y; Su Z; Sun X; Tang W; Wang F; Wang J; Wang S; Wang Y; Yang C; Yu F; Zhang D; Zhang H; Zhao M; Zhao X; Zheng L; Zhou Z; Coresh J; Jayne D; Levey A; Perkovic V; Saran R; Feldman H; Jha V; Levin A; Ronco P; Tang S; Chen M; Fu P; Li G; Liang X; Lin H; Liu Z; Ding J; Li D; Li S; Liao Y; Liu J; Ma Y; Yu X-Q; Hong C, 2019, 'China Kidney Disease Network (CK-NET) 2015 Annual Data Report', KIDNEY INTERNATIONAL SUPPLEMENTS, 9,
    Journal articles | 2019
    Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R; Watts NB; Neal B, 2019, 'Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program', Diabetologia, 62, pp. 1854 - 1867,
    Journal articles | 2019
    Zhou Z; Lindley RI; RÃ¥dholm K; Jenkins B; Watson J; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Shaw W; Oh R; Desai M; Matthews DR; Neal B, 2019, 'Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results from the Randomized CANVAS Program Trials', Stroke, 50, pp. 396 - 404,
    Journal articles | 2019
    2019, 'When should treatment be started for hypertension?', Aust Prescr, 42, pp. 180 - 181,
    Journal articles | 2018
    Heerspink HJL; Andress DL; Bakris G; Brennan JJ; Correa-Rotter R; Dey J; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray J; Perkovic V; Tobe S; Wigderson M; Parving HH; de Zeeuw D, 2018, 'Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy', Diabetes, Obesity and Metabolism, 20, pp. 1369 - 1376,
    Journal articles | 2018
    Heerspink HJL; Andress DL; Bakris G; Brennan JJ; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray J; Perkovic V; Tobe S; Wigderson M; Yi T; Parving HH; de Zeeuw D, 2018, 'Baseline characteristics and enrichment results from the SONAR trial', Diabetes, Obesity and Metabolism, 20, pp. 1829 - 1835,
    Journal articles | 2018
    Heerspink HJL; List J; Perkovic V, 2018, 'New clinical trial designs for establishing drug efficacy and safety in a precision medicine era', Diabetes, Obesity and Metabolism, 20, pp. 14 - 18,
    Journal articles | 2018
    Heerspink HJL; Perkovic V, 2018, 'Trial design innovations to accelerate therapeutic advances in chronic kidney disease: Moving from single trials to an ongoing platform', Clinical Journal of the American Society of Nephrology, 13, pp. 946 - 948,
    Journal articles | 2018
    Jardine MJ; Mahaffey KW; Neal B; Agarwal R; Bakris GL; Brenner BM; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Edwards R; Greene T; Heerspink HJL; Levin A; Pollock C; Wheeler DC; Xie J; Zhang H; Zinman B; Desai M; Perkovic V, 2018, 'The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics', American Journal of Nephrology, 46, pp. 462 - 472,
    Journal articles | 2018
    Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M, 2018, 'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Care, 41, pp. 163 - 170,
    Journal articles | 2018
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018,
    Journal articles | 2018
    Mahaffey KW; Neal B; Perkovic V; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Fabbrini E; Sun T; Li Q; Desai M; Matthews DR, 2018, 'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)', Circulation, 137, pp. 323 - 334,
    Journal articles | 2018
    Matthews DR; Perkovic V; Mahaffey KW, 2018, 'Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"', Circulation, 138, pp. 660 - 661,
    Journal articles | 2018
    Mohammedi K; Chalmers J; Herrington W; Li Q; Mancia G; Marre M; Poulter N; Rodgers A; Williams B; Perkovic V; Coresh J; Woodward M, 2018, 'Associations between body mass index and the risk of renal events in patients with type 2 diabetes', Nutrition and Diabetes, 8,
    Journal articles | 2018
    Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine MJ; Bakris G; Perkovic V, 2018, 'Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function data from the CANVAS program', Circulation, 138, pp. 1537 - 1550,
    Journal articles | 2018
    Neuen BL; Ohkuma T; Neal B; Matthews DR; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine M; Bakris G; Perkovic V, 2018, 'Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease', DIABETES, 67,
    Journal articles | 2018
    Neuen BL; Perkovic V, 2018, 'Reducing cardiovascular risk in people with diabetes and kidney disease', Medical Journal of Australia, 209, pp. 438 - 439,
    Journal articles | 2018
    Okpechi IG; Alrukhaimi M; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Braam B; Feehally J; Harris DC; Jha V; Jindal K; Johnson DW; Kalantar-Zadeh K; Kazancioglu R; Levin A; Lunney M; Olanrewaju TO; Perkovic V; Perl J; Rashid HU; Rondeau E; Salako BL; Samimi A; Sola L; Tchokhonelidze I; Wiebe N; Yang CW; Ye F; Zemchenkov A; Zhao MH; Bello AK, 2018, 'Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology', Kidney International Supplements, 8, pp. 82 - 89,
    Journal articles | 2018
    Ovalle F; Dumas R; Fabbrini E; Slee A; Perkovic V, 2018, 'Abstract #233 Outcomes with Canagliflozin in Patients By Age Subgroups: Results from the Canvas Program', Endocrine Practice, 24, pp. 45 - 45,
    Journal articles | 2018
    Pecoits-Filho R; Perkovic V, 2018, 'Are SGLT2 inhibitors ready for prime time for CKD?', Clinical Journal of the American Society of Nephrology, 13, pp. 318 - 320,
    Journal articles | 2018
    Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal B, 2018, 'Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials', The Lancet Diabetes and Endocrinology, 6, pp. 691 - 704,
    Journal articles | 2018
    Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK, 2018, 'Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): A randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk', Cardiovascular Diabetology, 17,
    Journal articles | 2018
    RÃ¥dholm K; Figtree G; Perkovic V; Solomon SD; Mahaffey KW; De Zeeuw D; Fulcher G; Barrett TD; Shaw W; Desai M; Matthews DR; Neal B, 2018, 'Canagliflozin and heart failure in type 2 diabetes mellitus: Results from the CANVAS program', Circulation, 138, pp. 458 - 468,
    Journal articles | 2018
    Rådholm K; Wu JH; Wong MG; Foote C; Fulcher G; Mahaffey KW; Perkovic V; Neal B, 2018, 'Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review', Diabetes Research and Clinical Practice, 140, pp. 118 - 128,
    Journal articles | 2018
    Smyth B; Perkovic V, 2018, 'New hypoglycemic agents and the kidney: What do the major trials tell us?.', F1000Research, 7,
    Journal articles | 2018
    Tong A; Manns B; Wang AYM; Hemmelgarn B; Wheeler DC; Gill J; Tugwell P; Pecoits-Filho R; Crowe S; Harris T; Van Biesen W; Winkelmayer WC; Levin A; Thompson A; Perkovic V; Ju A; Gutman T; Bernier-Jean A; Viecelli AK; O'Lone E; Shen J; Josephson MA; Cho Y; Johnson DW; Sautenet B; Tonelli M; Craig JC; Sinha A; Ong A; Denny A; Dart A; Eddy A; Kelly A; Davenport A; Narva A; Sharma A; Warrens A; Chapman A; Teixeira-Pinto A; Murphy B; Padilla B; Canaud B; Pullin B; Schiller B; Robinson B; Hanson C; Hawley C; Logeman C; Lok C; Wanner C; Herzog C; Rutherford C; Ahn C; Sumpton D; Rosenbloom D; Harris D; Baron D; White D; Gipson D; Fouque D; Eilers D; Bockenhauer D; O'Donoghue D; Chen D; Dunning D; Brown E; Bavlovlenkov E; Mannon E; Poggio E; Chemla E; Dobbels F; Zannad F; Caskey F; Tentori F; Hurst F; Schaefer F; Wong G; Brunier G; Strippoli G; Rangan G; Knoll G; Obrador G; Feldman H; Coolican H; Yap HK; Groothoff J; Sloand J; Tan J; Locke J; Perl J; Chapman J; Dong J; Malyszko J; Fox J; Dapueto J; Tze-Wah Kao J; Chow KM; Manera K; Azukaitis K; Polkinghorne K, 2018, 'Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop', Kidney International, 94, pp. 1053 - 1068,
    Journal articles | 2018
    Wong MG; Heerspink HJL; Perkovic V, 2018, 'ACCORDION: Ensuring that we hear the music clearly', Clinical Journal of the American Society of Nephrology, 13, pp. 1621 - 1623,
    Journal articles | 2018
    Wong MG; Jardine M; Perkovic V, 2018, 'Glucose lowering and the kidney: are all drug classes equal?', The Lancet Diabetes and Endocrinology, 6, pp. 835 - 837,
    Journal articles | 2018
    de Zeeuw D; Heerspink HJL; Jardine M; Perkovic V, 2018, 'Renal trials in diabetes need a platform: time for a global approach?', The Lancet Diabetes and Endocrinology, 6, pp. 356 - 358,
    Journal articles | 2018
    de Zeeuw D; Renfurm RW; Bakris G; Rossing P; Perkovic V; Hou FF; Nangaku M; Sharma K; Heerspink HJL; Garcia-Hernandez A; Larsson TE, 2018, 'Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial', The Lancet Diabetes and Endocrinology, 6, pp. 925 - 933,
    Journal articles | 2017
    Atkins ER; Hirakawa Y; Salam A; Woodward M; Cooper M; Hamet P; Harrap S; Lees K; Liu L; Mancia G; Marre M; Perkovic V; Poulter N; Williams B; Chalmers J; Rodgers A, 2017, 'Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: An analysis of the PROGRESS and ADVANCEtrials', Journal of Hypertension, 35, pp. 1318 - 1325,
    Journal articles | 2017
    Groop PH; Cooper ME; Perkovic V; Hocher B; Kanasaki K; Haneda M; Schernthaner G; Sharma K; Stanton RC; Toto R; Cescutti J; Gordat M; Meinicke T; Koitka-Weber A; Thiemann S; von Eynatten M, 2017, 'Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial', Diabetes, Obesity and Metabolism, 19, pp. 1610 - 1619,
    Journal articles | 2017
    Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P, 2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, 22, pp. 548 - 554,
    Journal articles | 2017
    Heerspink HJL; Desai M; Jardine M; Balis D; Meininger G; Perkovic V, 2017, 'Canagliflozin slows progression of renal function decline independently of glycemic effects', Journal of the American Society of Nephrology, 28, pp. 368 - 375,
    Journal articles | 2017
    Heerspink HJL; Makino H; Andress D; Brennan JJ; Correa-Rotter R; Coll B; Davis JW; Idler K; Kohan DE; Liu M; Perkovic V; Remuzzi G; Tobe SW; Toto R; Parving HH; de Zeeuw D, 2017, 'Comparison of exposure response relationship of atrasentan between North American and Asian populations', Diabetes, Obesity and Metabolism, 19, pp. 545 - 552,
    Journal articles | 2017
    Jardine MJ; Kasiske B; Adu D; Alrukhaimi M; Ashuntantang GE; Basnet S; Chailimpamontree W; Craig JC; O'Donoghue DJ; Perkovic V; Powe NR; Roberts CJ; Suzuki Y; Tanaka T; Uhlig K, 2017, 'Closing the gap between evidence and practice in chronic kidney disease', Kidney International Supplements, 7, pp. 114 - 121,
    Journal articles | 2017
    Jardine MJ; Zuo L; Gray NA; De Zoysa JR; Chan CT; Gallagher MP; Monaghan H; Grieve SM; Puranik R; Lin H; Eris JM; Zhang L; Xu J; Howard K; Lo S; Cass A; Perkovic V, 2017, 'A trial of extending hemodialysis hours and quality of life', Journal of the American Society of Nephrology, 28, pp. 1898 - 1911,
    Journal articles | 2017
    Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR, 2017, 'Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation', American Journal of Kidney Diseases, 69, pp. 734 - 743,
    Journal articles | 2017
    Levin A; Tonelli M; Bonventre J; Coresh J; Donner JA; Fogo AB; Fox CS; Gansevoort RT; Heerspink HJL; Jardine M; Kasiske B; Köttgen A; Kretzler M; Levey AS; Luyckx VA; Mehta R; Moe O; Obrador G; Pannu N; Parikh CR; Perkovic V; Pollock C; Stenvinkel P; Tuttle KR; Wheeler DC; Eckardt KU; Adu D; Agarwal SK; Alrukhaimi M; Anders HJ; Ashuntantang G; Basnet S; Bello AK; Chailimpamontree W; Correa-Rotter R; Craig J; Douthat WG; Feldman HI; Ganji MR; Garcia-Garcia G; Gharbi MB; Harris DC; Jha V; Johnson DW; Kazancioglu R; Langham R; Liu ZH; Massy ZA; Nangaku M; Nelson RG; O'Donoghue D; Okpechi I; Pecoits-Filho R; Powe NR; Remuzzi G; Roberts C; Rossert J; Sola L; Stengel B; M EKS; Suzuki Y; Tanaka T; Tatiyanupanwong S; Thomas B; Uhlig K; Walker R; White SL; Wiecek A; Yang CW, 2017, 'Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy', The Lancet, 390, pp. 1888 - 1917,
    Journal articles | 2017
    Liyanage T; Ninomiya T; Perkovic V; Woodward M; Stirnadel-Farrant H; Matsushita K; Iseki K; Seong HL; Monaghan H; Jha V, 2017, 'Chronic kidney disease in Asia: Protocol for a collaborative overview', Nephrology, 22, pp. 456 - 462,
    Journal articles | 2017
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S, 2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2017,
    Journal articles | 2017
    Lv J; Zhang H; Wong MG; Jardine MJ; Hladunewich M; Jha V; Monaghan H; Zhao M; Barbour S; Reich H; Cattran D; Glassock R; Levin A; Wheeler D; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Wang HY; Perkovic V, 2017, 'Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial', JAMA - Journal of the American Medical Association, 318, pp. 432 - 442,
    Journal articles | 2017
    Marx N; McGuire DK; Perkovic V; Woerle HJ; Broedl UC; Von Eynatten M; George JT; Rosenstock J, 2017, 'Composite primary end points in cardiovascular outcomes trials involving type 2 diabetes patients: Should unstable angina be included in the primary end point?', Diabetes Care, 40, pp. 1144 - 1151,
    Journal articles | 2017
    Matsushita K; Ballew SH; Coresh J; Arima H; Ärnlöv J; Cirillo M; Ebert N; Hiramoto JS; Kimm H; Shlipak MG; Visseren FLJ; Gansevoort RT; Kovesdy CP; Shalev V; Woodward M; Kronenberg F; Chalmers J; Perkovic V; Grams ME; Sang Y; Schaeffner E; Martus P; Levin A; Djurdjev O; Tang M; Heine G; Seiler S; Zawada A; Emrich I; Sarnak M; Katz R; Brenner H; Schöttker B; Rothenbacher D; Saum KU; Köttgen A; Schneider M; Eckardt KU; Green J; Kirchner HL; Chang AR; Black C; Marks A; Prescott G; Clark L; Fluck N; Jee SH; Mok Y; Chodick G; Wetzels JFM; Blankestijn PJ; van Zuilen AD; Bots M; Peralta C; Hiromoto J; Bottinger E; Nadkarni GN; Ellis SB; Nadukuru R; Kenealy T; Elley CR; Collins JF; Drury PL; Bakker SJ; Heerspink HJL; Jassal SK; Bergstrom J; Ix JH; Barrett-Connor E; Kalantar-Zadeh K; Carrero JJ; Gasparini A; Qureshi AR; Barany P; Algra A; van der Graaf Y; Evans M; Segelmark M; Stendahl M; Schön S; Tangri N; Sud M; Naimark D; Lannfelt L; Larsson A; Hallan S; Levey AS; Chen J; Kwak L, 2017, 'Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data', The Lancet Diabetes and Endocrinology, 5, pp. 718 - 728,
    Journal articles | 2017
    Neal B; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Law G; Desai M; Matthews DR, 2017, 'Canagliflozin and cardiovascular and renal events in type 2 diabetes', New England Journal of Medicine, 377, pp. 644 - 657,
    Journal articles | 2017
    Neal B; Perkovic V; Mahaffey KW; Fulcher G; Erondu N; Desai M; Shaw W; Law G; Walton MK; Rosenthal N; de Zeeuw D; Matthews DR, 2017, 'Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials', Diabetes, Obesity and Metabolism, 19, pp. 926 - 935,
    Journal articles | 2017
    Neal B; Perkovic V; Matthews DR; Mahaffey KW; Fulcher G; Meininger G; Erondu N; Desai M; Shaw W; Vercruysse F; Yee J; Deng H; de Zeeuw D, 2017, 'Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS-R): A randomized, placebo-controlled trial', Diabetes, Obesity and Metabolism, 19, pp. 387 - 393,
    Journal articles | 2017
    Neal B; Perkovic V; Matthews DR, 2017, 'Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Reply', NEW ENGLAND JOURNAL OF MEDICINE, 377, pp. 2099 - 2099,
    Journal articles | 2017
    Neal B; Perkovic V; Matthews DR, 2017, 'The authors reply', New England Journal of Medicine, 377, pp. 2099,
    Journal articles | 2017
    Neuen BL; Chadban SJ; Demaio AR; Johnson DW; Perkovic V, 2017, 'Chronic kidney disease and the global NCDs agenda', BMJ Global Health, 2,
    Journal articles | 2017
    Patel A; Pieper K; Myburgh JA; Perkovic V; Finfer S; Yang Q; Li Q; Billot L, 2017, 'Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST)', New England Journal of Medicine, 377, pp. 298 - 300,
    Journal articles | 2017
    Pena MJ; de Zeeuw D; Andress D; Brennan JJ; Correa-Rotter R; Coll B; Kohan DE; Makino H; Perkovic V; Remuzzi G; Tobe SW; Toto R; Parving HH; Sharma S; Corringham T; Sharma K; Heerspink HJL, 2017, 'The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy', Diabetes, Obesity and Metabolism, 19, pp. 749 - 753,
    Journal articles | 2017
    Perkovic V; Craig JC; Chailimpamontree W; Fox CS; Garcia-Garcia G; Benghanem Gharbi M; Jardine MJ; Okpechi IG; Pannu N; Stengel B; Tuttle KR; Uhlig K; Levey AS, 2017, 'Action plan for optimizing the design of clinical trials in chronic kidney disease', Kidney International Supplements, 7, pp. 138 - 144,
    Journal articles | 2017
    Perkovic V; Levin A; Wheeler D; Koitka-Weber A; Mattheus M; George J; von Eynatten M; Wanner C, 2017, 'SO019EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME® TRIAL', Nephrology Dialysis Transplantation, 32, pp. iii12 - iii12,
    Journal articles | 2017
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D, 2017, 'Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis', PLoS ONE, 12,
    Journal articles | 2017
    Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H, 2017, 'Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis', American Journal of Kidney Diseases, 69, pp. 69 - 77,
    Journal articles | 2017
    Wanner C; Levin A; Perkovic V; Koitka-Weber A; Mattheus M; von Eynatten M; Wheeler D, 2017, 'SP259EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME® TRIAL', Nephrology Dialysis Transplantation, 32, pp. iii193 - iii194,
    Journal articles | 2017
    Webb DJ; Coll B; Heerspink HJL; Andress D; Pritchett Y; Brennan JJ; Houser M; Correa-Rotter R; Kohan D; Makino H; Perkovic V; Remuzzi G; Tobe SW; Toto R; Busch R; Pergola P; Parving HH; de Zeeuw D, 2017, 'Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial', Drugs in R and D, 17, pp. 441 - 448,
    Journal articles | 2017
    Yu J; Zhou Z; McEvoy RD; Anderson CS; Rodgers A; Perkovic V; Neal B, 2017, 'Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: A systematic review and meta-analysis', JAMA - Journal of the American Medical Association, 318, pp. 156 - 166,
    Journal articles | 2016
    Anderson C; Arnolda L; Cowley D; Dowden J; Gabb G; Golledge J; Hankey G; Howes F; Leckie L; Mangoni A; Perkovic V; Schlaich M; Zwar N; Medley T; Wilson J; Branagan M, 2016, 'National Heart Foundation Hypertension Guideline - 2016', Heart, Lung and Circulation, 25, pp. S18 - S18,
    Journal articles | 2016
    Badve SV; Palmer SC; Strippoli GFM; Roberts MA; Teixeira-Pinto A; Boudville N; Cass A; Hawley CM; Hiremath SS; Pascoe EM; Perkovic V; Whalley GA; Craig JC; Johnson DW, 2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 68, pp. 554 - 563,
    Journal articles | 2016
    Chan KE; Giugliano RP; Patel MR; Abramson S; Jardine M; Zhao S; Perkovic V; Maddux FW; Piccini JP, 2016, 'Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF', Journal of the American College of Cardiology, 67, pp. 2888 - 2899,
    Journal articles | 2016
    Dal-Ré R; Jha V; Lv J; Chaudhury RR; Wang Y; Perkovic V, 2016, 'International trials in middle-income countries: different local scenarios require different ethical approaches', Journal of the Royal Society of Medicine, 109, pp. 47 - 51,
    Journal articles | 2016
    Fulcher G; Matthews DR; Perkovic V; de Zeeuw D; Mahaffey KW; Mathieu C; Woo V; Wysham C; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B; Home P; Anderson J; Campbell I; Lachin J; Scharfstein D; Solomon S; Uzzo R; Amerena J; Chow C; Figtree G; French G; Hillis J; Jenkins B; Lindley R; McGrath B; Street A; Watson J, 2016, 'Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes', Diabetes, Obesity and Metabolism, 18, pp. 82 - 91,
    Journal articles | 2016
    Gabb GM; Mangoni A; Anderson CS; Cowley D; Dowden JS; Golledge J; Hankey GJ; Howes FS; Leckie L; Perkovic V; Schlaich M; Zwar NA; Medley TL; Arnolda L, 2016, 'Guideline for the diagnosis and management of hypertension in adults — 2016', Medical Journal of Australia, 205, pp. 85 - 89,
    Journal articles | 2016
    Gallagher M; Wong MG; Perkovic V, 2016, 'ALTITUDE: Defining a ceiling for blockade of the renin-angiotensin system?', The Lancet Diabetes and Endocrinology, 4, pp. 289 - 290,
    Journal articles | 2016
    Knight J; Perkovic V, 2016, 'The Affordable Dialysis Prize steams ahead', The Lancet, 387, pp. 1040,
    Journal articles | 2016
    Liyanage T; Ninomiya T; Wang A; Neal B; Jun M; Wong MG; Jardine M; Hillis GS; Perkovic V, 2016, 'Effects of the mediterranean diet on cardiovascular outcomes-a systematic review and meta-analysis', PLoS ONE, 11,
    Journal articles | 2016
    Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GFM; Jardine MJ, 2016, 'Interventions for lowering plasma homocysteine levels in dialysis patients', Cochrane Database of Systematic Reviews, 2016,
    Journal articles | 2016
    Olsen MH; Angell SY; Asma S; Boutouyrie P; Burger D; Chirinos JA; Damasceno A; Delles C; Gimenez-Roqueplo AP; Hering D; López-Jaramillo P; Martinez F; Perkovic V; Rietzschel ER; Schillaci G; Schutte AE; Scuteri A; Sharman JE; Wachtell K; Wang JG, 2016, 'A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension', The Lancet, 388, pp. 2665 - 2712,
    Journal articles | 2016
    Patel MR; Armstrong PW; Bhatt DL; Braunwald E; Camm AJ; Fox KAA; Harrington RA; Hiatt WR; James SK; Kirtane AJ; Leon MB; Lincoff AM; Mahaffey KW; Mauri L; Mehran R; Mehta SR; Montalescot G; Nicholls SJ; Perkovic V; Peterson ED; Pocock SJ; Roe MT; Sabatine MS; Sekeres M; Solomon SD; Steg G; Stone GW; Van De Werf F; Wallentin L; White HD; Gibson CM, 2016, 'Sharing data from cardiovascular clinical trials \- a proposal', New England Journal of Medicine, 375, pp. 407 - 409,
    Journal articles | 2016
    Perkovic V; Agarwal R; Fioretto P; Hemmelgarn BR; Levin A; Thomas MC; Wanner C; Kasiske BL; Wheeler DC; Groop PH; Bakris GL; Cooper ME; Chae DW; Davidson MH; de Boer IH; de Zeeuw D; Fornoni A; Gnudi L; Herzog CA; Hung AM; Jafar TH; Jardine M; Jha V; Ji L; Kahn SE; Langham RG; Lerma EV; Ma RCW; Makino H; Marre M; Mauer M; Metsärinne K; Nelson RG; Pecoits-Filho R; Pollock CA; Rajapurkar M; Rossing P; Rychlík I; Sharma K; Stanton RC; TesaÅ™ V; Tikkanen I; Tomson CRV; Toto RD; Tsukamoto Y; Tuttle KR; Wada T; Williams WW; Zhang H; Zoungas S, 2016, 'Management of patients with diabetes and CKD:Ìýconclusions from a “Kidney Disease: Improving Global Outcomes†(KDIGO) Controversies Conference', Kidney International, 90, pp. 1175 - 1183,
    Journal articles | 2016
    Perkovic V, 2016, 'Commentary', Annals of Internal Medicine, 165, pp. JC71,
    Journal articles | 2016
    Quach K; Lvtvyn L; Baigent C; Bueti J; Garg AX; Hawley C; Haynes R; Manns B; Perkovic V; Rabbat CG; Wald R; Walsh M, 2016, 'The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 68, pp. 591 - 598,
    Journal articles | 2016
    Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Isbel NM; Krum H; Pascoe EM; Perkovic V; Scaria A; Tonkin AM; Vergara LA; Hawley CM; Levin A; Hare D; Martin A; Wheeler DC; Fulcher G; Brown H; Colquhoun D; Korczyk D; Mather A; Wong A; Bisscheroux P; Gillies A; Garvey L; Tan KS; Lennan E; Pitkin M; Ahearn K; Carroll RP; Scott E; Cooper B; Pearse J; Snelling P; Burman J; Hand S; Pedagogos E; Karschimkus C; Pilmore A; Walker R; Ellis G; Marshall MR; Paul C; Johnson D; Helyar J; Morrish A; Paul-Brent PA; Reidlinger D; Zhang L, 2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, 67, pp. 902 - 911,
    Journal articles | 2016
    Rodgers A; Perkovic V, 2016, 'A randomized trial of intensive versus standard blood-pressure control [10]', New England Journal of Medicine, 374, pp. 2295,
    Journal articles | 2016
    Schievink B; De Zeeuw D; Smink PA; Andress D; Brennan JJ; Coll B; Correa-Rotter R; Hou FF; Kohan D; Kitzman DW; Makino H; Parving HH; Perkovic V; Remuzzi G; Tobe S; Toto R; Hoekman J; Lambers Heerspink HJ, 2016, 'Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers', European Journal of Preventive Cardiology, 23, pp. 758 - 768,
    Journal articles | 2016
    Sukkar L; Hong D; Wong MG; Badve SV; Perkovic V; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413,
    Journal articles | 2016
    Sukkar L; Hong D; Wong MG; Badve SV; Rogers K; Perkovic V; Walsh M; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), 355,
    Journal articles | 2016
    Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ, 2016, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', Cochrane Database of Systematic Reviews, 2016,
    Journal articles | 2016
    Wong MG; Perkovic V; Chalmers J; Woodward M; Li Q; Cooper ME; Hamet P; Harrap S; Heller S; Macmahon S; Mancia G; Marre M; Matthews D; Neal B; Poulter N; Rodgers A; Williams B; Zoungas S, 2016, 'Long-term benefits of intensive glucose Control for preventing end-stage kidney disease: ADVANCE-ON', Diabetes Care, 39, pp. 694 - 700,
    Journal articles | 2016
    Wong MG; Perkovic V, 2016, 'Knowing what we do not know: statin therapy in advanced chronic kidney disease', The Lancet Diabetes and Endocrinology, 4, pp. 801 - 803,
    Journal articles | 2016
    Wu JHY; Foote C; Blomster J; Toyama T; Perkovic V; Sundström J; Neal B, 2016, 'Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: A systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, 4, pp. 411 - 419,
    Journal articles | 2016
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A, 2016, 'Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis', The Lancet, 387, pp. 435 - 443,
    Journal articles | 2016
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H, 2016, 'Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients with CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials', American Journal of Kidney Diseases, 67, pp. 728 - 741,
    Journal articles | 2016
    Zhang L; Coombes J; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, 21, pp. 14 - 23,
    Journal articles | 2015
    Agodoa L; Estacio R; Schrier R; Lubsen J; Chalmers J; Cutler J; Davis B; Wing L; Poulter NR; Sever P; Remuzzi G; Ruggenenti P; Nissen S; Lindholm LH; Fukui T; Ogihara T; Saruta T; Black H; Sleight P; Lievre M; Suzuki H; Fox K; Lisheng L; Ohkubo T; Imai Y; Yusuf S; Bulpitt CJ; Lewis E; Brown M; Palmer C; Wang J; Pepine C; Ishii M; Yui Y; Kuramoto K; Pfeff Er M; Asselbergs FW; Van Gilst WH; Byington B; Pitt B; Brenner B; Remme WJ; De Zeeuw D; Rahman M; Viberti G; Teo K; Zanchetti A; Malacco E; Mancia G; Staessen J; Fagard R; Holman R; Hansson L; Kostis J; Kanno Y; Lueders S; Matsuzaki M; Poole-Wilson P; Schrader J; Rahimi K; Anderson C; Chapman N; Collins R; MacMahon S; Neal B; Rodgers A; Whelton P; Woodward M, 2015, 'Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: A meta-analysis of randomised trials', The Lancet, 385, pp. 867 - 874,
    Journal articles | 2015
    Badve SV; Zhang L; Coombes JS; Pascoe EM; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R, 2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, 2,
    Journal articles | 2015
    Cooper ME; Perkovic V; McGill JB; Groop PH; Wanner C; Rosenstock J; Hehnke U; Woerle HJ; Von Eynatten M, 2015, 'Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data from a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes', American Journal of Kidney Diseases, 66, pp. 441 - 449,
    Journal articles | 2015
    Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A, 2015, 'Blood pressure lowering in type 2 diabetes : A systematic review and meta-analysis', JAMA - Journal of the American Medical Association, 313, pp. 603 - 615,
    Journal articles | 2015
    Fulcher G; Matthews DR; Perkovic V; de Zeeuw D; Mahaffey KW; Weiss R; Rosenstock J; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B, 2015, 'Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial', Diabetes Therapy, 6, pp. 289 - 302,
    Journal articles | 2015
    Groop PH; Cooper ME; Perkovic V; Sharma K; Schernthaner G; Haneda M; Hocher B; Gordat M; Cescutti J; Woerle HJ; Von Eynatten M, 2015, 'Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2Dâ„¢ trial', Diabetes and Vascular Disease Research, 12, pp. 455 - 462,
    Journal articles | 2015
    Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2015, 'Erratum. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients With type 2 diabetes. Diabetes Care 2014;37:295-303', Diabetes Care, 38, pp. 1393,
    Journal articles | 2015
    Jardine M; Perkovic V, 2015, 'First Light after the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial', American Journal of Kidney Diseases, 66, pp. 379 - 382,
    Journal articles | 2015
    Jardine MJ; Zuo L; Gray NA; De Zoysa J; Chan CT; Gallagher MP; Howard K; Hertier S; Cass A; Perkovic V, 2015, 'Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Study', Nephrology, 20, pp. 257 - 265,
    Journal articles | 2015
    Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R; Tonkin A; Forbes A; Levin A; Wheeler DC; Jardine M; Burman J; Hand S; Garvey L; Suranyi M; Gilbert M; Endre Z; McNamara K; Snelling P; Mahadevan K; Pollock A; Leary D; Ratanjee S; Kirby J; Juneja R; Hill K; Cook N; Bisscheroux P; McMahon L; Kent A; Raspudic M; Steinwandel U; Dogra S; Pellicano S; Paul-Brent PA, 2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, 65, pp. 49 - 57,
    Journal articles | 2015
    Jun M; James MT; Manns BJ; Quinn RR; Ravani P; Tonelli M; Perkovic V; Winkelmayer WC; Ma Z; Hemmelgarn BR, 2015, 'The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: Population based observational study', The BMJ, 350,
    Journal articles | 2015
    Jun M; Turin TC; Woodward M; Perkovic V; Lambers Heerspink HJ; Manns BJ; Tonelli M; Hemmelgarn BR, 2015, 'Assessing the validity of surrogate outcomes for ESRD: A meta-analysis', Journal of the American Society of Nephrology, 26, pp. 2289 - 2302,
    Journal articles | 2015
    Kang A; Nigwekar SU; Perkovic V; Kulshrestha S; Zoungas S; Navaneethan SD; Cass A; Gallagher MP; Ninomiya T; Strippoli GFM; Jardine MJ, 2015, 'Interventions for lowering plasma homocysteine levels in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2015,
    Journal articles | 2015
    Kohan DE; Heerspink HJL; Coll B; Andress D; Brennan JJ; Kitzman DW; Correa-Rotter R; Makino H; Perkovic V; Hou FF; Remuzzi G; Tobe SW; Toto R; Parving HH; De Zeeuw D, 2015, 'Predictors of atrasentan-associated fluid retention and change in albuminuria in patients with diabetic nephropathy', Clinical Journal of the American Society of Nephrology, 10, pp. 1568 - 1574,
    Journal articles | 2015
    Laba TL; Usherwood T; Leeder S; Yusuf F; Gillespie J; Perkovic V; Wilson A; Jan S; Essue B, 2015, 'Co-payments for health care: What is their real cost?', Australian Health Review, 39, pp. 33 - 36,
    Journal articles | 2015
    Liyanage T; Ninomiya T; Jha V; Neal B; Patrice HM; Okpechi I; Zhao MH; Lv J; Garg AX; Knight J; Rodgers A; Gallagher M; Kotwal S; Cass A; Perkovic V, 2015, 'Worldwide access to treatment for end-stage kidney disease: A systematic review', The Lancet, 385, pp. 1975 - 1982,
    Journal articles | 2015
    Lo C; Toyama T; Hirakawa Y; Jun M; Cass A; Hawley C; Pilmore H; Badve S; Perkovic V; Zoungas S, 2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews
    Journal articles | 2015
    Neal B; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Ways K; Desai M; Shaw W; Capuano G; Alba M; Jiang J; Vercruysse F; Meininger G; Matthews D, 2015, 'Efficacy and safety of canaglif lozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes', Diabetes Care, 38, pp. 403 - 411,
    Journal articles | 2015
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GFM, 2015, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Sao Paulo Medical Journal, 133, pp. 541,
    Journal articles | 2015
    Perkovic V; Jardine M; Vijapurkar U; Meininger G, 2015, 'Renal effects of canagliflozin in type 2 diabetes mellitus', Current Medical Research and Opinion, 31, pp. 2219 - 2231,
    Journal articles | 2015
    Perkovic V; Rodgers A, 2015, 'Redefining blood-pressure targets - SPRINT starts the marathon', New England Journal of Medicine, 373, pp. 2175 - 2178,
    Journal articles | 2015
    Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Hawley CM; Isbel NM; Krum H; Pascoe EM; Tonkin AM; Vergara LA; Perkovic V, 2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, 20, pp. 140 - 147,
    Journal articles | 2015
    Thomas MC; Woodward M; Neal B; Li Q; Pickering R; Marre M; Williams B; Perkovic V; Cooper ME; Zoungas S; Chalmers J; Hillis GS, 2015, 'Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes', Diabetes Care, 38, pp. 1891 - 1897,
    Journal articles | 2015
    Tong A; Crowe S; Chando S; Cass A; Chadban SJ; Chapman JR; Gallagher M; Hawley CM; Hill S; Howard K; Johnson DW; Kerr PG; McKenzie A; Parker D; Perkovic V; Polkinghorne KR; Pollock C; Strippoli GFM; Tugwell P; Walker RG; Webster AC; Wong G; Craig JC, 2015, 'Research Priorities in CKD: Report of a National Workshop Conducted in Australia', American Journal of Kidney Diseases, 66, pp. 212 - 222,
    Journal articles | 2015
    Toyama T; Furuichi K; Shimizu M; Hara A; Iwata Y; Sakai N; Perkovic V; Kobayashi M; Mano T; Kaneko S; Wada T, 2015, 'Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with normal or mildly reduced kidney function', PLoS ONE, 10,
    Journal articles | 2015
    Wong MG; Wanner C; Knight J; Perkovic V, 2015, 'Lowering cholesterol in chronic kidney disease: Is it safe and effective?', European Heart Journal, 36, pp. 2988 - 2995,
    Journal articles | 2015
    Zhu B; Zhu CF; Lin Y; Perkovic V; Li XF; Yang R; Tang XL; Zhu XL; Cheng XX; Li Q; Chen HY; Sun Y; Chen QW; Wang YJ, 2015, 'Clinical characteristics of IgA nephropathy associated with low complement 4 levels', Renal Failure, 37, pp. 424 - 432,
    Journal articles | 2014
    Badve SV; Roberts MA; Palmer SC; Hiremath SS; Hawley CM; Perkovic V; Whalley GA; Strippoli GFM; Johnson DW, 2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32,
    Journal articles | 2014
    Bose B; Badve SV; Hiremath SS; Boudville N; Brown FG; Cass A; De Zoysa JR; Fassett RG; Faull R; Harris DC; Hawley CM; Kanellis J; Palmer SC; Perkovic V; Pascoe EM; Rangan GK; Walker RJ; Walters G; Johnson DW, 2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413,
    Journal articles | 2014
    De Zeeuw D; Coll B; Andress D; Brennan JJ; Tang H; Houser M; Correa-Rotter R; Kohan D; Heerspink HJL; Makino H; Perkovic V; Pritchett Y; Remuzzi G; Tobe SW; Toto R; Viberti G; Parving HH, 2014, 'The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy', Journal of the American Society of Nephrology, 25, pp. 1083 - 1093,
    Journal articles | 2014
    Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2014, 'The relative and combined ability of high-sensitivity cardiac troponin t and n-terminal pro-b-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes', Diabetes Care, 37, pp. 295 - 303,
    Journal articles | 2014
    Huxley RR; Perkovic V, 2014, 'The modifiable burden of worldwide mortality from cardiovascular diseases', LANCET DIABETES & ENDOCRINOLOGY, 2, pp. 604 - 606,
    Journal articles | 2014
    Huxley RR; Perkovic V, 2014, 'The modifiable burden of worldwide mortality from cardiovascular diseases', The Lancet Diabetes and Endocrinology, 2, pp. 604 - 606,
    Journal articles | 2014
    Johnson DW; Pascoe E; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Scaria A; Walker R; Vergara LA; Hawley CM, 2014, 'A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL', NEPHROLOGY, 19, pp. 29 - 29,
    Journal articles | 2014
    Knight J; Wong MG; Perkovic V, 2014, 'Optimal targets for blood pressure control in chronic kidney disease: The debate continues', Current Opinion in Nephrology and Hypertension, 23, pp. 541 - 546,
    Journal articles | 2014
    Morrish AT; Hawley CM; Johnson DW; Badve SV; Perkovic V; Reidlinger DM; Cass A, 2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30,
    Journal articles | 2014
    Ninomiya T; Perkovic V, 2014, 'Authors' reply to Ladapo and Ogedegbe', BMJ (Online), 348,
    Journal articles | 2014
    Palmer SC; Navaneethan SD; Craig JC; Johnson DD; Perkovic V; Hegbrant J; Strippoli GFM, 2014, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Sao Paulo Medical Journal, 132, pp. 314,
    Journal articles | 2014
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GFM, 2014, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Cochrane Database of Systematic Reviews, 2014,
    Journal articles | 2014
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GFM, 2014, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', Cochrane Database of Systematic Reviews, 2014,
    Journal articles | 2014
    Perkovic V; Turnbull F; Wilson A, 2014, 'Is it time for medi-change?', Medical Journal of Australia, 200, pp. 566 - 567,
    Journal articles | 2014
    Pilmore H; Dogra G; Roberts M; Lambers Heerspink HJ; Ninomiya T; Huxley R; Perkovic V, 2014, 'Cardiovascular disease in patients with chronic kidney disease', Nephrology, 19, pp. 3 - 10,
    Journal articles | 2014
    Sundström J; Arima H; Woodward M; Jackson R; Karmali K; Lloyd-Jones D; Baigent C; Emberson J; Rahimi K; Macmahon S; Patel A; Perkovic V; Turnbull F; Neal B; Agodoa L; Estacio R; Schrier R; Lubsen J; Chalmers J; Cutler J; Davis B; Wing L; Poulter NR; Sever P; Remuzzi G; Ruggenenti P; Nissen S; Lindholm LH; Fukui T; Ogihara T; Saruta T; Black H; Sleight P; Lievre M; Suzuki H; Fox K; Lisheng L; Ohkubo T; Imai Y; Yusuf S; Bulpitt CJ; Lewis E; Brown M; Palmer C; Wang J; Pepine C; Ishii M; Yui Y; Kuramoto K; Pfeffer M; Asselbergs FW; van Gilst WH; Byington B; Pitt B; Brenner B; Remme WJ; de Zeeuw D; Rahman M; Viberti G; Teo K; Zanchetti A; Malacco E; Mancia G; Staessen J; Fagard R; Holman R; Hansson L; Kostis J; Kanno Y; Lueders S; Matsuzaki M; Poole-Wilson P; Schrader J; Anderson C; Chapman N; Collins R; Rodgers A; Whelton P, 2014, 'Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data', The Lancet, 384, pp. 591 - 598,
    Journal articles | 2014
    Wang AY; Ninomiya T; Al-Kahwa A; Perkovic V; Gallagher MP; Hawley C; Jardine MJ, 2014, 'Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials', American Journal of Kidney Diseases, 63, pp. 968 - 978,
    Journal articles | 2014
    Yamout H; Perkovic V; Davies M; Woo V; De Zeeuw D; Mayer C; Vijapurkar U; Kline I; Usiskin K; Meininger G; Bakris G, 2014, 'Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy', American Journal of Nephrology, 40, pp. 64 - 74,
    Journal articles | 2014
    Zhang L; Pascoe EM; Badve SV; Cass A; Clarke P; Coombes JS; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35,
    Journal articles | 2014
    Zoungas S; Chalmers J; Neal B; Billot L; Li Q; Biostat M; Hirakawa Y; Arima H; Monaghan H; Joshi R; Colagiuri S; Cooper ME; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Matthews DR; Mogensen CE; Perkovic V; Poulter N; Rodgers A; Williams B; MacMahon S; Patel A; Woodward M, 2014, 'Follow-up of blood-pressure lowering and glucose control in type 2 diabetes', New England Journal of Medicine, 371, pp. 1392 - 1406,
    Journal articles | 2013
    Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, 2013,
    Journal articles | 2013
    Groop PH; Cooper M; Perkovic V; Emser A; Seck T; Eynatten MV; Woerle HJ, 2013, 'Effekt des DPP-4-Inhibitors Linagliptin auf die Albuminurie bei Patienten mit Typ-2-Diabetes und diabetischer Nephropathie', Diabetologie und Stoffwechsel, 8,
    Journal articles | 2013
    Groop PH; Cooper ME; Perkovic V; Emser A; Woerle HJ; Von Eynatten M, 2013, 'Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction', Diabetes Care, 36, pp. 3460 - 3468,
    Journal articles | 2013
    Hillis G; Welsh P; Chalmers J; Chow C; Li Q; Perkovic V; Neal B; Zoungas S; Jun M; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2013, 'The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus', Heart, Lung and Circulation, 22, pp. S68 - S68,
    Journal articles | 2013
    Hillis GS; Welsh P; Chalmers J; Chow CK; Perkovic V; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2013, 'High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus', European Heart Journal, 34, pp. P1546 - P1546,
    Journal articles | 2013
    Hou W; Lv JA; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H, 2013, 'Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and meta-analysis', European Heart Journal, 34,
    Journal articles | 2013
    Jardine MJ; Liyanage T; Buxton E; Perkovic V, 2013, 'MTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): The question remains open', Nephrology Dialysis Transplantation, 28, pp. 242 - 244,
    Journal articles | 2013
    Jun M; Jardine MJ; Gray N; Masterson R; Kerr PG; Agar JWM; Hawley CM; Van Eps C; Cass A; Gallagher M; Perkovic V, 2013, 'Outcomes of extended-hours hemodialysis performed predominantly at home', American Journal of Kidney Diseases, 61, pp. 247 - 253,
    Journal articles | 2013
    Jun M, 2013, 'Antioxidants for chronic kidney disease', Nephrology, 18, pp. 576 - 578,
    Journal articles | 2013
    Levin A; Perkovic V, 2013, 'Epidemiology: Global Burden of Disease Study 2010: Implications for nephrology', Nature Reviews Nephrology, 9, pp. 195 - 197,
    Journal articles | 2013
    Lv J; Ehteshami P; Sarnak MJ; Tighiouart H; Jun M; Ninomiya T; Foote C; Rodgers A; Zhang H; Wang H; Strippoli GFM; Perkovic V, 2013, 'Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis', CMAJ. Canadian Medical Association Journal, 185, pp. 949 - 957,
    Journal articles | 2013
    MacMahon S; Perkovic V; Patel A, 2013, 'Industry-sponsored clinical trials in emerging markets: Time to review the terms of engagement', JAMA, 310, pp. 907 - 908,
    Journal articles | 2013
    Mooney JF; Ranasinghe I; Chow CK; Perkovic V; Barzi F; Zoungas S; Holzmann MJ; Welten GM; Biancari F; Wu VC; Tan TC; Cass A; Hillis GS, 2013, 'Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: A systematic review and meta-analysis', Anesthesiology, 118, pp. 809 - 824,
    Journal articles | 2013
    Neal B; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Stein P; Desai M; Shaw W; Jiang J; Vercruysse F; Meininger G; Matthews D, 2013, 'Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS) - A randomized placebo-controlled trial', American Heart Journal, 166,
    Journal articles | 2013
    Neuen BL; Taylor GE; Demaio AR; Perkovic V, 2013, 'Global kidney disease', The Lancet, 382, pp. 1243,
    Journal articles | 2013
    Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GFM, 2013, 'Antiplatelet agents for chronic kidney disease', Cochrane Database of Systematic Reviews, 2013,
    Journal articles | 2013
    Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GFM, 2013, 'Antiplatelet agents for chronic kidney disease.', Cochrane database of systematic reviews (Online), 2
    Journal articles | 2013
    Palmer SC; Di Micco L; Razavian M; Craig JC; Ravani P; Perkovic V; Tognoni G; Graziano G; Jardine M; Pellegrini F; Nicolucci A; Webster A; Strippoli GFM, 2013, 'Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis', American Journal of Kidney Diseases, 61, pp. 112 - 122,
    Journal articles | 2013
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GFM, 2013, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews, 2013,
    Journal articles | 2013
    Perkovic V; Heerspink HL; Chalmers J; Woodward M; Jun M; Li Q; Macmahon S; Cooper ME; Hamet P; Marre M; Mogensen CE; Poulter N; Mancia G; Cass A; Patel A; Zoungas S, 2013, 'Intensive glucose control improves kidney outcomes in patients with type 2 diabetes', Kidney International, 83, pp. 517 - 523,
    Journal articles | 2013
    Perkovic V; Woodward M; Zoungas S; Chalmers J, 2013, 'The authors reply', Kidney International, 84, pp. 622,
    Journal articles | 2013
    Perkovic V, 2013, 'Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: Meta-analysis of randomised controlled trials', BMJ (Online), 347,
    Journal articles | 2013
    Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD, 2013, 'ACEIs for cardiovascular risk reduction Have we taken our eye off the ball?', AUSTRALIAN FAMILY PHYSICIAN, 42, pp. 634 - 638,
    Journal articles | 2013
    Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD, 2013, 'ACEIs for cardiovascular risk reduction: Have we taken our eye off the ball?', Australian Family Physician, 42, pp. 634 - 638
    Journal articles | 2013
    Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2013, 'Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials', Nephrology Dialysis Transplantation, 28, pp. 2875 - 2888,
    Journal articles | 2013
    Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2013, 'Erratum: Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials (Nephrology Dialysis Transplantation (2013) 28:11 (2875-2888) DOI: 10.1093/ndt/gft406)', Nephrology Dialysis Transplantation, 28, pp. 3127,
    Journal articles | 2013
    Wong MG; Perkovic V; Woodward M; Chalmers J; Li Q; Hillis GS; Yaghobian Azari D; Jun M; Poulter N; Hamet P; Williams B; Neal B; Mancia G; Cooper M; Pollock CA, 2013, 'Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus', Kidney International, 83, pp. 278 - 284,
    Journal articles | 2013
    Zhu B; Wang Y; Jardine M; Jun M; Lv JC; Cass A; Liyanage T; Chen HY; Wang YJ; Perkovic V, 2013, 'Tripterygium preparations for the treatment of CKD: A systematic review and meta-analysis', American Journal of Kidney Diseases, 62, pp. 515 - 530,
    Journal articles | 2012
    Becker GJ; Wheeler DC; De Zeeuw D; Fujita T; Furth SL; Holdaas H; Mendis S; Oparil S; Perkovic V; Saad Rodrigues CI; Sarnak MJ; Schernthaner G; Tomson CRV; Zoccali C, 2012, 'Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease', Kidney International Supplements, 2, pp. 337 - 414,
    Journal articles | 2012
    Foote C; Ninomiya T; Gallagher M; Perkovic V; Cass A; McDonald SP; Jardine M, 2012, 'Survival of elderly dialysis patients is predicted by both patient and practice characteristics', Nephrology Dialysis Transplantation, 27, pp. 3581 - 3587,
    Journal articles | 2012
    Foote C; Perkovic V; Neal B, 2012, 'Effects of SGLT2 inhibitors on cardiovascular outcomes', Diabetes and Vascular Disease Research, 9, pp. 117 - 123,
    Journal articles | 2012
    Hillis GS; Hata J; Woodward M; Perkovic V; Arima H; Chow CK; Zoungas S; Patel A; Poulter NR; Mancia G; Williams B; Chalmers J, 2012, 'Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus.', Journal of the American Heart Association, 1,
    Journal articles | 2012
    Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J, 2012, 'Prediction of kidney-related outcomes in patients with type 2 diabetes', American Journal of Kidney Diseases, 60, pp. 770 - 778,
    Journal articles | 2012
    Jardine MJ; Kang A; Zoungas S; Navaneethan SD; Ninomiya T; Nigwekar SU; Gallagher MP; Cass A; Strippoli G; Perkovic V, 2012, 'The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: Systematic review and meta-analysis', BMJ (Online), 344,
    Journal articles | 2012
    Jun M; Badve SV; Hawley CM; Pilmore H; White S; Cass A; Perkovic V; Zoungas S, 2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews,
    Journal articles | 2012
    Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster A; Perkovic V, 2012, 'Antioxidants for chronic kidney disease', Cochrane Database of Systematic Reviews
    Journal articles | 2012
    Jun M; Zhu B; Tonelli M; Jardine MJ; Patel A; Neal B; Liyanage T; Keech A; Cass A; Perkovic V, 2012, 'Effects of fibrates in kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 60, pp. 2061 - 2071,
    Journal articles | 2012
    Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B, 2012, 'Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis', Circulation: Cardiovascular Quality and Outcomes, 5, pp. 808 - 818,
    Journal articles | 2012
    Lv J; Neal B; Ehteshami P; Ninomiya T; Woodward M; Rodgers A; Wang H; MacMahon S; Turnbull F; Hillis G; Chalmers J; Perkovic V, 2012, 'Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis', PLoS Medicine, 9,
    Journal articles | 2012
    Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GFM, 2012, 'Antihypertensive agents for preventing diabetic kidney disease', Cochrane Database of Systematic Reviews, 2012,
    Journal articles | 2012
    Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H, 2012, 'Corticosteroid therapy in IgA nephropathy', Journal of the American Society of Nephrology, 23, pp. 1108 - 1116,
    Journal articles | 2012
    Matthews DR; Fulcher G; Perkovic V; de Zeeuw D; Mahaffey KW; Rosenstock J; Davies M; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B, 2012, 'Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes', DIABETOLOGIA, 55, pp. S314 - S315,
    Journal articles | 2012
    McMahon LP; Cai MX; Baweja S; Holt SG; Kent AB; Perkovic V; Leikis MJ; Becker GJ, 2012, 'Mortality in dialysis patients may not be associated with ESA dose: A 2-year prospective observational study', BMC Nephrology, 13,
    Journal articles | 2012
    Palmer SC; Micco LD; Razavian M; Craig JC; Perkovic V; Pellegrini F; Copetti M; Graziano G; Tognoni G; Jardine M; Webster A; Nicolucci A; Zoungas S; Strippoli GFM, 2012, 'Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease:A systematic review and meta-analysis', Annals of Internal Medicine, 156, pp. 445 - 459,
    Journal articles | 2012
    Perkovic V; Neal B, 2012, 'Trials in kidney disease - Time to EVOLVE', New England Journal of Medicine, 367, pp. 2541 - 2542,
    Journal articles | 2012
    Perkovic V; Patil V; Wei L; Lv J; Petersen M; Patel A, 2012, 'Global randomized trials: The promise of India and China', Journal of Bone and Joint Surgery, 94, pp. 92 - 96,
    Journal articles | 2012
    Razavian M; Heeley EL; Perkovic V; Zoungas S; Weekes A; Patel AA; Anderson CS; Chalmers JP; Cass A, 2012, 'Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)', Nephrology Dialysis Transplantation, 27, pp. 1396 - 1402,
    Journal articles | 2012
    Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ, 2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, 17, pp. 433 - 444,
    Journal articles | 2012
    Wong G; Zoungas S; Lo S; Chalmers J; Cass A; Neal B; Woodward M; Perkovic V; Glasziou P; Williams B; Howard K; Chapman JR; Craig JC, 2012, 'The risk of cancer in people with diabetes and chronic kidney disease', Nephrology Dialysis Transplantation, 27, pp. 3337 - 3344,
    Journal articles | 2012
    Zhu B; Jun M; Jardine MJ; Wang YJ; Perkovic V, 2012, 'Haemodialysis duration, frequency and intensity for endstage kidney disease (Protocol)', Cochrane Database of Systematic Reviews,
    Journal articles | 2011
    Badve SV; Brown F; Hawley CM; Johnson DW; Kanellis J; Rangan GK; Perkovic V, 2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, 7, pp. 295 - 300,
    Journal articles | 2011
    Badve SV; Roberts MA; Hawley CM; Cass A; Garg AX; Krum H; Tonkin A; Perkovic V, 2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 58, pp. 1152 - 1161,
    Journal articles | 2011
    Czernichow S; Zanchetti A; Turnbull F; Barzi F; Ninomiya T; Kengne AP; Lambers Heerspink HJ; Perkovic V; Huxley R; Arima H; Patel A; Chalmers J; Woodward M; MacMahon S; Neal B, 2011, 'The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials', Journal of Hypertension, 29, pp. 4 - 16,
    Journal articles | 2011
    Gangadharan komala M; Pianta T; Jardine MJ; Webster A; Perkovic V, 2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients (Protocol)', The Cohrane Collaboratiion, Issue 12, pp. 1 - 11
    Journal articles | 2011
    Huxley RR; Barzi F; Lam TH; Czernichow S; Fang X; Welborn T; Shaw J; Ueshima H; Zimmet P; Jee SH; Patel JV; Caterson I; Perkovic V; Woodward M, 2011, 'Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region', Circulation, 124, pp. 2056 - 2064,
    Journal articles | 2011
    Jun M; Jo J; Perkovic V; Jardine MJ, 2011, 'Managing cardiovascular risk in people with chronic kidney disease: A review of the evidence from randomized controlled trials', Therapeutic Advances in Chronic Disease, 2, pp. 265 - 278,
    Journal articles | 2011
    Lambers Heerspink HJ; Perkovic V; De Zeeuw D, 2011, 'Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials?', Nephron - Clinical Practice, 119,
    Journal articles | 2011
    Lv J; Perkovic V, 2011, 'Blood pressure management in diabetes: A path forward?', Journal of Hypertension, 29, pp. 1283 - 1284,
    Journal articles | 2011
    Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JFE; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Maria Manfreda V; Gentile G; Strippoli GFM, 2011, 'Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro-and macroalbuminuria and other cardiovascular risk factors: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, 26, pp. 2827 - 2847,
    Journal articles | 2011
    Mooney J; Ranasinghe I; Chow C; Barzi F; Zoungas S; Tan T; Perkovic V; Hillis G, 2011, 'Pre-operative Kidney Function as a Predictor of Adverse Outcomes after Surgery—A Systematic Review and Meta-analysis', Heart, Lung and Circulation, 20, pp. S212 - S212,
    Journal articles | 2011
    Perkovic V; Huxley R, 2011, 'Prognostic value of CRP in stable coronary artery disease unclear due to a variety of biases in existing studies, therefore no clinical practice recommendations can be made', Evidence-Based Medicine, 16, pp. 23 - 24,
    Journal articles | 2011
    Zentner D; Hunt D; Chan W; Barzi F; Grigg L; Perkovic V, 2011, 'Prospective evaluation of aortic stenosis in end-stage kidney disease: A more fulminant process?', Nephrology Dialysis Transplantation, 26, pp. 1651 - 1655,
    Journal articles | 2010
    Badve S; Beller E; Cass A; Francis D; Hawley C; Macdougall I; Perkovic V; Johnson D, 2010, 'INTERVENTIONS FOR ERYTHROPOIETIN-RESISTANT ANAEMIA IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW', NEPHROLOGY, 15, pp. 80 - 80,
    Journal articles | 2010
    Badve S; Hawley C; Perkovic V; Cass A; Roberts M, 2010, 'beta-RECEPTOR ANTAGONISTS IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS', NEPHROLOGY, 15, pp. 71 - 71,
    Journal articles | 2010
    Baigent C; Landray M; Reith C; Dasgupta T; Emberson J; Herrington W; Lewis D; Mafham M; Collins R; Bray C; Chen Y; Baxter A; Young A; Hill M; Knott C; Cass A; Feldt-Rasmussen B; Fellström B; Grobbee R; Grönhagen-Riska C; Haas M; Holdaas H; Hooi LS; Jiang L; Kasiske B; Krairittichai U; Levin A; Massy Z; Tesar V; Walker R; Wanner C; Wheeler D; Wiȩcek A; Majoni W; Simpson D; Strony J; Musliner T; Agodoa L; Armitage J; Chen Z; Craig J; De Zeeuw D; Gaziano M; Grimm R; Krane V; Neal B; Ophascharoensuk V; Pedersen T; Sleight P; Tobert J; Tomson C; Sandercock P; Keech A; Whelton P; Yusuf S; Peto R; Parish S; Dolph L; Bahu T; Booth-Davey E; Brewster A; Yau F; Denis E; Frederick K; Haywood D; Heineman J; Howard S; Jayne K; Madgwick Z; Michell S; Murphy K; Ning L; Nolan J; Nunn M; Roberts J; Wickman M; Bowman L; Bulbulia R; Haynes R; Rahimi K; Rahman N; Ait-Sadi R; Barton I; Zhu W; Clark S; Kourellias K; Radley M; Brown K; Worthing D; Coates G; Goodenough B; Lucas N; Carreras A; Currie R; Donaldson O; Fjalling E; Gallagher M; Gibson K; Goddard J; Healy J, 2010, 'Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease', American Heart Journal, 160, pp. 785 - 794,
    Journal articles | 2010
    Gallagher MP; Kelly PJ; Jardine M; Perkovic V; Cass A; Craig JC; Eris J; Webster AC, 2010, 'Long-term cancer risk of immunosuppressive regimens after kidney transplantation', Journal of the American Society of Nephrology, 21, pp. 852 - 858,
    Journal articles | 2010
    Jardine MJ; Ninomiya T; Perkovic V; Cass A; Turnbull F; Gallagher MP; Zoungas S; Lambers Heerspink HJ; Chalmers J; Zanchetti A, 2010, 'Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial', Journal of the American College of Cardiology, 56, pp. 956 - 965,
    Journal articles | 2010
    Jun M; Foote C; Lv J; Neal B; Patel A; Nicholls SJ; Grobbee DE; Cass A; Chalmers J; Perkovic V, 2010, 'Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis', The Lancet, 375, pp. 1875 - 1884,
    Journal articles | 2010
    Jun M; Lambers Heerspink HJ; Ninomiya T; Gallagher M; Bellomo R; Myburgh J; Finfer S; Palevsky PM; Kellum JA; Perkovic V; Cass A, 2010, 'Intensities of renal replacement therapy in acute kidney injury: A systematic review and meta-analysis', Clinical Journal of the American Society of Nephrology, 5, pp. 956 - 963,
    Journal articles | 2010
    Jun M; Zoungas S; Perkovic V; Webster AC, 2010, 'How to read a report of a randomized controlled trial', Nephrology, 15, pp. 153 - 157,
    Journal articles | 2010
    Lambers Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J, 2010, 'Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease', European Heart Journal, 31, pp. 2888 - 2896,
    Journal articles | 2010
    Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J, 2010, 'Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial', Journal of Hypertension, 28, pp. 1141 - 1149,
    Journal articles | 2010
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Tonelli M; Garg AX; Pellegrini F; Ravani P; Jardine M; Perkovic V; Graziano G; McGee R; Nicolucci A; Tognoni G; Strippoli GFM, 2010, 'Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease', Annals of Internal Medicine, 153, pp. 23 - 33,
    Journal articles | 2010
    Perkovic V; Cass A, 2010, 'Glomerular filtration rate and the risk of stroke', BMJ (Online), 341, pp. 739,
    Journal articles | 2010
    Perkovic V; Jun M; Neal B, 2010, 'Authors' reply', The Lancet, 376, pp. 1051 - 1052,
    Journal articles | 2010
    Tsukamoto Y; Jha V; Becker G; Chen HC; Perkovic V; Prodjosudjadi W; Tungsanga K; Wang H; Morad Z, 2010, 'A challenge to chronic kidney disease in Asia: The report of the second Asian forum of chronic kidney disease initiative', Nephrology, 15, pp. 248 - 252,
    Journal articles | 2009
    De Galan BE; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Neal B; Poulter N; Harrap S; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Glasziou P; Grobbee DE; MacMahon S; Chalmers J, 2009, 'Lowering blood pressure reduces renal events in type 2 diabetes', Journal of the American Society of Nephrology, 20, pp. 883 - 892,
    Journal articles | 2009
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J, 2009, 'Cyclosporine withdrawal improves long-term graft survival in renal transplantation', Transplantation, 87, pp. 1877 - 1883,
    Journal articles | 2009
    Heerspink HJL; Ninomiya T; Zoungas S; de Zeeuw D; Grobbee DE; Jardine MJ; Gallagher M; Roberts MA; Cass A; Neal B; Perkovic V, 2009, 'Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials', The Lancet, 373, pp. 1009 - 1015,
    Journal articles | 2009
    Hu J; Jiang X; Li N; Yu X; Perkovic V; Chen B; Zhao L; Neal B; Wu Y, 2009, 'Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: A randomized controlled trial', Hypertension Research, 32, pp. 282 - 288,
    Journal articles | 2009
    Huxley R; Clifton P; Perkovic V; Woodward M; Neal B, 2009, 'How many Australian deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?', Nutrition and Dietetics, 66, pp. 158 - 163,
    Journal articles | 2009
    Huxley R; Lee CMY; Barzi F; Timmermeister L; Czernichow S; Perkovic V; Grobbee DE; Batty D; Woodward M, 2009, 'Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis', Archives of Internal Medicine, 169, pp. 2053 - 2063,
    Journal articles | 2009
    Joshi R; de Galan BE; Chalmers J; Perkovic V; Patel A, 2009, 'Routine blood pressure lowering and intensive glucose control in patiens with type 2 diabetes: The ADVANCE trial', Expert Review of Endocrinology and Metabolism, 4, pp. 111 - 118,
    Journal articles | 2009
    Kang A; Nigwekar SU; Perkovic V; Kulshrestha S; Zoungas S; Navaneethan SD; Cass A; Gallagher MP; Ninomiya T; Strippoli GFM; Jardine MJ, 2009, 'Interventions for lowering plasma homocysteine levels in kidney transplant recipients', Cochrane Database of Systematic Reviews,
    Journal articles | 2009
    Lambers Heerspink HJ; Perkovic V; De Zeeuw D, 2009, 'Renal and cardio-protective effects of direct renin inhibition: A systematic literature review', Journal of Hypertension, 27, pp. 2321 - 2331,
    Journal articles | 2009
    Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF, 2009, 'HMG CoA reductase inhibitors (statins) for dialysis patients.', Cochrane database of systematic reviews (Online)
    Journal articles | 2009
    Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews,
    Journal articles | 2009
    Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Cochrane Database of Systematic Reviews,
    Journal articles | 2009
    Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.', Cochrane database of systematic reviews (Online)
    Journal articles | 2009
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', Cochrane Database of Systematic Reviews,
    Journal articles | 2009
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients.', Cochrane database of systematic reviews (Online)
    Journal articles | 2009
    Navaneethan SD; Perkovic V; Nigwekar SU; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', ,
    Journal articles | 2009
    Nigwekar SU; Cass A; Gallagher MP; Jardine MJ; Kang A; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GFM; Zoungas S, 2009, 'Interventions for lowering plasma homocysteine levels in dialysis patients', Cochrane Database of Systematic Reviews,
    Journal articles | 2009
    Ninomiya T; Perkovic V; De Galan BE; Zoungas S; Pillai A; Jardine M; Patel A; Cass A; Neal B; Poulter N; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; MacMahon S; Chalmers J, 2009, 'Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes', Journal of the American Society of Nephrology, 20, pp. 1813 - 1821,
    Journal articles | 2009
    Ninomiya T; Perkovic V; Verdon C; Barzi F; Cass A; Gallagher M; Jardine M; Anderson C; Chalmers J; Craig JC; Huxley R, 2009, 'Proteinuria and Stroke: A Meta-analysis of Cohort Studies', American Journal of Kidney Diseases, 53, pp. 417 - 425,
    Journal articles | 2009
    O'Seaghdha CM; Perkovic V; Lam TH; McGinn S; Barzi F; Gu DF; Cass A; Suh I; Muntner P; Giles GG; Ueshima H; Woodward M; Huxley R, 2009, 'Blood pressure is a major risk factor for renal death: An analysis of 560 352 participants from the asia-pacific region', Hypertension, 54, pp. 509 - 515,
    Journal articles | 2009
    Perkovic V; Heerspink HL; Ninomiya T; Cass A; Neal B, 2009, 'Blood pressure in dialysis patients-look before we leap - Authors' reply', The Lancet, 373, pp. 1945 - 1946,
    Journal articles | 2009
    White SL; Perkovic V; Cass A; Chang CL; Poulter NR; Spector T; Haysom L; Craig JC; Salmi IA; Chadban SJ; Huxley RR, 2009, 'Is Low Birth Weight an Antecedent of CKD in Later Life? A Systematic Review of Observational Studies', American Journal of Kidney Diseases, 54, pp. 248 - 261,
    Journal articles | 2009
    Zoungas S; De Galan BE; Ninomiya T; Grobbee D; Hamet P; Heller S; MacMahon S; Marre M; Neal B; Patel A; Woodward M; Chalmers J, 2009, 'Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial', Diabetes Care, 32, pp. 2068 - 2074,
    Journal articles | 2009
    Zoungas S; Ninomiya T; Huxley R; Cass A; Jardine M; Gallagher M; Patel A; Vasheghani-Farahani A; Sadigh G; Perkovic V, 2009, 'Systematic review: Sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy', Annals of Internal Medicine, 151, pp. 631 - 638,
    Journal articles | 2008
    Gallagher MP; Webster AC; Jardine MJ; Perkovic V; Cass A; Eris JM, 2008, 'TWENTY YEAR CANCER OUTCOMES OF A RANDOMISED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL', Transplantation, 86, pp. 102 - 102,
    Journal articles | 2008
    Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Arima H; Anderson C; Neal B; Woodward M; Omae T; MacMahon S; Chalmers J, 2008, 'Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial', Kidney International, 73, pp. 963 - 970,
    Journal articles | 2008
    Perkovic V; Cass A; Patel AA; Suriyawongpaisal P; Barzi F; Chadban S; MacMahon S; Neal B, 2008, 'High prevalence of chronic kidney disease in Thailand', Kidney International, 73, pp. 473 - 479,
    Journal articles | 2008
    Perkovic V; Verdon C; Ninomiya T; Barzi F; Cass A; Patel A; Jardine M; Gallagher M; Turnbull F; Chalmers J; Craig J; Huxley R, 2008, 'The relationship between proteinuria and coronary risk: A systematic review and meta-analysis', PLoS Medicine, 5, pp. 1486 - 1495,
    Journal articles | 2008
    Strippoli GFM; Navaneethan SD; Johnson DW; Perkovic V; Pellegrini F; Nicolucci A; Craig JC, 2008, 'Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials', BMJ, 336, pp. 645 - 651,
    Journal articles | 2008
    Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S; Agodoa L; Anderson C; Asselbergs FW; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; Malacco E; Mancia G; Matsuzaki M; Ohkubo T; Ogihara T; Palmer C; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Poulter N; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Suzuki H; Teo K; Van Gilst WH; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A, 2008, 'Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials', European Heart Journal, 29, pp. 2669 - 2680,
    Journal articles | 2008
    Turnbull F, 2008, 'Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: Meta-analysis of randomised trials', BMJ, 336, pp. 1121 - 1123,
    Journal articles | 2008
    White SL; McGeechan K; Jones M; Cass A; Chadban SJ; Polkinghorne KR; Perkovic V; Roderick PJ, 2008, 'Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand', American Journal of Public Health, 98, pp. 1306 - 1313,
    Journal articles | 2007
    Agodoa L; Anderson C; Asseibergs F; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; MacMahon S; Malacco E; Mancia G; Matsuzaki M; Neal B; Nissen S; Ohkubo T; Ogihara T; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Turnbull F; Kostis J; Algert C; Woodward M; Zanchetti A, 2007, 'Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system', Journal of Hypertension, 25, pp. 951 - 958,
    Journal articles | 2007
    Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A, 2007, 'New insights from ADVANCE.', Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 25 Suppl 1
    Journal articles | 2007
    Glasziou P; Alexander J; Beller E; Clarke P; Chalmers J; MacMahon S; Cooper M; Ferrannini E; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Mogensen C; Neal B; Yu Pan C; Patel A; Poulter N; Rodgers A; William B; Woodward M; Collins R; Holman R; Sleight P; Adams M; Branley M; Fulcher G; Jenkins B; Louis D; Lou W; Lowe H; McCormack A; Mitchell P; Ong S; Pollock C; Watson J; Wong T; Allen S; Bompoint S; Carreras A; Chen T; Flynn S; Gibbo S; Han D; Hough S; Jayne K; Joshi R; Kengne AP; Linn J; Monaghan H; Ng R; Perkovic V; Regaglia J; Schmidt M; Xin D; Yufang B; Holloway T; Gray B; Milne A; Adderkin A; Guertin MR; de Guise D; Liyuan M; Reid J; Subramaniam R; Wen W; Williamson K, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, 5,
    Journal articles | 2007
    Perkovic V; Huxley R; Wu Y; Prabhakaran D; MacMahon S, 2007, 'The burden of blood pressure-related disease: A neglected priority for global health', Hypertension, 50, pp. 991 - 997,
    Journal articles | 2007
    Perkovic V; Ninomiya T; Arima H; Gallagher M; Jardine M; Cass A; Neal B; MacMahon S; Chalmers J, 2007, 'Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: Data from the PROGRESS study', Journal of the American Society of Nephrology, 18, pp. 2766 - 2772,
    Journal articles | 2007
    Zentner D; Chan W; Perkovic V; Grigg L; Hunt D, 2007, 'Outcomes of Aortic Stenosis—A Comparison of Dialysis Patients Versus Controls', Heart, Lung and Circulation, 16, pp. S79 - S79,
    Journal articles | 2006
    Chalmers J; Perkovic V; Joshi R; Patel A, 2006, 'ADVANCE: Breaking new ground in type 2 diabetes', Journal of Hypertension, 24,
    Journal articles | 2006
    Chalmers J; Perkovic V; Joshi RC; Patel A, 2006, 'ADVANCE : breaking new ground in type 2 diabetes', Journal of Hypertension (Supplement), 24, pp. S22 - S28
    Journal articles | 2006
    Gallagher M; Perkovic V; Chalmers J, 2006, 'Diuretics: A modern day treatment option? (Review article)', Nephrology, 11, pp. 419 - 427,
    Journal articles | 2006
    Suranyi MG, 2006, 'ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.', Blood Pressure, 15, pp. 340 - 346
    Journal articles | 2005
    Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'The CARI guidelines. Dialysis adequacy (HD) guidelines.', Nephrology (Carlton, Vic.), 10 Suppl 4
    Journal articles | 2005
    Packham DK; Perkovic V; Savige J; Broome MRA, 2005, 'Hematuria in thin basement membrane nephropathy', Seminars in Nephrology, 25, pp. 146 - 148,
    Journal articles | 2005
    2005, 'Blood urea sampling methods', Nephrology, 10,
    Journal articles | 2005
    2005, 'Dialysis membranes', Nephrology, 10,
    Journal articles | 2005
    2005, 'Duration and frequency of haemodialysis therapy', Nephrology, 10,
    Journal articles | 2005
    2005, 'Haemodialysis anticoagulation and adequacy', Nephrology, 10,
    Journal articles | 2005
    2005, 'Water quality for haemodialysis', Nephrology, 10,
    Journal articles | 2003
    Perkovic V; Hewitson TD; Kelynack KJ; Martic M; Tait MG; Becker GJ, 2003, 'Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells', Kidney and Blood Pressure Research, 26, pp. 27 - 33,
    Journal articles | 2003
    Perkovic V; Hunt D; Griffin SV; du Plessis M; Becker GJ, 2003, 'Accelerated progression of calcific aortic stenosis in dialysis patients.', Nephron. Clinical practice, 94,
    Journal articles | 2002
    Kelynack KJ; Hewitson TD; Martic M; Perkovic V; McTaggart S; Becker GJ, 2002, 'LOVASTATIN DOWNREGULATES RENAL MYOFIBROBLAST FUNCTION IN VITRO', Nephrology, 7,
    Journal articles | 2002
    Perkovic V; Hewitson TD; Kelynack KJ; Martic M; Tait MG; Becker GJ, 2002, 'PARATHYROID HORMONE HAS A PROSCLEROTIC EFFECT ON VASCULAR SMOOTH MUSCLE CELLS', Nephrology, 7,
    Journal articles | 2002
    Perkovic V; Hunt D; Griffin SV; Plessis MD; Becker GJ, 2002, 'ACCELERATED PROGRESSION OF CALCIFIC AORTIC STENOSIS IN DIALYSIS PATIENTS', Nephrology, 7, pp. A106 - A106,
    Journal articles | 2002
    Perkovic V; Thomson KR; Becker GJ, 2002, 'Factors affecting outcome after percutaneous renal artery stent insertion', Journal of Nephrology, 15, pp. 649 - 654
    Journal articles | 2002
    Perkovic V; Thomson KR; Becker GJ, 2002, 'LONG TERM OUTCOMES OF STENT INSERTION FOR RENAL ARTERY STENOSIS', Nephrology, 7,
    Journal articles | 2001
    Becker GJ; Perkovic V; Hewitson TD, 2001, 'Pharmacological intervention in renal fibrosis and vascular sclerosis', Journal of Nephrology, 14, pp. 332 - 339
    Journal articles | 2001
    Perkovic V; Thomson KR; Mitchell PJ; Gibson RN; Atkinson N; Field PL; Becker GJ, 2001, 'Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes', Australasian Radiology, 45, pp. 438 - 443,
    Journal articles | 1999
    Perkovic V; Came NA; Grigg AP; Becker GJ, 1999, 'Haemolytic uraemic syndrome and prostatic cancer', Australian and New Zealand Journal of Medicine, 29, pp. 383 - 384,
  • Preprints | 2023
    Jun M; Wick J; Neuen B; Kotwal S; Badve S; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine M; Perkovic V; Gallagher M; Ronksley P, 2023, The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset, ,
    Preprints | 2023
    Neuen B; Jun M; Wick J; Kotwal S; Badve S; Jardine M; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley P, 2023, Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care, ,
    Conference Posters | 2022
    Barratt J; Rovin B; Zhang H; Kashihara N; Maes B; Rizk D; Trimarchi H; Sprangers B; Meier M; Kollins D; Wang W; Magirr A; Perkovic V, 2022, 'POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS', Vol. 7, pp. S236 - S236,
    Conference Abstracts | 2022
    Feng Y; Li Q; Finfer S; Myburgh J; Bellomo R; Perkovic V; Jardine M; Wang AY; Gallagher M; Hong D, 2022, 'POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION', in Kidney International Reports, Elsevier BV, Vol. 7, pp. S8 - S8,
    Conference Abstracts | 2022
    Kim D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Billot L; Zhang H; Perkovic V; Wong MG, 2022, 'EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISONE IN IGA NEPHROPATHY: THE TESTING TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 14 - 14,
    Conference Papers | 2022
    Kolkailah AA; Marx N; Rosenstock J; Johansen OE; Cooper ME; Alexander JH; Toto R; Wanner C; Espeland MA; Mattheus M; Schnaidt S; Perkovic V; Gollop ND; McGuire DK, 2022, 'Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, IL, Chicago, 05 November 2022 - 06 November 2022,
    Conference Abstracts | 2022
    Koshino A; Schechter M; Sen T; Neuen B; Arnott C; Perkovic V; Hansen MK; Heerspink HL, 2022, 'Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial', in DIABETES, AMER DIABETES ASSOC, Vol. 71,
    Conference Abstracts | 2022
    Neuen B; Fletcher R; Arnott C; Vadagunathan M; Perkovic V; Jardine M; Neal B; Mahaffey K; Heerspink H; Pollock C, 2022, 'CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 15 - 15,
    Conference Papers | 2022
    Perkovic V; Baeres F; Bakris G; Bosch-Traberg H; Idorn T; Mahaffey K; Mann J; Mersebach H; Rossing P; Tuttle K; Pratley R, 2022, 'BASELINE CHARACTERISTICS OF THE FLOW TRIAL POPULATION: KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, FRANCE, Paris, pp. I893 - I894, presented at 59th Congress of the European-Renal-Association (ERA), FRANCE, Paris, 19 May 2022 - 22 May 2022,
    Conference Abstracts | 2022
    Perkovic V; Baeres F; Bakris G; Bosch-Traberg H; Idorn T; Mahaffey K; Mann J; Mersebach H; Rossing P; Tuttle K; Pratley R, 2022, 'FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 37,
    Conference Presentations | 2022
    Pratley RE; Baeres FMM; Bakris G; Lawson J; Mahaffey KW; Mann JF; Mersebach H; Rossing P; Tuttle KR; Perkovic V, 2022, 'Baseline Characteristics of Subjects in the Once-Weekly (OW) Semaglutide FLOW Kidney Outcomes Trial',
    Conference Abstracts | 2022
    Schechter M; Koshino A; Jongs N; Neal B; Arnott C; Perkovic V; Hansen MK; Heerspink HJL, 2022, 'Novel subgroups of patients with type 2 diabetes show differential cardiovascular and kidney benefits with canagliflozin: a data-driven proteomic cluster analysis', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S132 - S132, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022,
    Conference Abstracts | 2022
    Tye S; Jong N; Coca SG; Sundstrom J; Arnott C; Neal B; Perkovic V; Vart P; Heerspink HJL, 2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney outcome guided by HbA(1c) and predicted risk of kidney failure', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S278 - S278, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022,
    Conference Abstracts | 2021
    Arnott C; Li JW; Cannon CP; de Zeeuw D; Neuen BL; Heerspink HJL; Charytan DM; Agarwal A; Huffman MD; Figtree GA; Bakris G; Chang TIH; Feng K; Rosenthal N; Zinman B; Jardine MJ; Perkovic V; Neal B; Mahaffey KW, 2021, 'The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial', in Diabetes, Obesity and Metabolism, Vol. 23, pp. 1652 - 1659,
    Preprints | 2021
    Billot L; Monaghan H; Wong MG; Perkovic V, 2021, Statistical Analysis Plan for the Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING), ,
    Conference Abstracts | 2021
    Feng KY; Gogate J; Damaraju CV; Li J; Jardine MJ; Perkovic V; Blais JD; Pfeifer M; Neal B; Mahaffey KW, 2021, 'Canagliflozin Reduces All-cause Hospitalization in Patients with Type 2 Diabetes Mellitus', in METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO-ELSEVIER INC, Vol. 116, pp. 17 - 18,
    Conference Papers | 2021
    Neuen BL; Oshima M; Perkovic V; Arnott C; Bakris G; Cannon CP; Charytan DM; Jardine M; Levin A; Neal B; Pollock C; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 2647 - 2647,
    Conference Papers | 2021
    Perkovic V; Blackorby A; Cizman B; Carroll K; Cobitz A; Davies R; DiMino T; Jha V; Johansen K; Lopes R; Kler L; Macdougall I; McMurray J; Meadowcroft A; Obrador G; Solomon S; Taft L; Wanner C; Waikar SS; Wheeler D; Wiecek AJ; Singh A, 2021, 'ASCEND-ND: STUDY DESIGN AND BASELINE CHARACTERISTICS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, presented at 58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA), ELECTR NETWORK, 05 June 2021 - 08 June 2021,
    Conference Abstracts | 2021
    Perkovic V; Rovin B; Zhang H; Kashihara N; Maes B; Rizk D; Wang W; Meier M; Kollins D; Papachristofi O; Charney A; Barratt J, 2021, 'A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LNP023 IN PRIMARY IGA NEPHROPATHY PATIENTS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 36, pp. 160 - 160, presented at 58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA), ELECTR NETWORK, 05 June 2021 - 08 June 2021,
    Conference Papers | 2021
    Tiku A; Boudville N; Brown F; Cass A; Clarke P; Day R; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Pascoe E; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S; Dalbeth N, 2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373,
    Conference Papers | 2021
    Tuttle KR; Brosius FC; Cavender MA; Fioretto P; Fowler KJ; Heerspink HJL; Manley T; McGuire DK; Molitch ME; Mottl AK; Perreault L; Rosas SE; Rossing P; Sola L; Vallon V; Wanner C; Perkovic V, 2021, 'Sglt2 inhibition for ckd and cardiovascular disease in type 2 diabetes: Report of a scientific workshop sponsored by the national kidney foundation', in Diabetes, pp. 1 - 16,
    Conference Abstracts | 2021
    Wheeler DC; Weir MR; Gogate J; Perkovic V; Mahaffey KW, 2021, 'Effects of canagliflozin on major adverse cardiovascular events by baseline albuminuria: integrated analyses from the CANVAS Program and CREDENCE trial', in DIABETOLOGIA, SPRINGER, Vol. 64, pp. 227 - 227,
    Conference Posters | 2020
    Ferrannini E; Baldi S; Scozzaro T; Tesfaye F; Shaw W; Rosenthal N; Mahaffey KW; Neal B; Perkovic V; Hansen MK, 2020, 'The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020,
    Conference Abstracts | 2020
    Heerspink HJL; Oshima M; Jardine MJ; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Levin A; Mahaffey KW; Neal B; Pollock C; Rosenthal N; Wheeler DC; Zhang H; Perkovic V, 2020, 'Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, Vol. 63, pp. S269 - S269, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020,
    Conference Abstracts | 2020
    Jun M; Jardine M; Heerspink HL; Perkovic V; Badve S; Kotwal S; Gallagher M; Harris K; Chalmers J; Woodward M, 2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22,
    Conference Abstracts | 2020
    Kang A; Arnold R; Gallagher M; Snelling P; Green J; Fernando M; Kiernan M; Hand S; Grimley K; Burman J; Heath A; Rogers K; Bhattacharya A; Smyth B; Bradbury T; Hawley C; Perkovic V; Krishnan AV; Jardine M, 2020, 'THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 11 - 11,
    Conference Abstracts | 2020
    Kang A; Neuen B; Heerspink HL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M, 2020, 'CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 35, pp. 1336 - 1336, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020,
    Conference Abstracts | 2020
    Kang A; Smyth B; Neuen B; Heerspink HL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M, 2020, 'CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 35, pp. 1342 - 1342, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020,
    Conference Abstracts | 2020
    Kotwal S; Mehta Y; Lee V; Mallawarchchi A; Ritchie A; Wong M; Makris A; Badve S; Yong K; Jardine M; Perkovic V; Bose B, 2020, 'GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)', in NEPHROLOGY, WILEY, Vol. 25, pp. 50 - 50,
    Conference Papers | 2020
    Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K, 2020, 'Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency', in American Journal of Kidney Diseases, pp. 84 - 104,
    Conference Posters | 2020
    Li J; Neal B; Heerspink HL; Arnott C; Cannon C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Greene T; Levin A; Oh R; Pollock CA; Wheeler DC; Yavin Y; Zhang H; Zinman B; Di Tanna GL; Perkovic V; Mahaffey KW; Jardine M, 2020, 'Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020,
    Conference Abstracts | 2020
    Li J; Sen T; Neal B; Neuen BL; Perkovic V; de Zeeuw D; Mahaffey KW; Yavin Y; Rosenthal N; Hansen MK; Heerspink HL, 2020, 'Association between the Inflammatory Marker GDF-15 and Kidney Disease Progression: Results from the CANVAS Trial', in DIABETES, AMER DIABETES ASSOC, ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020,
    Conference Abstracts | 2020
    Mahaffey KW; Bakris G; Blais J; Cannon C; Cherney D; Damaraju CV; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Kosiborod M; Levin A; Lingvay I; Weir M; Perkovic V, 2020, 'Effects of canagliflozin on cardiovascular death and hospitalisation for heart failure by eGFR: integrated analyses of the CANVAS Program and CREDENCE', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, Vol. 63, pp. S267 - S268, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020,
    Conference Abstracts | 2020
    Mahaffey KW; Bakris G; Blais J; Cannon CP; Cherney D; Damaraju C; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Kosiborod M; Levin A; Lingvay I; Weir M; Perkovic V, 2020, 'Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 41, pp. 3316 - 3316, presented at European-Society-of-Cardiology (ESC) Congress, ELECTR NETWORK, 29 August 2020 - 01 September 2020,
    Conference Abstracts | 2020
    Mahaffey KW; Li J; Chang T; Sarraju A; Agarwal R; Charytan DM; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Yavin Y; Jardine M; Perkovic V; Cannon GP, 2020, 'Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 41, pp. 1175 - 1175, presented at European-Society-of-Cardiology (ESC) Congress, ELECTR NETWORK, 29 August 2020 - 01 September 2020,
    Conference Papers | 2020
    Mann JFE; Buse JB; Idorn T; Leiter LA; Pratley R; Rasmussen S; Vilsboll T; Wolthers B; Perkovic V, 2020, 'Renoprotection with semaglutide and liraglutide: Direct or indirect effects?', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, pp. S67 - S68, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020,
    Conference Abstracts | 2020
    Neuen B; Mahaffey K; Cannon CP; Jardine M; Heerspink HL; Neal B; Arnott C; Zhou Z; Charytan DM; Agarwal R; Bakris GL; De Zeeuw D; Greene T; Levin A; Wheeler DC; Rosenthal N; Zhang H; Zinman B; Perkovic V; Pollock C, 2020, 'EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 75, pp. 1852 - 1852, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), IL, Chicago, 28 March 2020 - 30 March 2020,
    Conference Papers | 2020
    O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Herrington WG; Herzog CA; Jafar TH; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Wheeler DC; Manns B; Pecoits-Filho R; Harris T; Winkelmayer W; Kleinpeter M; Ju A; Cho Y; Gutman T; Bernier-Jean A; James L; Hamiwka L; Jardine A; Bello A; Stengel B; Schiller B; Johnson D; Bavlovlenkov E; Caskey F; Gillespie B; Block G; Phan HA; Heerspink HL; Madero M; Ruospo M; Unruh M; Laville M; Bansal N; Mark P; Blankestijn PJ; Roy-Chaudhury P; Perlman R; Agarwal R; Mehrotra R; Seliger S; Shafi T; Hiemstra T; Jassal V; Perkovic V; Simplice A; White D; Eilers D; Alexander H; Landry Y; Landry G; Wilkie C, 2020, 'Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop', in American Journal of Kidney Diseases, pp. 109 - 120,
    Conference Presentations | 2020
    Oshima M; Jardine MJ; Agarwal R; Bakris G; Cannon C; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Mahaffey KW; Neal B; Pollock CA; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Perkovic V; Heerspink HL, 2020, 'Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE', presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020,
    Conference Abstracts | 2020
    Sarraju A; Li J; Cannon CP; Chang TI; Agarwal R; Bakris GL; Charytan DM; de Zeeuw D; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey KW, 2020, 'CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 75, pp. 1018 - 1018, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), IL, Chicago, 28 March 2020 - 30 March 2020,
    Conference Abstracts | 2020
    Sen T; Li J; Neal B; Neuen BL; Jardine MJ; Ix J; Shlipak MG; Perkovic V; Yavin Y; Rosenthal N; Hansen MK; Heerspink HL, 2020, 'Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial', in DIABETES, AMER DIABETES ASSOC, ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020,
    Conference Abstracts | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61,
    Conference Abstracts | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60,
    Conference Abstracts | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29,
    Conference Papers | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60,
    Conference Papers | 2020
    Tuttle K; Cherney D; Hadjadj S; Idorn T; Mosenzon O; Perkovic V; Rasmussen S; Wolthers B; Bain SC, 2020, 'EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, pp. 152 - 152, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020,
    Conference Papers | 2020
    Tuttle K; Cherney D; Hadjadj S; Idorn T; Mosenzon O; Perkovic V; Rasmussen S; Wolthers B; Bain SC, 2020, 'REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, pp. 183 - 183, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020,
    Conference Abstracts | 2020
    Young T; Li J-W; Kang A; Heerspink H; Hockham C; Arnott C; Neuen B; Zoungas S; Mahaffey KW; Perkovic V; De Zeeuw D; Fulcher G; Neal B; Jardine M, 2020, 'EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 35, pp. 1351 - 1351, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020, http://dx.doi.org/10.1093/ndt/gfaa142|iii1351
    Conference Posters | 2020
    Zhou Z; Jardine M; Heerspink H; Neuen B; Li Q; Arnott C; Mahaffey K; Perkovic V; Neal B, 2020, 'EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION', Chicago, IL, Vol. 75, pp. 221 - 221, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), Chicago, IL, 28 March 2020 - 30 March 2020,
    Conference Abstracts | 2020
    Zhou Z; Jardine M; Li Q; Lindley R; Neuen B; Cannon CP; De Zeeuw D; Edwards R; Greene T; Levin A; Mahaffey K; Perkovic V; Neal B, 2020, 'EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 75, pp. 215 - 215, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), IL, Chicago, 28 March 2020 - 30 March 2020,
    Conference Abstracts | 2020
    de Zeeuw D; Arnott C; Li J-W; Cannon CP; Neuen BL; Heerspink HJL; Neal B; Charytan DM; Bakris G; Chang T-H; Rosenthal N; Zinman B; Perkovic V; Jardine MJ; Mahaffey KW, 2020, 'The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, Vol. 63, pp. S61 - S62, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020,
    Conference Papers | 2019
    Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris GL; Brenner BM; Charytan D; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine M; Levin A; Li J-W; Neal B; Pollock C; Wheeler D; Zhang H; Zinman B; Mahaffey KW, 2019, 'Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at Scientific Sessions of the American-Heart-Association, PA, Philadelphia, 16 November 2019 - 18 November 2019,
    Conference Abstracts | 2019
    Mahaffey KW; Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; de Zeeuw D; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S340 - S341, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019,
    Conference Papers | 2019
    Marx N; McGuire DK; Johansen O; Rosenstock J; Kahn SE; Cooper ME; Toto R; Wanner C; Pfarr E; Schnaidt SY; George JT; Von Eynatten M; Perkovic V; Zinman B; Alexander JA, 2019, 'First plus recurrent CV and hospitalization events in the CArdiovascular and Renal Microvascular outcomE study with LINAgliptin (CARMELINA) in patients with type 2 diabetes and cardiorenal disease', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, FRANCE, Paris, pp. 3877 - 3877, presented at Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, FRANCE, Paris, 31 August 2019 - 04 September 2019,
    Conference Abstracts | 2019
    Neal B; Li J; Perkovic V; Woodward M; Figtree GA; Heerspink HL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR, 2019, 'An exploration of factors mediating the effects of canagliflozin on heart failure in patients with type 2 diabetes', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S343 - S343, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019,
    Conference Abstracts | 2019
    Neuen BL; Perkovic V; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Oh R; Li Q; Jardine M, 2019, 'Canagliflozin in patients with type 2 diabetes and macroalbuminuria: data from the CANVAS program', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S341 - S342, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019,
    Conference Abstracts | 2019
    Oshima M; Ohkuma T; Neal B; Li Q; De Zeeuw D; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V, 2019, 'DIFFERENT EGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, HUNGARY, Budapest, Vol. 34, pp. 206 - 206, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, HUNGARY, Budapest, 13 June 2019 - 16 June 2019,
    Conference Abstracts | 2019
    Perkovic V; Bain S; Bakris G; Buse J; Gondolf T; Idorn T; Lausvig N; Mahaffey K; Marso S; Nauck M; Pratley R; Rossing P; Zinman B; Mann J, 2019, 'EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, HUNGARY, Budapest, Vol. 34, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, HUNGARY, Budapest, 13 June 2019 - 16 June 2019,
    Conference Abstracts | 2019
    Perkovic V; Bain S; Bakris G; Buse J; Idorn T; Mahaffey K; Marso S; Nauck M; Pratley R; Rasmussen S; Rossing P; Tornoe K; Zinman B; Mann J, 2019, 'EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) - A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, HUNGARY, Budapest, Vol. 34, pp. 205 - U715, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, HUNGARY, Budapest, 13 June 2019 - 16 June 2019,
    Conference Abstracts | 2019
    Perkovic V; Bain S; Bakris G; Buse J; Idorn T; Mahaffey K; Marso S; Nauck M; Pratley R; Rasmussen S; Rossing P; Tornoe K; Zinman B; Mann J, 2019, 'EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, HUNGARY, Budapest, Vol. 34, pp. 338 - 338, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, HUNGARY, Budapest, 13 June 2019 - 16 June 2019,
    Conference Abstracts | 2019
    Perkovic V; Bain SC; Bakris G; Buse JB; Gondolf T; Idorn T; Lausvig N; Mahaffey K; Marso SP; Nauck MA; Pratley R; Rossing P; Zinman B; Mann J, 2019, 'Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S484 - S485, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019,
    Conference Papers | 2019
    Rosenstock J; Kahn SE; Johansen OE; Cooper ME; Marx N; Alexander JH; Toto R; Wanner C; Pfarr E; Schnaidt S; George JT; von Eynatten M; McGuire DK; Perkovic V; Zinman B, 2019, 'Interrelationship between hypoglycemia and CV and mortality outcomes in type 2 diabetes in the CARMELINA Trial', in DIABETES-METABOLISM RESEARCH AND REVIEWS, WILEY, PEOPLES R CHINA, Xiamen, presented at 23rd Scientific Meeting of the Chinese-Diabetes-Society, PEOPLES R CHINA, Xiamen, 20 November 2019 - 23 November 2019,
    Conference Abstracts | 2018
    Haber A; Smyth B; Trongtrakul K; Talbot B; Hawley C; Perkovic V; Woodward M; Jardine M, 2018, 'RELATIVE CONTRIBUTIONS TO MAJOR DIALYSIS RANDOMISED CONTROLLED TRIALS FROM TEN GLOBAL REGIONS', in NEPHROLOGY, WILEY, Vol. 23, pp. 29 - 29,
    Conference Papers | 2018
    McGuire DKK; Alexander JH; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Toto R; Kahn SE; Zinman B; Woerle HJ; Baanstra D; Pfarr E; Schnaidt SY; Meinicke T; von Eynatten M; George JT; Johansen OE; Marx N, 2018, 'Effects of the DPP-4 Inhibitor Linagliptin on Heart Failure Outcomes in Patients With Type 2 Diabetes and Cardio-Renal Disease in CARMELINA', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, pp. E771 - E772, presented at Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium, IL, Chicago, 09 November 2018 - 12 November 2018,
    Conference Papers | 2018
    Ohkuma T; Jun M; Esq MW; Chalmers J; Perkovic V; Rodgers A, 2018, 'Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes-The ADVANCE Trial', in DIABETES, AMER DIABETES ASSOC, FL, Orlando, presented at 78th Scientific Sessions of the American-Diabetes-Association, FL, Orlando, 22 June 2018 - 26 June 2018,
    Conference Abstracts | 2018
    Perkovic V; Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Bakris G, 2018, 'CANAGLIFLOZIN AND RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, TX, Austin, Vol. 71, pp. 574 - 574, presented at Spring Clinical Meeting of the National-Kidney Foundation (NKD), TX, Austin, 10 April 2018 - 14 April 2018,
    Conference Papers | 2018
    Perkovic V; Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine M; Bakris G, 2018, 'Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease', in DIABETOLOGIA, SPRINGER, GERMANY, Berlin, pp. S39 - S39, presented at 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), GERMANY, Berlin, 01 October 2018 - 05 October 2018,
    Conference Abstracts | 2018
    Smyth B; Chan C; Grieve S; Puranik R; Zuo L; Hong D; Gray N; De Zoysa J; Scaria A; Gallagher M; Perkovic V; Jardine M, 2018, 'FACTORS ASSOCIATED WITH REGRESSION OF LEFT VENTRICULAR MASS INDEX IN THE ACTIVE DIALYSIS TRIAL', in NEPHROLOGY, WILEY, Vol. 23, pp. 28 - 28,
    Conference Abstracts | 2018
    Smyth B; Howard K; Zuo L; De Zoysa J; Chan C; Gray N; Cass A; Gallagher M; Perkovic V; Jardine M, 2018, 'IMPACT OF EXTENDED HOURS DIALYSIS ON UTILITY-BASED QUALITY OF LIFE: RESULTS FROM THE ACTIVE DIALYSIS TRIAL', in NEPHROLOGY, WILEY, Vol. 23, pp. 11 - 12,
    Conference Abstracts | 2018
    Smyth B; Van den Broek-Best O; Hong D; Howard K; Rogers K; Gray N; De Zoysa JR; Chan CT; Lin H; Zheng L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M, 2018, 'THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS', in NEPHROLOGY, WILEY, Vol. 23, pp. 28 - 28,
    Conference Papers | 2017
    Mahaffey KW; Neal B; Perkovic V; de Zeeuw D; Fulcher G; Erondu N; Shaw W; Sun T; Desai M; Matthews DR, 2017, 'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, CA, Anaheim, pp. E454 - E455, presented at Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, CA, Anaheim, 11 November 2017 - 15 November 2017,
    Conference Papers | 2017
    Perkovic V; Levin A; Wheeler D; Koitka-Weber A; Mattheus M; George J; von Eynatten M; Wanner C, 2017, 'EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME (R) TRIAL', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, pp. 12 - 12,
    Conference Papers | 2017
    Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Kahn SE; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; George JT; Broedl UC; Woerle H-J; Von Eynatten M; Mcguire DK, 2017, 'CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk', in DIABETES, AMER DIABETES ASSOC, CA, San Diego, pp. A344 - A344, presented at 77th Scientific Sessions of the American-Diabetes-Association, CA, San Diego, 09 June 2017 - 13 June 2017,
    Conference Papers | 2017
    Wanner C; Levin A; Perkovic V; Koitka-Weber A; Mattheus M; von Eynatten M; Wheeler D, 2017, 'EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME (R) TRIAL', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS,
    Conference Papers | 2016
    Baigent C; Herrington WG; Coresh J; Landray MJ; Levin A; Perkovic V; Pfeffer MA; Rossing P; Walsh M; Wanner C; Wheeler DC; Winkelmayer WC; McMurray JJV; Abu-Alfa A; Archdeacon P; Block GA; Caskey FJ; Cheung AK; Cooper B; Craig JC; Dember LM; Eknoyan G; Gansevoort RT; Gill JS; Gillespie B; Greene T; Harris DC; Haynes R; Hemmelgarn BR; Herzog CA; Hiemstra TF; Inker LA; Jardine MJ; Jha V; Jiang L; Johansen KL; Kewalramani R; Lambers Heerspink HJ; Lefkowitz M; Lok CE; Loud F; MaÄiulaitis R; Maddux DW; Maddux FW; Madero M; Mariz S; Mauer M; Nally JV; Nangaku M; Okpechi IG; Parfrey PS; Pecoits-Filho R; Pereira BJG; Rocco MV; Rossignol P; Schaefer F; Tentori F; Thompson A; Tonelli M; Tong A; Toto RD; Tuttle KR; Vetter T; Moon Wang AY; Zannad F, 2016, 'Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference', in Kidney International, Paris, France, pp. 297 - 305, presented at KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology, Paris, France, 08 September 2016 - 11 September 2016,
    Conference Papers | 2016
    Heerspink HJL; Desai M; Jardine M; Meininger G; Perkovic V, 2016, 'Canagliflozin (CANA) Slows Progression of Renal Function Decline Independent of Glycemic Effects', in DIABETES, AMER DIABETES ASSOC, LA, New Orleans, pp. A18 - A18, presented at 76th Scientific Sessions of the American-Diabetes-Association, LA, New Orleans, 10 June 2016 - 14 June 2016,
    Conference Papers | 2016
    Heerspink HJL; Desai M; Jardine M; Meininger G; Perkovic V, 2016, 'Canagliflozin slows progression of renal function decline independent of glycaemic effects', in DIABETOLOGIA, SPRINGER, GERMANY, Munich, pp. S28 - S28, presented at 52nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), GERMANY, Munich, 12 September 2016 - 16 September 2016,
    Conference Papers | 2016
    Hong D; Ren S; Wang A; Jardine M; Li G; Perkovic V, 2016, 'IS IMMUNOSUPPRESSIVE THERAPY BENEFICIAL FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SYSTEMATIC REVIEW AND TRIAL SEQUENTIAL ANALYSIS OF PUBLISHED TRIALS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 112 - 112,
    Conference Papers | 2016
    Kang A; Toyama T; Hirakawa Y; Perkovic V; Jardine M, 2016, 'TRENDS IN THE RELATIVE SURVIVAL OF MIDDLE AGED AND OLDER PEOPLE ON DIALYSIS IN AUSTRALIA', in NEPHROLOGY, WILEY-BLACKWELL, pp. 98 - 98,
    Conference Papers | 2016
    Mallawaarachchi A; Ninomiya T; Laba T; Pearson S; Perkovic V; Jardine M, 2016, 'TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. 119 - 120,
    Conference Abstracts | 2016
    Sukkar L; Hong D; Wong M; Badve S; Rogers K; Perkovic V; Walsh M; Yu X; Hillis G; Gallagher M; Jardine M, 2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 108 - 108,
    Conference Papers | 2016
    Sukkar L; Hong D; Wong MG; Badve SV; Perkovic V; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, AUSTRIA, Vienna, pp. 413 - 413, presented at 53rd ERA-EDTA Congress, AUSTRIA, Vienna, 21 May 2016 - 24 May 2016,
    Conference Papers | 2015
    Liyanage T; Ninomiya T; Wang A; Jun M; Neal B; Wong MG; Jardine M; Hillis G; Perkovic V, 2015, 'EFFECTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, CA, San Diego, pp. A1448 - A1448, presented at Scientific Session of the American-College-of-Cardiology (ACC), CA, San Diego, 14 March 2015 - 16 March 2015,
    Conference Papers | 2014
    Groop P-H; Perkovic V; Cooper M; Crowe S; Lee J; Patel S; Von Eynatten M, 2014, 'Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease', in DIABETES, AMER DIABETES ASSOC, pp. A264 - A264,
    Conference Papers | 2014
    Jardine M; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Perkovic V; Heerspink HL; Wu Y; Yan L; Neal B, 2014, 'DIETARY SODIUM REDUCTION REDUCED ALBUMINURIA IN 1,903 RURAL CHINESE: A CLUSTER RANDOMISED TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. 28 - 28,
    Conference Papers | 2014
    Tong A; Crowe S; Chando S; Cass A; Chadban SJ; Chapman JR; Gallagher M; Gillis J; Hawley C; Hill S; Howard K; Johnson DW; Kerr P; Mathew T; Mckenzie A; Parker D; Polkinghorne K; Perkovic V; Pollock C; Strippoli GFM; Tugwell P; Walker RG; Webster AC; Wilson A; Wong G; Craig JC, 2014, 'RESEARCH PRIORITIES IN CHRONIC KIDNEY DISEASE: A PRIORITY SETTING PARTNERSHIP', in NEPHROLOGY, WILEY-BLACKWELL, pp. 52 - 52,
    Conference Papers | 2013
    Fulcher G; Matthews D; Perkovic V; Mahaffey KW; Weiss R; Rosenstock J; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B, 2013, 'Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Sulfonylurea (SU) Monotherapy: A CANVAS Substudy', in DIABETES, AMER DIABETES ASSOC, pp. A292 - A292,
    Conference Papers | 2013
    Hillis GS; Welsh P; Chalmers J; Chow CK; Perkovic V; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2013, 'High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 301 - 301, presented at Congress of the European-Society-of-Cardiology (ESC), NETHERLANDS, Amsterdam, 31 August 2013 - 04 September 2013,
    Conference Papers | 2013
    Wang A; Al-Kahwa A; Perkovic V; Gallagher M; Hawley C; Jardine M, 2013, 'THE IMPACT OF HAEMODIAFILTRATION, HAEMOFILTRATION AND HAEMODIALYSIS ON CLINICAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 28 - 28,
    Conference Papers | 2012
    Groop P-H; Cooper M; Perkovic V; Emser A; Von Eynatten M; Woerle H-J, 2012, 'Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment for Diabetic Nephropathy', in DIABETES, AMER DIABETES ASSOC, pp. A243 - A243,
    Conference Papers | 2012
    Wang Y; Ivany JN; Barzi F; Perkovic V; Gallagher MP; Jardine MJ, 2012, 'ANTICOAGULANTS FOR PREVENTION OF INTRAVASCULAR CATHETERS MALFUNCTION IN PATIENTS UNDERGOING HEMODIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 31 - 32,
    Conference Papers | 2011
    Cai M; McMahon L; Baweja S; Holt SG; Kent A; Perkovic V; Leikis M; Becker G, 2011, 'AGE AND CO-MORBIDITY, BUT NOT ESA DOSE OR HAEMOGLOBIN, ARE IMPORTANT ASSOCIATIONS WITH MORTALITY IN A PROSPECTIVELY FOLLOWED COHORT OF DIALYSIS PATIENTS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 63 - 63,
    Conference Abstracts | 2011
    Cooper ME; Zoungas S; Jardine M; Hata J; Perkovic V; Ninomiya T; Arima H; Woodward M; Cass A; Hamet P; Marre M; Mogensen CE; Patel A; Chalmers J, 2011, 'Risk of major renal events in people with type 2 diabetes: prediction models based on the ADVANCE study population', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, Vol. 54, pp. S442 - S442, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011,
    Conference Abstracts | 2011
    Jardine M; Hata J; Perkovic V; Ninomiya T; Arima H; Woodward M; Zoungas S; Cass A; Patel A; Marre M; Chalmers J, 2011, 'NEW MODELS FOR THE PREDICTION OF EARLY AND LATE RENAL EVENTS IN TYPE 2 DIABETES', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 16, pp. 61 - 61,
    Conference Papers | 2011
    Jun M; Jardine MJ; Gray N; Masterson R; Kerr PG; Agar JWM; Van Eps C; Hawley CM; Cass A; Gallagher M; Perkovic V, 2011, 'OUTCOMES OF PATIENTS RECEIVING EXTENDED HOURS HAEMODIALYSIS (EHHD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. 63 - 63,
    Conference Abstracts | 2011
    Perkovic V; Zoungas S; Heerspink HL; Woodward M; Jun M; Cass A; Macmahon S; Chalmers J, 2011, 'INTENSIVE GLUCOSE LOWERING AND END STAGE KIDNEY DISEASE - NEW DATA FROM THE ADVANCE TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 16, pp. 42 - 42,
    Conference Papers | 2011
    Wong MG; Qiang L; Min J; Woodward M; Chalmer J; Panchapakesan U; Qi W; Chen X-M; Perkovic V; Pollock C, 2011, 'CIRCULATING BONE MORPHOGENETIC PROTEIN-7 (BMP7) AND TRANSFORMING GROWTH FACTOR-beta 1 (TGF beta 1) AS POTENTIAL BIOMARKERS FOR RENAL ENDPOINTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 24 - 24,
    Conference Abstracts | 2011
    Zoungas S; Lambers Heerspink HJ; Chalmers J; Woodward M; Jun M; Cass A; MacMahon S; Cooper ME; Hamet P; Marre M; Mogensen CE; Perkovic V, 2011, 'Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, Vol. 54, pp. S23 - S23, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011,
    Conference Papers | 2010
    Foote C; Ninomiya T; Gallagher M; Perkovic V; Cass A; McDonald S; Jardine M, 2010, 'FACTORS ASSOCIATED WITH SURVIVAL IN ELDERLY DIALYSIS PATIENTS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 27 - 27,
    Conference Papers | 2010
    Jardine M; Krishnan A; Gallagher M; Snelling P; Hawley C; Pussell B; Suranyi M; Perkovic V; Kiernan M; Eris J, 2010, 'URAEMIC NEUROPATHY REMAINS UBIQUITIOUS: RATIONALE AND FEASIBILITY OF THE FINESSE (FILTRATION IN THE NEUROPATHY OF END STAGE KIDNEY DISEASE SYMPTOM EVOLUTION) TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. 88 - 88,
    Conference Papers | 2010
    Jardine M; Ninomiya T; Cass A; Turnbull F; Gallagher M; Zoungas S; Heerspink HL; Chalmers J; Zanchetti A; Perkovic V, 2010, 'ASPIRIN BENEFIT INCREASES AS eGFR DECLINES: RESULTS FROM A RANDOMISED CONTROLLED TRIAL IN A HYPERTENSIVE POPULATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. 49 - 49,
    Conference Papers | 2010
    Jun M; Jardine M; Gray N; Masterson R; Kerr P; Agar J; van Eps C; Hawley C; Cass A; Gallagher M; Perkovic V, 2010, 'OUTCOMES ASSOCIATED WITH EXTENDED HOURS HAEMODIALYSIS (EHHD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. 38 - 38,
    Conference Papers | 2009
    Heerspink HL; Ninomiya T; Zoungas S; de Zeeuw D; Grobbee DE; Jardine MJ; Gallagher M; Cass A; Neal B; Perkovic V, 2009, 'BLOOD PRESSURE LOWERING REDUCES CARDIOVASCULAR EVENTS AND MORTALITY IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S181 - S181, presented at 19th European Meeting on Hypertension, ITALY, Milan, 12 June 2009 - 16 June 2009,
    Conference Papers | 2009
    Jardine MJ; Ninomiya T; Cass A; Turnbull F; Gallagher MP; Zoungas S; Heerspink HL; Zanchetti A; Chalmers J; Perkovic V, 2009, 'ASPIRIN BENEFIT INCREASES WITH DECLINING RENAL FUNCTION AMONG PEOPLE WITH HYPERTENSION', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S178 - S178, presented at 19th European Meeting on Hypertension, ITALY, Milan, 12 June 2009 - 16 June 2009,
    Conference Papers | 2009
    Kang A; Nigwekar SU; Perkovic V; Zoungas S; Ninomiya T; Navaneethan SD; Gallagher MP; Strippoli G; Cass A; Jardine MJ, 2009, 'EFFECT OF HOMOCYSTEINE LOWERING ON CLINICAL OUTCOMES IN PEOPLE WITH KIDNEY DISEASE: A META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A39 - A40,
    Conference Papers | 2009
    Komala M; Lee N; Cooper B; Coleman P; Shen YY; Mather A; Roxburgh S; Perkovic V; Waugh D; Mcginn S, 2009, 'A COMPARISON OF CT GUIDED VERSUS REALTIME ULTRASOUND GUIDED PERCUTANEOUS RENAL BIOPSY', in NEPHROLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A49 - A49,
    Conference Papers | 2009
    Lambers Heerspink HJ; Ninomiya T; Zoungas S; Patel A; Perkovic V; MacMahon S; Neal B; Woodward M; Chalmers J, 2009, 'THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Sydney, pp. 1502 - 1502, presented at 31st Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Sydney, 01 December 2009 - 03 December 2009,
    Conference Papers | 2009
    Ninomiya T; Zoungas S; de Galan B; Patel A; Perkovic V; Grobbee D; Harrap S; Heller S; Cooper M; Macmahon S; Mancia G; Marre M; Neal B; Woodward M; Chalmers J, 2009, 'THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S179 - S179, presented at 19th European Meeting on Hypertension, ITALY, Milan, 12 June 2009 - 16 June 2009,
    Conference Papers | 2009
    Zoungas S; Ninomiya T; Patel A; Perkovic V; Woodward M; Grobbee D; Harrap S; Macmahon S; Mancia G; Marre M; Mogensen C; Neal B; Poulter N; Williams B; Chalmers J, 2009, 'THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S314 - S314, presented at 19th European Meeting on Hypertension, ITALY, Milan, 12 June 2009 - 16 June 2009,
    Conference Papers | 2008
    Gallagher M; Webster A; Jardine M; Perkovic V; Cass A; Eris J, 2008, 'TWENTY YEAR CANCER OUTCOMES OF A RANDOMIZED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A119 - A119,
    Conference Papers | 2008
    Huxley R; Clifton P; Perkovic V; Woodward M; Neal B, 2008, 'How many deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 603 - 603,
    Conference Papers | 2008
    Ninomiya T; Perkovic V; de Galan BE; Zoungas S; Jardine M; Patel A; Cass A; Neal B; Cooper M; MacMahon S; Chalmers J, 2008, 'INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1115 - 1115, presented at 30th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Melbourne, 03 December 2008 - 05 December 2008,
    Conference Papers | 2008
    Perkovic V; De Galan B; Chalmers J; Ninomiya T; Patel A; Cass A; Cooper M; Neal B; Macmahon S, 2008, 'RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A121 - A121,
    Conference Papers | 2008
    Zoungas S; Perkovic V; Ninomiya T; de Galan B; Pillai I; Patel A; Neal B; Chalmers J, 2008, 'JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1103 - 1103, presented at 30th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Melbourne, 03 December 2008 - 05 December 2008,
    Conference Papers | 2008
    de Galan BE; Chalmers J; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Macmahon S; Neal B; Mogensen C-E; Marre M; Harrap SB; Poulter NR; Cooper ME; Mancia G, 2008, 'Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Berlin, pp. S189 - S189, presented at 18th Scientific Meeting of the European-Society-of-Hypertension/22nd Scientific Meeting of the International-Society-of-Hypertension, GERMANY, Berlin, 14 June 2008 - 19 June 2008,
    Conference Papers | 2007
    Gallagher M; Jardine M; Cass A; McDonald S; Perkovic V; Petrie J; Eris J, 2007, '20 year outcomes of the Australian multicentre randomised trial of cyclosporine withdrawal in renal transplantation.', in AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL PUBLISHING, CA, San Francisco, pp. 206 - 207, presented at Annual American Transplant Congress, CA, San Francisco, 05 May 2007 - 09 May 2007,
    Conference Papers | 2007
    Gallagher M; Jardine M; Cass A; Perkovic V; Petrie J; Mcdonald S; Eris J, 2007, '20 YEAR OUTCOMES OF THE AUSTRALIAN MULTICENTRE RANDOMISED TRIAL OF CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. A19 - A19,
    Conference Papers | 2007
    Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Neal B; Macmahon S; Chalmers J, 2007, 'THE EFFICACY OF LOWER BLOOD PRESSURE GOALS ON THE PREVENTION OF STROKE IN CHRONIC KIDNEY DISEASE: DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31,
    Conference Papers | 2006
    Howard K; Salkeld G; White S; Chadban S; Craig J; Cass A; Mcdonald S; Perkovic V, 2006, 'COST EFFECTIVENESS OF SCREENING FOR THE EARLY DIAGNOSIS AND TREATMENT OF RISK FACTORS FOR CHRONIC KIDNEY DISEASE: A MARKOV MONTE CARLO MICROSIMULATION USING MARCK-E (MODEL FOR THE ASSESSMENT OF RISK FACTORS FOR CHRONIC KIDNEY DISEASE - ECONOMICS)', in NEPHROLOGY, WILEY-BLACKWELL, pp. A9 - A9,
    Conference Papers | 2006
    Lian M; Nicholls K; Perkovic V; Becker G, 2006, 'THE ROLE OF NOCTURNAL HAEMODIALYSIS AND ARTERIAL STIFFNESS', in NEPHROLOGY, WILEY-BLACKWELL, pp. A30 - A30,
    Conference Papers | 2006
    Perkovic V; Algert C; Arima H; Gallagher M; Cass A; Neal B; Macmahon S; Chalmers J, 2006, 'THE PREDICTIVE ABILITY OF DIFFERENT MEASURES OF KIDNEY FUNCTION: NEW DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A46 - A46,
    Conference Papers | 2006
    White S; Mcgeechan K; Jones M; Cass A; Chadban S; Perkovic V; Roderick P, 2006, 'THE RELATIONSHIP BETWEEN CHRONIC KIDNEY DISEASE AND INDIVIDUAL-LEVEL SOCIOECONOMIC FACTORS: THE THREE COUNTRY KIDNEY DISEASE STUDY (3CKD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. A13 - A14,
    Conference Papers | 2005
    Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'Dialysis adequacy (HD) guidelines: Dose of haemodialysis', in Nephrology,
    Conference Papers | 2003
    Masterson R; Leikis M; Perkovic V; Nicholls K; Walker R, 2003, 'Sirolimus: A single center experience in combination with calcineurin inhibitors', in Transplantation Proceedings, pp. S99 - S104,